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Abstract 
The prevalence, and associated burden of type-two diabetes mellitus (T2DM), is rapidly increasing 
globally, and in South Africa, with men and women of all ages being affected. While there has been 
an extensive research into the pathophysiological mechanisms, and to some extent, the management 
of T2DM, healthcare systems are still not able to adequately deal with the increasing number of 
patients being diagnosed with the disease. Professional- and community-led lifestyle interventions 
have recently showed the most promise in combating T2DM. There is however, a paucity of data on 
comprehensive lifestyle interventions in communities of low socio-economic status (SES), where 
the incidence of T2DM and its related complications is high. 
 
The primary aim of this study was to determine the effectiveness of a community-based, 10-week 
lifestyle intervention on physiological, psychological and health-related outcomes in adults 
suffering with T2DM in a low SES community. 
 
Forty-three participants completed the study (age 59.5 ± 12.2 years, 25 Women; 18 Men), of which 
23 made up the experimental group (EXP; BMI: 33.8 ± 7.5; HbA1c: 8.8 ± 2.1) and 20 made up the 
control group (CON; BMI: 34.4 ± 9.7; HbA1c: 9.4 ± 2.3). The control group completed a pre- and 
post-testing session, while experimental completed an additional post-testing retention session. The 
experimental group participated in a 10-week comprehensive lifestyle intervention. A number of 
anthropometric, cardiovascular and functional measurements were carried out, and questionnaires 
related to health-related quality of life (HRQoL), social support, dietary habits and lifestyle 
behaviours, as well as health professional usage were also administered. 
 
Following the 10-week comprehensive lifestyle intervention, there was a positive change in the 
outcome variables measured. There was a statistically significant decrease (p < 0.05) in body fat 
percentage, diastolic blood pressure and HbA1c, with a statistically significant increase in the total 
distance walked during the six-minute walk test (6MWT) (p < 0.05). Furthermore, there was a 
statistically significant improvement (p < 0.05) in all but three of the HRQoL domains. Dietary 
habits and lifestyle behaviours improved significantly (p < 0.05), with the exception of eating times 
where there was no change. The frequency at which the participants actively sought professional 
assistance with the management of their T2DM did not change significantly (p > 0.05). The results 
from the retention period, obtained 10-weeks after the conclusion of the intervention, suggest that 
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the changes as a result of the program were maintained, however, it is uncertain if those results can 
be attributed to the use of the post-intervention guide. 
 
The findings of this study indicate that a 10-week comprehensive lifestyle intervention is effective 
in improving physiological, psychological and health-related outcomes in adults with T2DM living 
in a low SES community. The use of a post-intervention guide as an assistive device to maintain 
these improvements requires further investigation and revision. Furthermore, this study reveals the 
opportunity for community-based interventions to assist the primary healthcare sector in the 
management and prevention of T2DM. 
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Abstrak 
Die toeneemende voorkoms en geassosieerde las van tipe-twee diabetes mellitus (T2DM), global en 
in Suid Afrika, affekteer beide mans en vrouens van alle ouderdomme. Alhoewel daar ekstensiewe 
navorsing gedoen is in patofisologiese meganismes en tot sekere mate die bestuur van T2DM, 
sukkel gesondheidsorg stestels nogsteeds met ‘n toename in pasïente gediagnoseerd met die siekte. 
Onlangs is dit bewys dat professionele- en geemeenskap begeleide leefstyl intervensies toon die 
hoogste potensiaal om T2DM teen te werk. Daar is egter min data oor volledige leefstyl 
intervensies in geemeenskappe van lae-ekonomiese status (LES) waar die voorkoms van T2DM en 
sy verwante komplikasies hoog is. 
 
Die primêre doel van die studie was om die effektiwiteit van ‘n gemeenskap-gebaseerde 10-weke 
leefstyl intervensie op fisiologiese, sielkundige en gesonheids-verwante uitkomste in volwassenes 
met T2DM in LES gemeenskap te bepaal. 
 
Drie en veertig deelnemers het die studie voltooi (ouderdom 59.5 ± 12.2 jaar, 25 Vrouens; 18 
Mans). 23 deelnemers was deel van die eksperimentele groep (EKS; LMI: 33.8 ± 7.5; HbA1c: 8.8 ± 
2.1) en 20 deelnemers het gedien as die kontrole groep (KON; LMI: 34.4 ± 9.7; HbA1c: 9.4 ± 2.3). 
Die kontrole groep het voor en na toetsing vooltooi, terwyl die eksperimentele groep ‘n addisionele 
toetsing na ‘n retensie periode afgelê het. Die eksperimentele groep het deelgeneem in ‘n 10-weke 
volledige leefstyl intervensie. Antropometriese, kardiovaskulêre en funksionele metings is geneem, 
en vraelyste aangaande gesondheids verwante lewens kwaliteit (HRQoL), sosiale bystand, dieet en 
leefstyl gewoontes, asook gebruik van mediese dienste was geadministreer. 
 
Daar was positiewe uitkomsveranderlikes na die 10-weke volledige leefstyl intervensie. Daar was 
‘n statistiese beduidende daling (p < 0.05) in liggaamsvet persentasie, diastoliese bloeddruk, en 
HbA1c, met ‘n statistiese beduidende toename (p < 0.05) in die totale afstand gestap gedurende die 
ses minute stap toets (6MST). Verder, was daar ‘n statistiese beduidende verbetering (p < 0.05) in 
almal behalwe drie van die HRQoL domeine. Dieet en leefstyle gewoontes het statisties beduidende 
verbeter (p < 0.05) met die uitsondering van etenstye waar geen verandering plaasgevind het nie. 
Daar was geen statistiese beduidende verandering (p > 0.05) in die gebruik van mediese dienste om 
T2DM te bestuur nie. Na gelang van die 10-weke retensie periode blyk dit dat die uitkomste van die 
Stellenbosch University  https://scholar.sun.ac.za
vi | P a g e  
 
intervensie behoue gebly het, alhoewel dit onseker is of dit toegesryf kan word aan die oefenings 
handleiding. 
 
Die bevindinge van die studie bewys dat ‘n 10-weke volledige leefstyl intervensie effektief is om 
fisiologiese, sielkundige en gesonheids-verwante uitkomste in volwassenes met T2DM in LES 
gemeenskappe te verbeter. Die oefenings handleiding as ‘n addisionele hulpbron om die verbetering 
te behou verg verdere ondersoek. Die studie toon die geleentheid vir verder gemeenskap 
gebasseerde intervensies om die primêre gesonheidsdiens sektor by te staan met die bestuur en 
voorkoms van T2DM. 
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Chapter 1  
Introduction & Problem Statement 
1.1. Introduction 
Type 2 diabetes mellitus (T2DM) is a life-style related disease of catastrophic proportions and is 
one of the greatest burdens to healthcare systems and providers globally (Laakso & Kuusisto, 
2007). Two clinical subtypes of diabetes exist, namely type 1 diabetes mellitus (T1DM) and T2DM. 
They are clinically different from each other in a number of ways, although they result in a common 
manifestation of high blood glucose levels known as hyperglycaemia. T1DM is characterised by 
insufficient insulin production by the beta cells of the pancreas due to auto-immune destruction of 
the cells. T2DM is characterised by decreased sensitivity to the action of insulin (insulin resistance) 
as a result of abnormally high levels of free fatty acids in the blood stream as well as sustained 
hyperglycaemia. T2DM is a lifestyle-related chronic disease, and while pharmacological action is 
most often utilised, it can be modulated through exercise and dietary interventions, whereas T1DM 
requires exogenous insulin as a treatment modality (Silverthorn, 2007; Srinivasan & Davies, 2014; 
Motahari-Tabari et al., 2015). Chronic hyperglycaemia has a number of associated complications, 
including renal failure (Nolan et al., 2011), neuropathies (Bertram et al., 2013) and the formation of 
atherosclerotic plaques (Laakso & Kuusisto, 2007). 
While the cardiovascular and systemic complications of long-term diabetes have been well 
documented (Yood et al., 2009; Liu et al., 2010; Mcauliffe & Christein, 2013; Umamahesh et al., 
2013), a study by Matsha et al. (2012) also found that the highest cardiovascular disease (CVD) risk 
is in hyperglycaemic individuals. Interestingly, they also found a trend towards increased risk of 
CVD in individuals of normal weight and high glycaemic levels. A common technique of assessing 
a non-fatal disease burden is to calculate years lost to disability (YLD). In South Africa, it was 
found that in 2009, 50 496 YLD could be attributed to diabetes alone, with a further 28 404 YLD 
being attributed to complications that arise as a result of diabetes (Bertram et al., 2013). 
The rise in world-wide urbanisation and consequent changes in lifestyle, are considered a primary 
cause for an increase in diabetes, especially in sub-Saharan Africa (Mbanya et al., 2010). Relative 
to other sub-Saharan countries, South Africa has the highest incidence of diabetes and obesity, with 
prevalence rates as high as 28 % and 45 %, respectively (Kengne et al., 2013). Recent research has 
revealed that of all African countries, South Africa has the second highest incidence rate of 
diabetes, of which most reported cases are under the age of 60 years old (Peer et al., 2014). When 
examining the provincial incidence rates, a study by Erasmus et al. (2012) revealed that in a 
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community with a low socio-economic status in the Western Cape, the prevalence of diabetes and 
the metabolic syndrome was higher than in a similar study conducted 15 years ago in the same 
community (Levitt et al., 1999). These results may be partially attributed to low socioeconomic 
status, considering the link between socioeconomic status and incidence rate of T2DM has been 
well-established, with a lower socioeconomic status being associated with a higher incidence of 
diabetes (Krishnan et al., 2010; Lysy et al., 2013). 
Implementing effective strategies to slow, and hopefully decrease the rise in diabetes prevalence are 
continuously recommended, however, a number of barriers have to be overcome in the process. 
Primary barriers identified are poor communication between the patients and the medical personnel, 
and the overall medical care provided in communities with a low socio-economic status (Pilkington 
et al., 2011; Bhojani et al., 2013; Webb et al., 2014). A more recent approach, based on 
community- or peer-led interventions, has been found to be cost effective when compared to 
standard individualised care, especially in cases where the individuals cannot afford, or do not have 
access to private health care (Prezio et al., 2014). Furthermore, this type of intervention has been 
shown to be globally successful in modulating the physiological, as well as psycho-social 
parameters associated with T2DM (Kontogianni et al., 2012; Weber et al., 2012; Tang et al., 2014; 
Chen et al., 2015; Simmons et al., 2015). With more individuals facing financial hardships, the 
effect of community-based interventions on disease management in low-income populations has 
been the focus of recent research. In resource-limited settings, almost all studies showed 
improvements in a number of diabetes-related parameters, with results comparable to affluent 
research populations (Cleland et al., 2012; Prezio et al., 2013; Tucker et al., 2014; Assah et al., 
2015; McDermott et al., 2015). 
While clinical diabetes research in South Africa is reasonably extensive, community-based research 
is very limited when compared to the volume of research on a global scale. Furthermore, studies on 
socially disadvantaged populations are even scarcer. Only eight community-based studies have 
been conducted to date globally, of which five took place in communities with a low socio-
economic status. Van der Does & Mash (2013) found significant improvements in self-care 
activities after a four-week intervention period in a number of community clinics in a rural town in 
George, in the Western Cape. Katz et al. (2009) examined whether a structured program could 
assist primary health care nurses in accurately identifying and managing diabetic patients in a rural 
setting and once again found encouraging results. They also identified a definite need for proper 
education and even distribution of workload in the health care sector. 
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While there have been positive results coming from the respective studies with respect to overall 
management of the disease, there remain challenges with the community health workers and/or 
individuals who are tasked with implementing the programs. These challenges include language 
barriers, lack of funding, lack of resources and extremely long working hours (Katz et al., 2009; 
Ndou et al., 2013; Van der Does & Mash, 2013; Mash et al., 2014, Mash et al., 2015; Muchiri et 
al., 2015). 
A number of community interventions, both for the prevention and treatment of T2DM, have been 
conducted outside of South Africa. Data from a recent study have shown that a 12-week lifestyle 
intervention program for Arab-Americans was sufficient to cause physiological changes (e.g. 
weight loss) and promote participation in physical activity, which was maintained for at least 24 
weeks following the intervention (Jaber et al., 2011). Studies such as this, as well as additional 
studies examining the long-term effects of lifestyle interventions, formed the theoretical basis upon 
which this study was built (Keyserling et al., 2002; Koniak-Griffin et al., 2015; Pérez-Escamilla et 
al., 2015), with studies examining only one aspect of chronic disease or T2DM management, not 
proving to be as effective (Casey et al., 2010; Wycherley et al., 2012; Muchiri et al., 2015).  
Most T2DM prevention and treatment programs rely on nurses and community health workers for 
their implementation in the community (Gary et al., 2004). Community intervention programs in 
low- to middle-income countries, and communities with a low socio-economic status, have also 
shown promise.  For example, a recent study in uninsured Mexican-Americans illustrated that 
community health-workers were an integral component in a program aimed at reducing HbA1c, 
with significant improvements seen compared to usual care (Prezio et al., 2013). Furthermore, 
Weber et al. (2012) showed that the Diabetes Lifestyle Improvement Program (D-CLIP) is an 
adequate model to use for prevention and treatment of T2DM, as well as other chronic diseases, in 
low- and middle-income countries. 
Exercise interventions are the most widely reported in the literature for both the prevention and 
treatment of diabetes (De Lemos et al., 2012). It has been reported that even in the absence of 
individual lifestyle counselling, exercise and dietary interventions can result in a 50 % reduction in 
the incidence of T2DM (Sanz et al., 2010). While aerobic and resistance exercise have beneficial 
effects on a number of diabetes-related outcomes independently there are a number of studies which 
suggest that combined exercise has the most beneficial effects on glycaemic, lipid and 
cardiovascular parameters (Sigal et al., 2007; Church et al., 2010; Jorge et al., 2011). Furthermore, 
along with exercise, dietary education has been demonstrated to have a positive effect on a number 
of physiological variables, indirectly and directly related to diabetes, such as fasting plasma 
glucose, total serum cholesterol and improved dietary habits (Kontogianni et al., 2012). 
Stellenbosch University  https://scholar.sun.ac.za
4 | P a g e  
 
A very much overlooked aspect of the burden of diabetes is the economic impact on the individuals, 
the community, and country as a whole. Research in this area is limited, and although there is 
general consensus that there is a cost saving associated with diabetes interventions, the magnitude 
thereof varies (Gaziano et al., 2007). 
1.2. Problem statement 
To date, no known studies in South Africa have attempted to establish a comprehensive lifestyle 
intervention program, consisting of dietary, physical activity, and psychological components, in a 
low socio-economic community. Furthermore, although there are numerous prevention and 
treatment programs available, there is a lack of standardised intervention procedures and practices 
that prevent efficient implementation of these programs on a larger scale. While programs such as 
the Diabetes Prevention Program (DPP) have been successfully implemented in the United States 
and Europe, it is challenging to implement these and similar programs in resource-limited settings 
in other parts of the world. There are also a number of unique challenges which are faced by 
community health care workers in South Africa, with only minimal viable alternatives for T2DM 
patients to turn to, which include the costly use of private care, or the use of allied healthcare 
professionals for advice on the management of their disease. These challenges highlight the need 
for further research into structured programs to enhance primary healthcare influences and effects. 
1.3. Potential benefits of the study 
To the researcher’s knowledge, this is the first study in South Africa on the effectiveness of a 
comprehensive lifestyle intervention program in the management of T2DM in a low socio-
economic community. Through comprehensive assessment and intervention, this study hopes to 
make a significant contribution to the overall health and quality of life of individuals in 
Cloetesville, and if successful, persons in a number of low socio-economic communities in 
Stellenbosch and the greater Boland region. However, the results of this study may be applicable to 
low socio-economic communities globally, facing similar limitations in care and infrastructure for 
the prevention, management and treatment of T2DM. Furthermore, the study hopes to show that 
with a comprehensive approach to management of T2DM, it is possible to achieve a long-term 
reduction in the prevalence of T2DM and its associated complications. 
1.4. Primary aim of the study 
To assess the effects of a community-based lifestyle intervention program on the physiological, 
psychological and health-related outcomes of individuals with type 2 diabetes mellitus, in a low 
socio-economic status (SES) community. 
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1.4.1. Research Objective Hypotheses 
 Objective One – A 10-week comprehensive lifestyle intervention will result in significant 
changes in anthropometric, cardiovascular, haematological and functional capacity outcome 
variables.  
 Objective Two – A 10-week comprehensive lifestyle intervention will result in significant 
changes in dietary habits and lifestyle behaviours. 
 Objective Three – A 10-week comprehensive lifestyle intervention will result in significant 
changes in health-related quality of life (HRQoL). 
 Objective Four – A 10-week comprehensive lifestyle intervention will result in significant 
changes in health professional usage behaviour. 
 Objective Five – A post-intervention guide provided following a 10-week comprehensive 
lifestyle intervention will ensure that the significant improvements obtained during the 
program, will be maintained. 
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This literature review aims to outline the literature that currently exists on T2DM in low socio-
economic communities, as well as providing further information on the pathophysiology, risk 
factors and long-term complication of T2DM. The various management strategies and treatment 
options will then be discussed in further detail in order to highlight the necessity of the study in this 
very important field. 
2.2. T2DM in Communities with a Low Socio-Economic Status  
The association between socio economic status (SES) and non-communicable diseases (NCDs) 
such as cardiovascular disease (CVD) and T2DM are well-established, with dietary (Monteiro et 
al., 2004; Shahar et al., 2005) and physical activity behaviours (Boone-Heinonen et al., 2011; Chen 
et al., 2015; Tate et al., 2015) playing the most significant role in adequate management of the 
disease. 
Diet quality and dietary composition are negatively impacted by low SES due to limited access to 
higher quality foods (Inglis et al., 2005), reduced levels of dietary-specific knowledge and 
education (Hiza et al., 2013) and a propensity towards traditional eating-habits and customs (Shahar 
et al., 2005). Irrespective of the reasoning, individuals in low SES communities tend to consume 
less fruits and vegetables (Ball et al., 2015) and therefore have lower levels of vitamin and mineral 
intake (Raffensperger et al., 2010). Furthermore, low SES communities consume higher levels of 
saturated fat, sodium and processed foods than their high SES counterparts (Inglis et al., 2005; 
Shahar et al., 2005; Hiza et al., 2013). The implications for these unfavourable dietary choices were 
highlighted in a study by Salas-Salvadó et al. (2011) where it was reported that reduced 
consumption of vegetables was associated with an increase in inflammatory marker levels, while an 
increased consumption of saturated fat affected insulin action and subsequent sensitivity, both of 
which are hallmark features of T2DM. 
The lower levels of physical activity reported in low SES communities are likely linked to low 
levels of knowledge, self-efficacy and a lack of adequate resources to allow for participation in 
structured physical activity (Chen et al., 2015). These findings were reinforced by a recent study by 
Sundquist et al. (2015) who found an inverse relationship between neighbourhood deprivation, 
which is commonly found in low SES communities, and walkability, which strongly impacted on 
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T2DM prevalence. The same relationship was found between neighbourhood deprivation and 
physical activity in a study by Boone-Heinonen et al. (2011), where it was reported that high 
neighbourhood deprivation resulted in a 16 % decrease in physical activity levels. Considering the 
known link between physical inactivity and the risk of developing T2DM (Peer et al., 2014), the 
findings of these two studies are understandable. Smalls et al. (2015) added further credence to this 
theory, showing that neighbourhood aesthetics significantly impacted on glycaemic control as well 
as self-care activities, with impairments in glycaemic control being secondary to reduced levels of 
self-care. The association between low SES and self-care behaviours have been reported in diabetic 
and non-diabetic populations, with a significant positive association seen in both (Castillo et al., 
2010; Rabie et al., 2015). A recent study conducted in South Africa found that the low levels of 
self-care in low SES communities were related to a lack of adequate knowledge (Rabie et al., 
2015). This finding was also in line with Pampel et al. (2010) who found that knowledge on health 
behaviours and proper management of T2DM was lower in a low-SES group  compared to a high 
SES group. However, a 10-week community health worker (CHW) led program in a low SES 
community showed that by providing knowledge, there was a significant improvement in self-care 
behaviours among participants (Castillo et al., 2010). 
Socio-economic status, or socio-economic position (SEP), seems to be an important predictor of 
T2DM risk, with low SES being associated with T2DM development (Agardh et al., 2011; Lysy et 
al., 2013; Espelt et al., 2014; Felea et al., 2014). However, the true relationship between SES and 
the incidence of T2DM is unclear. Most studies report a higher incidence of T2DM in low-
socioeconomic communities (Connolly et al., 2000; Robbins et al., 2001; Maty et al., 2005; 
Krishnan et al., 2010; Agardh et al., 2011; Lysy et al., 2013; Siddiqui et al., 2015). SES comprises 
of a number of difference components, namely, income, educational level and occupational social 
class. When investigating each of these components separately, an inverse relationship with T2DM 
prevalence and incidence was observed with each of the respective components (Maty et al., 2005; 
Agardh et al., 2011; Lee et al., 2013). However, recent research indicates that this is not always the 
case, with some reports on greater incidence rates in higher socio-economic status communities 
(Peltzer, 2009; Peer et al., 2014).  
What is consistent amongst studies, however, is that urban lifestyle habits are increasing the 
incidence rates of T2DM irrespective of socio-economic status (Soria et al., 2009; Oyebode et al., 
2015; Siddiqui et al., 2015). These include reduced physical activity (Peer et al., 2014) which 
would lead to increases in body mass index (BMI) (Sundquist & Johansson, 1998), and decreased 
glycaemic control (Assah et al., 2011), as well as a higher consumption of refined, processed and 
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high saturated fat and carbohydrate foods, all of which impair insulin functioning (Mbanya et al., 
2010). 
Mumu et al. (2014) found that level of education and employment status was significantly 
associated with an individual’s awareness and understanding of the risks of T2DM, and the 
development thereof. This has a direct translational economic implication as was reported in a study 
by Mantwill & Schulz (2015), where low health literacy and awareness were associated with higher 
healthcare and medication costs, both to the state and the individual suffering from T2DM. 
Furthermore, by improving health literacy and increasing the number of T2DM patients who 
achieve their treatment targets, there is an approximate 70 % reduction in medical costs (Hunt et al., 
2015). 
A number of constraints have been identified that impact on the management and clinical outcomes 
of T2DM in communities with a low SES, including financial constraints, poor communication and 
lack of confidence in healthcare providers, as well as cultural and gender differences (Bhojani et al., 
2013). These underlying constraints could possibly explain the higher incidence of T2DM 
complications in communities with low SES. Numerous studies have confirmed this, with diabetes-
related complications occurring more frequently in communities with low-socioeconomic status, 
with women being more affected than men (Elgart et al., 2014; Collier et al., 2015; Islam et al., 
2015). 
Relative to the number of studies conducted in more affluent communities, there is limited research 
available that examined the various components of managing T2DM in communities with low SES 
(Glazier et al., 2006; Lepard et al., 2015). Progress has been made, however, in identifying 
intervention areas that are different from the main-stream T2DM management programs, which 
include a greater focus on health-related quality of life (HRQoL) (Nejhad et al., 2013), psychosocial 
factors (Walker et al., 2014), behavioural change strategies (Lepard et al., 2015) and a greater 
number of contact sessions between the patient and primary or allied health practitioners (Glazier et 
al., 2006). 
2.3. Basic Pathophysiology of T2DM 
Impaired insulin sensitivity, or insulin resistance, together with pancreatic β-cell dysfunction are the 
hallmarks underlying the pathogenesis of T2DM (Unger, 2012; Kahn et al., 2014; Cornell, 2015). 
There are numerous compounding events that ultimately lead to the above-mentioned cellular 
outcomes (Kahn et al., 2014). Normal glucose homeostasis, or normoglycaemia, is maintained 
through the synergistic actions of a number of hormones and organs (Unger, 2012; Kahn et al. 
2014; Cornell, 2015). For the purposes of this sub-section of the literature review, the integrated 
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processes in the pancreas, liver, brain, skeletal muscle and gastrointestinal tract (GIT), when a non-
diabetic individual ingests food, will be discussed. These processes will then be compared to an 
individual who is suffering from T2DM in order to better understand the pathophysiology and 
progression of the disease.  
When a person consumes food, the production of two hormones in the GIT is up-regulated within 
minutes of the food being ingested in order to start the processes of maintaining glucose 
homeostasis. These hormones, also known as incretins, are glucagon-like peptide-1 (GLP-1) and 
glucose dependent insulinotropic polypeptide (GIP) (Alsahli & Gerich, 2010; Nolan et al., 2011; 
Unger, 2012; Kahn et al., 2014; Cornell, 2015). GLP-1 and GIP up-regulation activates the release 
of insulin from the β-cells in the pancreas, and suppresses glycogenolysis and gluconeogenesis in 
the liver and slow gastric emptying. They also prevent the secretion of glucagon from the α-cells in 
the pancreas and promote the uptake of circulating glucose into adipose tissue and skeletal muscles, 
all in an effort to maintain blood glucose levels between 85 – 140 mg/dL (Alsahli & Gerich, 2010; 
Nolan et al., 2011; Unger, 2012; Kahn et al., 2014; Cornell, 2015). Amylin, leptin and ghrelin act 
on the brain by regulating satiety levels, which will reduce the likelihood of further food 
consumption, thereby aiding in the control of blood glucose levels (Unger, 2012; Cornell, 2015). As 
blood glucose levels drop over time after a meal, circulating levels of GLP-1 and GIP decrease, and 
the subsequent processes these hormones triggered, are down-regulated or up-regulated, thereby 
ensuring that the individual does not fall into a hypoglycaemic state (Alsahli & Gerich, 2010; 
Unger, 2012; Kahn et al., 2014; Cornell, 2015). 
Numerous studies acknowledged that T2DM is a progressive disease that develops over a number 
of years, and is preceded by a number of stages, which ultimately end in T2DM (Alsahli & Gerich, 
2010; McKenney & Short, 2011; Unger, 2012; Cornell, 2015). The first of these stages is the 
boundary between normal glucose tolerance (NGT) and impaired glucose tolerance (IGT), or put 
more simply, the inability of the body to adequately metabolise glucose. In diagnostic settings, an 
oral glucose tolerance test (OGTT) is used to evaluate whether an individual is suffering from IGT.  
As a result of unhealthy lifestyle choices and habits, there is a decrease in insulin sensitivity and β-
cell function. Despite this reduced capacity, blood glucose homeostasis following a meal is 
maintained, as the β-cells are still able to secrete sufficient insulin to promote the uptake of glucose 
into the skeletal muscle and adipose tissue, as well as promoting the hepatic storage of glycogen 
(Alsahli & Gerich, 2010). Without appropriate treatment occurring at this point, there are further 
decreases in β-cell function and a concomitant decrease in insulin sensitivity. The β-cells of the 
pancreas are still able to maintain glucose homeostasis during a fasted state, however, their capacity 
to regulate blood glucose levels after a meal is significantly affected, thereby resulting in sustained 
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elevated levels of blood glucose. Once again, should no treatment regime be implemented at this 
point, there will be a further reduction in β-cell function as well as a further decrease in insulin 
sensitivity. At this stage, due to the reduced β-cell function, blood glucose homeostasis in both the 
fasted and non-fasted state, is disrupted, with sustained hyperglycaemia being reported, and the 
individual being diagnosed with impaired fasting glucose (IFG). The final stage of the disease 
progression is T2DM, which is characterised by further decreases in insulin sensitivity and a 
significant reduction in β-cell functioning. In most cases, by the time of diagnosis, individuals have 
lost 50  - 80 % of their β-cell numbers, thereby making the reversibility of T2DM so challenging, 
while also highlighting the need for early intervention (Alsahli & Gerich, 2010; McKenney & 
Short, 2011; Unger et al., 2011; Cornell, 2015). 
The physiological mechanisms behind the destruction of the β-cells of the pancreas are far-reaching 
and extremely complex, with some areas still under investigation. However, what has been well 
established is that sustained hyperglycaemia and increased levels of circulating free fatty acids 
cause β-cell apoptosis through reactive oxygen species (ROS) and altered gene expression. 
Furthermore, higher levels of pro-inflammatory cytokines, such as tumour necrosis factor α (TNF-
α) and interleukin 1β (IL-1β), decrease β-cell proliferation and increase the rate of apoptosis. 
Interestingly, the incretins (GLP-1 and GIP), which usually facilitate proliferation of the β-cells, are 
less effective in persons with T2DM, and therefore an increase in β-cell apoptosis is seen (Alsahli 
& Gerich, 2010; McKenney & Short, 2011; Nolan et al., 2011; Unger et al., 2011; Cornell, 2015). 
Insulin resistance is the end result of glucotoxicity (Cornell, 2015), in addition to having a large 
genetic component (Henninger et al., 2015). As the name suggest, high levels of blood glucose has 
toxic effects on a number of organs and/or tissues, namely, the liver, muscle and adipose tissue. 
Sustained hyperglycaemia causes destruction and alterations in mitochondrial DNA, which would 
impact significantly on energy metabolism (Zheng et al., 2015). Disruption to mitochondrial energy 
metabolism results in increased levels of free fatty acids (FFA) in the blood stream. These high 
levels of FFA’s alter the intracellular mechanisms of skeletal muscles, which results in diminished 
activity of the glucose transporter type 4 (GLUT4), even when insulin levels are at a concentration 
that should ordinarily elicit a response. Less glucose is therefore taken into the muscle cell, with the 
end result of sustained hyperglycaemia (Yki-Järvinen, 2010; McKenney & Short, 2011; Nolan et 
al., 2011; Unger et al., 2011; Cornell, 2015). In response to this there is a further up-regulation of 
insulin production to combat the hyperglycaemia. This cycle is what results in insulin resistance and 
ultimately, in the latter stages of disease progression, to the destruction of pancreatic β-cells, which 
in turn results in lower insulin secretion and therefore the necessity to use exogenous insulin in 
Stellenbosch University  https://scholar.sun.ac.za
11 | P a g e  
 
addition to oral anti-hyperglycaemic medication (Yki-Järvinen, 2010; McKenney & Short, 2011; 
Nolan et al., 2011; Cornell, 2015).  
Insulin resistance has also been associated with overweight and obesity, and specifically the 
presence of visceral adipose tissue (VAT) (Snel et al., 2012). Insulin promotes the storage of fat, 
with high levels of VAT being associated with higher levels of circulating FFA’s, thereby 
exacerbating the mechanisms described above. 
The role of gene’s cannot be ignored, with numerous studies reporting a familial link to T2DM, as 
well as genetic susceptibility to T2DM as a result of abnormalities in the mitochondrial DNA 
(Emerson et al., 2009; Vaxillaire & Froguel, 2010; Nolan et al., 2011; Rieusset, 2011; Schäfer et 
al., 2011; Unger, 2012; Cheng & Almeida, 2014; Kahn et al., 2014). The pathogenesis of T2DM in 
most individuals is polygenic in origin, with at least 18 single nucleotide polymorphisms (SNP) and 
countless more gene loci being identified that contribute to the development of T2DM through β-
cell dysfunction and intracellular abnormalities, all triggered by environmental factors such as 
obesity, physical inactivity, and dietary habits, to name a few (Vaxillaire & Froguel, 2010; Nolan et 
al., 2011; Rieusset, 2011; Unger, 2012; Cheng & Almeida, 2014; Kahn et al., 2014). There is 
further evidence that in progeny of individuals who had T2DM, adipocyte hypertrophy and 
adipocyte dysfunction was present, in addition to higher measurements of insulin resistance 
(Henninger et al., 2015). 
2.4. Incidence Rates of T2DM 
Type 2 diabetes mellitus is one of the most common NCDs worldwide, with an estimate global 
prevalence of approximately eight percent, or put more crudely, a total of approximately 382 
million people (Ma & Tong, 2010; Wändell & Carlsson, 2013; Wang et al., 2015). What is of 
greater concern, is the growing numbers of children and adolescents that are being diagnosed with 
T2DM (Craig, 2009; Benhalima et al., 2011; Ke et al., 2015). North America (including Canada, 
the United States of America, and Mexico) is collectively the region with the highest global 
prevalence of T2DM (between 10 – 12 %), whereas Saudi Arabia is the country with the highest 
prevalence of T2DM, with 19 % of its population being affected (Ma & Tong, 2010). A number of 
recent studies have also identified Asia as a region of concern, with an exponential rise in T2DM 
diagnoses being reported in both urban and rural populations (Nagaya et al., 2006; Liu et al., 2007; 
Ke et al., 2015; Oyebode et al., 2015; Wang et al., 2015). Furthermore, the once apparent gap 
between urban and rural communities is rapidly diminishing, probably due to westernised 
influences on diet and lifestyle habits (Liu et al., 2007; Motala et al., 2008; Oyebode et al., 2015; 
Siddiqui et al., 2015).  
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In South Africa, the prevalence of T2DM was estimated to be between four and nine percent, and 
the overall prevalence amongst woman was higher than in men (Motala et al., 2008; Peltzer, 2009; 
Peer et al., 2014). In contrast, however, in Middle Africa (e.g. Angola, Cameroon, Congo) and 
Eastern Africa (E.g. Burundi, Ethiopia, Kenya) the prevalence rates of men were found to be higher 
than in women (Hilawe et al., 2013). Possible reasons for these differences were related to lifestyle 
behaviour differences such as alcohol consumption and smoking, differences in the levels of 
physical activity, as well as differences in psychosocial stress (Motala et al., 2008; Peltzer, 2009; 
Hilawe et al., 2013; Peer et al., 2014). 
The economic cost of T2DM to both the affected individual, as well as the public and private 
medical sector, cannot be discounted. Some studies examining Sub-Saharan Africa have reported a 
cost per patient of approximately $ 2 000 - $ 3 000 (approximately R 27 000 – R 41 000) per year, 
which includes in-hospital care and medications, among other services (Kengne et al., 2013; Peer et 
al., 2014). Globally this figure is substantially higher with approximately $ 200 billion being spent 
in the United States of America (USA) alone and with the total global costs approaching $ 400 
billion (Ali et al., 2010). What is encouraging, however, is that a recent study conducted in the 
South African setting outlines a framework upon which a cost-effective prevention program can be 
built in order to combat the rising healthcare costs (Volmink et al., 2014). This framework would 
enhance the working dynamic and cohesion between health professionals in the primary healthcare 
sector, which could result in more favourable patient outcomes. 
2.5. Risk Factors for T2DM 
There are a number of both non-modifiable and modifiable risk factors for the development of 
T2DM. Non-modifiable risk factors are inherent factors that cannot be manipulated to alter the risk 
of developing T2DM, whereas modifiable risk factors can be altered. A large proportion of the 
modifiable risk factors are lifestyle related, with improvements in each of the respective categories, 
resulting in a concomitant improvement in disease management parameters. 
2.5.1. Non-Modifiable Risk Factors 
2.5.1.1. Age 
It has been well established that the risk for developing T2DM increases with advancing age, with 
the current peak incidence rate occurring between 40 and 59 years of age (Chege, 2010; Mbanya et 
al., 2010; Bertram et al., 2013; Peer et al., 2014). This is no different in Southern and South Africa, 
with the highest incidence rate occurring in this age group. When examining the gender differences 
with respect to age, it was found that women tend to develop T2DM at a slightly younger age than 
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their male counterparts, with peak incidence occurring between 35 and 55 years of age (Fletcher et 
al., 2002; Bertram et al., 2013). One possible reason for this occurrence has been postulated to be 
gestational diabetes mellitus (GDM) which affects approximately 20 percent of pregnant women 
(Mohan & Chandrakumar, in press; Hod et al., 2015) and increases the risk of developing T2DM 
following the pregnancy (Wang et al., 2013; Hod et al., 2015). While there is still a higher 
proportion of adults with T2DM relative to adolescents and children, youth onset T2DM is 
becoming more prevalent, with a substantial increase of approximately 35 % over the last decade 
(Peer et al., 2014; Amed, 2015).  
A number of factors contribute to the development of T2DM in later life. First and foremost is the 
effect of poor diet and physical activity habits, which are less prevalent in children and adolescents 
than in adults (Hiza et al., 2013). Secondly, and very importantly, there is the presence of 
mitochondrial dysfunction which impacts on insulin action, increases the levels of ROS, and 
promotes the destruction of the β-cell of the pancreas (Pinkney et al., 2012; Marzetti et al., 2013; 
Lane et al., 2015). 
2.5.1.2. Gender 
There is still no clear indication whether men or women have a higher incidence of T2DM, with a 
number of studies indicating differences by global region (Almdal et al., 2008; Tuei et al., 2010; 
Hilawe et al., 2013). However, studies that have examined precursors to T2DM, namely IGT and 
IFG, found differences in the incidences of T2DM between men and women. In these instances, 
men were found to have a higher incidence of IFG, whereas women have a higher incidence of IGT 
(Hilawe et al., 2013). Possible mechanisms for higher levels of IFG in men are related to lifestyle 
habits, where men are found to be more likely to smoke than women (Townsend et al., 2006) and 
insulin sensitivity purportedly decreases with regular smoking (Nakanishi et al., 2000; Rafalson et 
al., 2009). Furthermore, it has been shown that the eating habits of men are generally poorer than 
that of women, with lower levels of vegetables and higher levels of fats and sugars being consumed 
by men (Hiza et al., 2013). The higher instances of IGT in women are most likely hormonally-
related, with increased levels of oestrogen and progesterone impairing insulin sensitivity (Van 
Genugten et al., 2006). 
2.5.1.3. Family History and Genetic Susceptibility 
There is a growing body of evidence which suggests that a family history of T2DM predisposes an 
individual to developing the disease. This is apparent in a number of studies globally, as well as in 
Southern Africa (Kelestimur et al., 1999; Motala et al., 2008; Emerson et al., 2009; Mbanya et al., 
2010; Nolan et al., 2011; Peer et al., 2014). It appears that underlying genetic predisposition is 
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already present, but is triggered by certain environmental stimuli such as obesity, physical inactivity 
and poor lifestyle habits (Emerson et al., 2009; Nolan et al., 2011). 
A number of different loci have been identified that substantially increase the likelihood of 
developing T2DM in a lifetime, and can be separated into two categories. Firstly, there are loci that 
are implicated in the impairment of β-cell function (GCK and GCKR), while there are also loci that 
are implicated in impaired insulin sensitivity (PPARG and IRS1) (Nolan et al., 2011; Kahn et al., 
2014). Glucokinase (GCK) and glucokinase regulator (GCKR) are two such gene loci that have 
been implicated in the β-cell dysfunction, with defects in these genes resulting in sustained 
hyperglycaemia and resultant β-cell destruction (Gloyn, 2003; Mohás et al., 2010; Ling et al., 
2011). Peroxisome proliferator-activated receptor gamma (PPARG) and insulin receptor substrate-1 
(IRS1) are genes responsible for fatty acid metabolism and insulin action, respectively, with 
mutations within these genes resulting in impaired insulin sensitivity (Rangwala & Lazar, 2004; 
Rung et al., 2009; Bermúdez et al., 2010). 
2.5.1.4. Ethnicity 
Those of Middle Eastern, and Indian descent appear to have the highest risk of developing T2DM, 
with Mexican-Americans having the next highest risk. People of European descent follows, while 
individuals of Black African descent have the lowest risk (Ma & Tong, 2010; Tuei et al., 2010; 
Danaei et al., 2011; Peer et al., 2014; Oyebode et al., 2015). Theories that have been postulated to 
explain these differences include genetic susceptibility, differing levels of urbanisation and 
differences in the various phases of epidemiological transition (Tuei et al., 2010; Choukem & 
Mbanya, 2013; Assah et al., 2015; Oyebode et al., 2015). Recent research on a South African 
population portray a slightly different picture, in which they found that differences in subcutaneous 
adipose tissue (SAT) and VAT between black and white South African women, is the mitigating 
factor in metabolic risk. In a study by Goedecke et al. (2015) it was found that black women with 
ectopic fat distribution had reduced insulin sensitivity when compared to white women who 
presented with the same fat distribution pattern. Additional factors proposed to influence insulin 
resistance in women of African ancestry are differences in adipose glucocorticoid metabolism, and 
adipose tissue inflammation, although more research is needed to substantiate these claims 
(Goedecke et al., 2013). 
2.5.1.5. Uterine Environment 
There is a definitive link between malnutrition during pregnancy and the incidence of T2DM in 
later life (Alsahli & Gerich, 2010; Peer et al., 2014). In addition, sustained hyperglycaemia and 
gestational diabetes have been shown to increase the risk of T2DM in the offspring and future 
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generations (Alsahli & Gerich, 2010; Ma et al., 2015). It is proposed that in both of these 
environments, β-cell development is in some way disrupted, as well as being conditioned to adapt 
should over nutrition occur at a later stage in life (Alsahli & Gerich, 2010; Peer et al., 2014; Ma et 
al., 2015). 
2.5.2. Modifiable Risk Factors 
2.5.2.1. Urbanisation 
Over the last decade, there has been a slow but steady rise in the number of individuals who are 
transitioning from rural to urban areas as places of residence (Muthuri et al., 2014). This change has 
resulted in a number of lifestyle-related challenges, such as reduced occupational and recreational 
physical activity and increased stress levels (Muthuri et al., 2014). Furthermore, changes in 
nutritional habits to more refined and convenience foods are additional compounding factors that 
increase the likelihood of an individual developing T2DM. Interestingly, Mbanya et al. (2010) 
found that those individuals who moved from a rural environment into an urban environment were 
more likely to have a higher BMI than those who had lived in an urban environment for most of 
their life. 
2.5.2.2. Sedentary Behaviour 
While physical inactivity has in the past incorporated sedentary behaviour as part of its global 
definition, there is an overwhelming number of studies that have been published over the last five 
years that provide substantial evidence as to why sedentary behaviour should be considered an 
independent risk factor for the development of T2DM and other NCDs (Healy et al., 2008; Owen et 
al., 2010; Thorp et al., 2011; King et al., 2016). Sedentary behaviour is traditionally measured via 
the use of an accelerometer, and can be quantified depending on the type of activity a person 
engages in (Chastin & Granat, 2010; Quante et al., 2015). These activities could range from sitting 
watching television, extended periods of driving in a vehicle, or sitting for extended periods of time 
as part of an individuals occupation (Owen et al., 2010; Thorp et al., 2011; King et al., 2016). It is 
evident that intermittent bouts of sedentary behaviour are preferable to extended bouts, and have 
shown to be associated with a better metabolic and cardiovascular outcome (Healy et al., 2008; 
Chastin & Granat, 2010). A number of studies have been conducted in T2DM populations, with 
lower levels of sedentary behaviour, in conjunction with increased levels of physical activity have 
shown to improve insulin sensitivity and weight loss over an extended period of time (Lahjibi et al., 
2013; Yates et al., 2015). Furthermore, it was found that men and women with T2DM who had 
higher levels of sedentary behaviour, had significantly higher levels of inflammation compared to 
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those who were found to be less sedentary (Falconer et al., 2014). Pedometer-based studies have 
also been utilised to measure the level of sedentary behaviour, as well as physical activity in T2DM 
populations, with encouraging short- and long-term results with respect to the reduction in 
sedentary behaviours reported (De Greef et al., 2010; De Greef et al., 2011), although increasing 
physical activity will not necessarily result in a concomitant decrease in sedentary behaviour (Wisse 
et al., 2010).  
2.5.2.3. Physical Activity 
Habitual participation in some form of physical activity has been associated with a decreased risk of 
developing T2DM and in some cases up to 34 % reduction in risk was found (Kelestimur et al., 
1999; Bi et al., 2012; Ding et al., 2015). Lower levels of physical activity are further associated 
with higher levels of obesity, as well as a higher incidence of IGT (Mbanya et al., 2010; Peer et al., 
2014). Aside from the impact of low levels of physical activity on the risk of developing T2DM, 
there is a significant increase in the risk of developing other cardiovascular and NCD’s, with a 
higher all-cause mortality rate (Fletcher et al., 2002; Bi et al., 2012; Wu et al., 2014). An important 
finding by Hu et al. (1999) showed that walking may reduce the risk of developing T2DM to the 
same extent as higher intensity exercise, which, considering the high levels of obesity in T2DM 
individuals is encouraging due to the decreased load on the joints, and therefore reduced risk of 
injury.  
The question of whether exercise alone can reduce risk of T2DM when compared to diet and 
exercise combined, has been examined extensively (Pan et al., 1997; Li et al., 2008). In a large 
scale study conducted by Eriksson & Lindgiirde (1991) it was found that only 11 % of the 
participants who took part in the study and received supervised exercise training and dietary advice, 
were diagnosed with T2DM at the five-year follow-up testing, compared to 21 % in the control 
group.  Two long-term studies by Tuomilehto et al. (2001) and Pan et al. (1997) found similar 
results. In the first study, participants diagnosed with IGT were randomised to a physical activity 
and dietary advice group with individualised advice, while the control group received the usual 
care. At a four year follow up, only 10 % of the experimental group had been diagnosed, while 
more than double from the control group were known to be diagnosed with T2DM (Tuomilehto et 
al., 2001). A further follow-up of these participants an additional three years later and in the 
absence of any structured experimental program, found similar findings, with the experimental 
group faring far better than the control group, with an approximately 40 % lower T2DM incidence 
rate (Lindström et al., 2006). In the second study, participants with IGT were randomised into one 
of four groups, control, diet only, exercise only, or combination diet and exercise. At the six-year 
follow up, all three of the experimental conditions resulted in significantly lower incidence rates of 
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T2DM, with the exercise only group showing the lowest incidence in this case (Pan et al., 1997). 
Once again, at an extended follow-up 14 years after the cessation of the trial (i.e. 20 year follow-
up), (Li et al., 2008) found that the incidence rate of the combined intervention groups was 43 % 
lower than that of the control group, with no data provided on the exercise only group. Most of 
these studies worked on the principle adopted by the ACSM that requires individuals to participate 
in at least 150 minutes of moderate to vigorous physical activity per week (American College of 
Sports Medicine, 2014), and suggest that exercise in isolation can result in lowering the risk of 
T2DM. However, long-term follow up studies suggest that a combination of both dietary changes 
and regular physical activity achieves better results.  
2.5.2.4. Adiposity 
In this instance, adiposity refers to the BMI, waist circumference and fat distribution patterns of an 
individual. Obesity (BMI ≥ 30 kg.m-2) has become one of the leading underlying causes of NCD 
world-wide with an estimated prevalence of approximately 30 % (Costanzo et al., 2015). If 
considering individuals who are overweight, or whose waist circumference falls outside of the 
established norms, this prevalence rate increases to almost 70 % (Tuei et al., 2010; McKenney & 
Short, 2011; Costanzo et al., 2015). This is a grievous figure when it is considered that of the over 
300 million people suffering from T2DM, only 15 % would be considered to have a normal weight 
(approximately 45 million people). What is of further concern, is that even at BMI values that are at 
the upper limit of the normal range (23.0 – 24.9 kg.m-2), the risk for the development of T2DM is 
substantially increased (Hauner, 2010; Costanzo et al., 2015). De Onis, et al. (2010) found that by 
2020 almost 10 % of children would be classified as obese, with a prevalence rate of almost 13 % in 
Africa alone. 
Fat distribution patterns are particularly important, considering that VAT has a strong positive 
correlation to the development of T2DM, whereas the correlation to subcutaneous adipose tissue 
(SAT) is smaller and less concrete (Fox et al., 2007). A large-scale study conducted in a South 
African population found that 10 % of men, and almost 50 % of women have a waist circumference 
that is higher than the designated norm by the ACSM for reduced cardiovascular risk, thereby 
indicating a greater degree of VAT (Shisana et al., 2014). This is particularly concerning 
considering that high levels of both VAT and SAT substantially increase the risk of adverse events 
in women more than in men (Fox et al., 2007). In the Southern Africa region, levels of overweight 
and obesity are high, with the prevalence rates between 12 % and 60 % (Mbanya et al., 2010).  
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2.5.2.5. Diet and Lifestyle Behaviours 
Due to the low manufacturing cost associated with processed and refined foods, more and more 
individuals are changing their dietary and lifestyle behaviours in favour of convenience and cost-
effectiveness, while sacrificing healthy choices in the process (Peer et al., 2014). In the South 
African, as well as sub-Saharan African context, there has been a definite shift towards nutrition-
related NCD, otherwise known as a nutrition transition (Abrahams et al., 2011). This is evident in 
the increasing number of individuals classified as overweight or obese, compared to the limited 
number of children born which are classified as underweight. Furthermore, the lack of dietary 
variety and food diversity, as well as lower nutrient content provide further evidence indicating that 
rural South Africans are engaging in non-favourable dietary habits (Abrahams et al., 2011; Steyn et 
al., 2012). Numerous studies have found that high consumption of sugar, refined products, and 
trans-fats are associated with an increased risk of developing T2DM, while consumption of 
monounsaturated fats, fibre and fresh vegetables are associated with a decrease in risk (Itsiopoulos 
et al., 2011; Bi et al., 2012; Kontogianni et al., 2012; Grosso et al., 2014; Cornell, 2015). Relative 
to T2DM, further research should address binge eating as a recent study by Herbozo et al. (2015) 
found that individuals who practiced binge eating had a higher BMI, and were less likely to adhere 
to healthy eating plans. 
Individuals who are diagnosed with IGT are recommended to decrease their total carbohydrate and 
saturated fat intake as a first-line measure to prevent progression to T2DM (Mann et al., 2004; 
Feinman et al., 2014). In most cases, it is the type and amount of carbohydrate consumed that is the 
issue in glycaemic control, and complete elimination of carbohydrate from the diet is not 
recommended (Mann et al., 2004; American Diabetes Association et al., 2008).  
There are a number of variables that could affect glycaemic response and control when consuming 
carbohydrates. These include the type of starch, the manner in which food is prepared, the extent to 
which the food is processed, the macronutrient composition of the meal and whether or not insulin 
resistance is present (American Diabetes Association et al., 2008). The glycaemic index (GI) of 
foods is particularly important for those at risk of developing T2DM, with low GI foods such as 
barley, lentils, legumes and rye bread having a more favourable glycaemic response than high GI 
foods (American Diabetes Association et al., 2008). A lower glycaemic response would place less 
pressure on the pancreatic β-cells to produce insulin and would decrease the pro-inflammatory state 
that hyperglycaemia induces. 
With regards to the consumption of dietary fat, low levels of trans-fat in the diet are associated with 
a better outcome and a lower likelihood of developing T2DM. These improvements would be 
secondary to the reduced levels of plasma low-density lipoprotein cholesterol (LDL-C) with a 
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concomitant increase in high-density lipoprotein cholesterol (HDL-C) concentration, both of which 
would improve insulin function (Howard, 2002; American Diabetes Association et al., 2008; 
Jelinek et al., 2013). Furthermore, consumption of monounsaturated and polyunsaturated fats, 
which are commonplace in the Mediterranean diet, have been shown to improve glycaemic control 
and insulin action through the same method of action as described above (Barnard et al., 2009; 
Esposito et al., 2010; Itsiopoulos et al., 2011; Koloverou et al., 2014). 
The consumption of daily dietary protein, which is nutrient dense, should be approximately 15 % in 
individuals who are at risk of developing T2DM (American Diabetes Association et al., 2008). The 
effect of protein on glycaemic control is related to the increase in serum insulin levels rather than 
the lower glycaemic response (Gannon et al., 2001; Franz, 2002). 
Regular consumption of alcohol, as well as smoking on a regular basis, have been implicated in the 
risk of developing T2DM, with an almost two-fold increase in risk (Kelestimur et al., 1999; 
Molsted et al., 2014; Ding et al., 2015). Two recent studies have reported that those individuals 
who are exposed to passive or environmental smoke are also at risk for developing T2DM, when 
compared to those who are not exposed, providing the evidence that non-smokers are also at risk 
(Ko et al., 2011; Wei et al., 2015). One would expect that following the cessation of smoking there 
would be an improvement in T2DM related parameters. However, even the cessation of smoking 
does not immediately have a direct positive impact on glycaemic control in type 2 diabetics. It has 
been reported that a total of three years of complete abstinence from smoking is required, in order 
to see improvements in glycaemic control (Lycett et al., 2015).  
There seems to be a general consensus that moderate consumption of alcohol protects against the 
development of T2DM due to its ability to enhance insulin sensitivity. However, at high levels, and 
especially when beer and spirits are consumed, there is a substantial increase in the risk of 
developing T2DM (Carlsson et al., 2000; Carlsson et al., 2005; Baliunas et al., 2009). Binge 
drinking is also associated with an increased risk of T2DM development due to the supposed 
damage to the α-cells of the pancreas, which would result in alcoholic ketoacidosis and high levels 
of blood glucose (Prevost et al., 2012). 
2.5.2.6. Psychological Stress 
The presence of depression, and its resulting consequences, have been widely reported in diabetic 
patients, and in the last decade, have also been implicated as a possible risk factor for T2DM 
(Pibernik-Okanovic et al., 2005; Knol et al., 2006; Peer et al., 2014; Ding et al., 2015). The 
mechanism underlying this risk is still being widely debated, however, the hypothalamic-pituitary-
adrenal axis (HPA) seems to play a central role in the pathogenic mechanism (Gragnoli, 2012). 
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Sleep duration, which is indirectly related to depressive symptoms, is also implicated in the risk of 
developing T2DM, with individuals sleeping more than nine hours, or less than six hours being 
equally at risk, while those who slept between seven and eight hours an occasion, had the lowest 
risk (Gutiérrez-Repiso et al., 2014; Cooper et al., 2015; Ding et al., 2015). 
2.6. Long Term-Complications of T2DM 
The long-term effects of living with T2DM are well documented and vary in severity depending on 
the management and complexity of the disease. Some of the most common long-term 
complications, some microvascular and others macrovascular, are discussed in further detail below. 
2.6.1. Peripheral Neuropathy 
Peripheral neuropathy, in all its various forms, is an extremely debilitating complication of T2DM 
and occurs in between 14 and 30 % of type 2 diabetics, and appears to affect women to a greater 
extent than men (Sharma et al., 2010; Ziegler, 2010; Bertram et al., 2013). Only a small percentage 
of these individuals progress to the stage where limb amputations are necessary, however, foot 
ulcerations and neuropathic pain impact significantly on quality of life and increased morbidity (Liu 
et al., 2010; Sharma et al., 2010; Ziegler, 2010; Sobngwi et al., 2012; Salvotelli et al., 2015). The 
pathological mechanisms behind peripheral neuropathy are multifaceted and complex. Increased 
levels of ROS and up-regulation of pro-inflammatory cytokines, reduced expression of 
neuroprotective factors such as nerve growth factor (NGF) and neurotropin-3 and reduced axonal 
transport, as well as alterations to nerve membrane structures, all contribute to the development of 
peripheral neuropathy, as well as its progression (Ziegler, 2010; Tahrani et al., 2012). There are a 
number of pharmacological and non-pharmacological treatment options to reduce the painful 
symptoms associated with peripheral neuropathy (Ziegler, 2010; Tuttle et al., 2012; Shehab et al., 
2015). Vitamin D deficiency has been identified as an independent risk factor for the development 
of peripheral neuropathy (Shehab et al., 2012), with extra supplementation resulting in an 
improvement in symptoms  (Shehab et al., 2015). Exercise has also been reported to be effective in 
reducing the progression of peripheral neuropathy, with an eight-week study by Dixit et al. (2014) 
finding significantly improved nerve conduction velocities, which would ultimately improve the 
individual’s exercise capacity. 
2.6.2. Retinopathy 
The incidence of diabetic retinopathy is slightly lower than peripheral neuropathy, with an overall 
prevalence rate of between 14 and 20 % (Scanlon, 2010; Shaikh et al., 2010). However, it appears 
that up to 50 % of individuals with T2DM suffer to some extent with a reduction in vision (Liu et 
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al., 2010; Scanlon, 2010; Sobngwi et al., 2012). Similar to peripheral neuropathy, the risk of 
developing diabetic retinopathy increases with disease duration and severity (Scanlon, 2010; Shaikh 
et al., 2010; Munch et al., 2011), and is also influenced by plasma homocysteine levels (Looker et 
al., 2003), blood pressure (Abougalambou & Abougalambou, 2015), serum lipid levels (Scanlon, 
2010) and the presence of microalbuminuria (Boelter et al., 2006).  
There are a number of events that occur, some simultaneously, that lead to the eventual 
development of diabetic retinopathy and include endothelial dysfunction characterised by micro 
aneurysms of, and increased permeability of the retinal capillaries (Collier et al., 1986; Joris et al., 
1987; Stitt et al., 1995), smooth muscle death (Malecki et al., 2008) and retinal ischemia secondary 
to capillary occlusion (Gardiner et al., 2007; Scanlon, 2010). Diabetic retinopathy accounts for 
almost one quarter of the cases world-wide where individuals are classified as blind (Cunningham, 
2001). Treatment options are extremely limited in these severe cases, with laser to target the micro 
aneurysms and pharmacological therapies being the only currently used modalities (Scanlon, 2010). 
The mechanism of action of the laser treatment, which is the most successful treatment strategy, is 
thought to be linked to positive histopathological and biochemical changes (Apple et al., 1973; 
Ogata et al., 2001), and an improvement in oxygen delivery to the affected area (Arnarsson & 
Stefánsson, 2000). These benefits have obvious implications on an individual’s HRQoL, allowing 
them to participate in activities that they may not ordinarily consider. 
2.6.3. Cardiovascular and Cerebrovascular Disease 
Cardiovascular diseases such as hypertension and peripheral artery disease (PAD) often occur prior 
to, or following the development of T2DM, and in conjunction with other metabolic diseases 
(Nilsson, 2010). The risk of an adverse cardiac event and/or subsequent death, is increased by two 
to five times in individuals with T2DM, with conflicting evidence as to whether men or women are 
at a greater risk (Nilsson, 2010; Umamahesh et al., 2013; Shah et al., 2015). The incidence of CVD 
and cardiovascular (CV) events varies greatly depending on geographical location, ethnicity and 
socio-economic status (Umamahesh et al., 2013). Lifestyle habits, and not diabetes duration, are the 
main predictors for the development of most CVD (Liu et al., 2010; Sobngwi et al., 2012; 
Umamahesh et al., 2013; Padilla & Peters, 2015). A further cardiovascular complication, which 
occurs exclusively in diabetic patients, is cardiac autonomic neuropathy (CAN), which alters the 
synergistic action of the sympathetic and parasympathetic nervous system on the heart. 
Interestingly, cardiac irregularities are also found in T2DM patients who do not present with CAN 
(Schnell et al., 2002).  
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The global prevalence of cerebrovascular events (CVE) in individuals with T2DM is between four 
and nine percent, despite having a two fold-increase in risk for a CVE when compared to non-
diabetics (Amory & Weinberger, 2010; Liu et al., 2010; Sobngwi et al., 2012). Interestingly, the 
likelihood of a transient ischemic attack (TIA) is lower in persons with T2DM, although the 
progression to a serious CVE is substantially higher (Sobngwi et al., 2012). Furthermore, the 
morbidity and mortality rates following a CVE are higher in type 2 diabetics than their non-diabetic 
counterparts (Weinberger et al., 1983; Tuomilehto et al., 1996; Johnston et al., 2007). The 
pathophysiology underlying the development of cerebrovascular disease in type 2 diabetics is 
multifaceted in nature. Carotid intima-media thickening has been reported in T2DM, and is a 
marker for early stage endothelial dysfunction (Malecki et al., 2008). A strong association between 
stroke risk and thickening of the carotid intima-media exists (Tsivgoulis et al., 2006). This 
thickening, together with impaired nitric oxide (NO) action, and an increased coagulability, all 
predispose an individual to a CVE (Yamada et al., 2000; Air & Kissela, 2007; Taffi et al., 2008). 
2.6.4. Cancer 
There have been a number of studies over the last two decades which have implicated T2DM in the 
risk of developing cancer of the pancreas, colon, liver, bladder and breast (Yood et al., 2009; Noto 
et al., 2010; Krämer et al., 2012; Mcauliffe & Christein, 2013; Gong et al., 2015). The exact 
pathological mechanism behind development of the various cancers is still not completely 
understood, although two hypotheses exist. The first hypothesis is related to the effects insulin has 
on the insulin receptor, insulin-like growth factor 1 (IGF-1) and its respective binding proteins 
(IGFBP-1 and IGFBP-2). It is proposed that by inhibiting IGFBP-1 and IGFBP-2, there are 
increased levels of IGF-1, which would alter the balance of cell proliferation and apoptosis (Yood 
et al., 2009; Gong et al., 2015). A second hypothesis is that sustained hyperglycaemia results in the 
production of ROS, which in turn would damage cellular DNA, which is ultimately the primary 
carcinogenic step (Noto et al., 2013; Gong et al., 2015). Adequate management of T2DM disease 
progression is therefore imperative to reduce the risk of cancer developing. 
2.6.5. Sexual Dysfunction 
Erectile dysfunction (ED) and female sexual dysfunction (FSD) are common occurrences in 
individuals suffering from T2DM, with the prevalence of ED being significantly higher than FSD 
(Giugliano et al., 2010; Giugliano, et al., 2010a). The prevalence of ED in men is between 35 and 
50 %, although in some cases it is as high as 60 %, whereas FSD is observed in approximately 20 % 
of women with T2DM (De Berardis et al., 2007). The prevalence of ED increases with age and 
disease duration, independent of the age-related decrease in testosterone levels (Derosa et al., 
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2015). The pathophysiology underlying ED in men with T2DM is related to failure of NO to induce 
smooth muscle relaxation, and endothelial dysfunction within the corpus cavernosum (Price, 2010). 
FSD is characterised by decreased arousal and lubrication, with a similar pathophysiology to ED, 
although there is still a paucity of data to verify these findings (Giugliano, et al., 2010a; Price, 
2010). Psychological well-being and health related quality of life are significantly affected by 
sexual dysfunction (Litwin et al., 1998; Malavige et al., 2014) and therefore any strategy to 
improve or reverse this complication would have wide-reaching effects into other areas of T2DM 
management. 
2.7. Management of T2DM 
Management of T2DM can be separated into two general categories, with several sub-categories. 
Pharmacological and non-pharmacological management of T2DM usually occur in conjunction 
with one another, although in some cases, one strategy is preferred over the other, and is used in 
isolation. There are a number of factors that ultimately affect the decision of the healthcare provider 
and these include disease severity, patient compliance and readiness to change, as well as resource 
availability. 
2.7.1. Pharmacological Management of T2DM 
The pharmacological management of T2DM is most often conducted through multiple 
pharmacological agents, although in some cases the use of one agent together with lifestyle 
modification is preferred (Chitre & Burke, 2006; Harper et al., 2013; Srinivasan & Davies, 2014; 
He et al., 2015). While there are a multitude of pharmacological agents available for use in T2DM 
patients, most relevant for this study are biguanides, exogenous insulin, sulfonylureas (SU) and 
thiazolidinediones (TZD) as the traditional options, with incretin mimetics and sodium-glucose 
cotransporter-2 (SGLT2) inhibitors as novel pharmacological strategies. 
Of the biguanides, Metformin is the most commonly used first-line therapy in combination with 
lifestyle changes. It has been found to decrease hepatic glucose production, increase insulin 
sensitivity in skeletal muscle and adipose tissue, decrease GIT absorption of glucose, decrease fatty 
acid oxidation and up-regulate the production of GLP-1. The mechanism of action of Metformin is 
not completely understood, however, it is postulated that it acts via the AMP-activated protein 
kinase (AMPK) pathway as well as altering the metabolism of gut microbes (Chitre & Burke, 2006; 
Joshi & Joshi, 2009; Srinivasan & Davies, 2014; Eriksson & Nyström, 2015; He et al., 2015). 
The use of exogenous insulin, in combination with other oral anti-diabetic agents, is a matter of 
debate in the current literature (Harper et al., 2013; Cefalu et al., 2014; Srinivasan & Davies, 2014; 
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Eriksson & Nyström, 2015). The time from initial treatment to the introduction of exogenous 
insulin, varies greatly between two and five years (Machado-Alba et al., 2015). The mechanism of 
action of insulin is well documented, and involves increasing the uptake of glucose into both 
skeletal muscle and adipose tissue cells through increased GLUT4 translocation, as well promoting 
the storage of FFA’s. Through these actions, exogenous insulin is able to mediate hyperglycaemia 
(Srinivasan & Davies, 2014; Eriksson & Nyström, 2015). 
Sulfonylureas exist in two generations, with the second generation SU being preferred due to its 
improved efficacy and safety. SU are insulin secretagogues (promote the secretion of insulin) and 
act by binding to the SU receptor on the pancreatic β-cells that are still functioning. This binding 
closes the ATP-dependent potassium channel (KATP), which in turn depolarises the β-cells, causing 
an influx of calcium (Ca
2+
) into the cell and a subsequent secretion of insulin (Chitre & Burke, 
2006; Joshi & Joshi, 2009; Cefalu et al., 2014; Srinivasan & Davies, 2014; Eriksson & Nyström, 
2015; He et al., 2015). Due to the presence of KATP in other cells of the body (heart, brain, 
endothelium), the safety of first-generation SU were questioned, although the possible negative 
outcomes have been significantly decreased with the development of the second-generation SU 
(Eriksson & Nyström, 2015). 
Thiazolidinediones are usually used in combination with other oral anti-diabetic agents, most 
commonly metformin or SU (Chitre & Burke, 2006; Srinivasan & Davies, 2014). The use of TZD is 
associated with an increase in insulin sensitivity (and therefore a decrease in insulin resistance), and 
a decrease in serum FFA levels. The mechanism of action is believed to occur through activation of 
the peroxisome proliferator-activated receptor γ (PPAR-γ), which is responsible for adipose tissue 
differentiation and insulin gene transcription (Joshi & Joshi, 2009; Srinivasan & Davies, 2014; 
Eriksson & Nyström, 2015; He et al., 2015). Unfortunately, the safety of PPAR-γ full antagonists 
has come into question, therefore the development of PPAR- γ partial antagonists is receiving 
urgent attention. From the results of recent clinical trials, it appears that a number of the PPAR-γ 
partial antagonists have similar, and sometimes greater, efficacies than the full antagonists, and a 
significant reduction in the adverse side-effects associated with long-term use of the drug 
(Chigurupati et al., 2015). 
Incretins were first mentioned in the pathophysiology section above, and were defined as GLP-1 
and GIP. With respect to the pharmacological use of incretin mimetics, GLP-1 receptor agonists 
and dipeptidyl peptidase 4 (DPP-4) inhibitors are novel pharmacological treatment agents used in 
T2DM patients, with improved efficacy and safety outcomes relative to the traditional agents 
discussed above (Nourparvar et al., 2004; Joshi & Joshi, 2009; Cuny et al., 2012). Under normal 
circumstances, GLP-1 and GIP have a very short half-life of two and seven minutes, respectively, 
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and are broken down by DPP-4. However, through the synergistic action of GLP-1 receptor 
agonists and DPP-4 inhibitors, the serum levels of GLP-1 remain elevated for a longer period of 
time, thereby allowing for the beneficial effects to last longer. These include increased insulin 
secretion and suppression of glucagon secretion, increased satiety levels, and delayed gastric 
emptying. Furthermore, pancreatic β-cell proliferation is increased (Nourparvar et al., 2004; Joshi 
& Joshi, 2009; Cuny et al., 2012; Cefalu et al., 2014; Srinivasan & Davies, 2014; He et al., 2015). 
Finally, sodium-glucose cotransporter-2 inhibitors are an additional novel pharmacological 
treatment modality and act by lowering the renal threshold for the excretion of glucose, thereby 
increasing the amount and rate of glucose disposal in the urine. Consequentially there will be a 
decrease in plasma glucose levels and, together with the action of other pharmacological agents, 
there will be an improvement in insulin sensitivity and response (Nourparvar et al., 2004; Cuny et 
al., 2012; Cefalu et al., 2014; Srinivasan & Davies, 2014; He et al., 2015). One of the reported side 
effects, however, is an increase in the prevalence of urinary tract infections (UTIs) and genital 
mycotic infections, with second generation SGLT2 inhibitors being developed to mitigate these 
complications (Cefalu et al., 2014; He et al., 2015). 
2.7.2. Non-Pharmacological Management of T2DM 
Lifestyle changes comprise the non-pharmacological management of T2DM and include various 
forms of exercise modalities as well as dietary management. Comprehensive lifestyle interventions 
are less frequently reported on, although their contribution to the overall management of T2DM 
cannot be discounted. 
2.7.2.1. Aerobic Exercise and the Management of T2DM 
Participation in regular aerobic exercise, irrespective of intensity, has been reported to have 
beneficial outcomes on glycaemic control, diabetes-related complications and HRQoL (Sardar et 
al., 2014; Emerenziani et al., 2015; Motahari-Tabari et al., 2015; Sari-Sarraf et al., 2015). Tessier et 
al. (2000) found that following a 16-week aerobic exercise program of moderate intensity in elderly 
men and women, there was an improvement in overall glycaemia and physical fitness levels. These 
findings were similar to two recent studies conducted in older adults that, in addition to 
improvements in glucose metabolism, also reported improvements in insulin sensitivity and serum 
lipid levels (Lee et al., 2015; Sari-Sarraf et al., 2015). The extent to which exercise influences blood 
lipid levels has been debated, with a meta-analysis by Kelley & Kelley (2007) only showing 
improvements in LDL-C levels. The mechanisms behind these improvements are related to the 
increase in glucose uptake into the actively contracting skeletal muscles, which occurs during 
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exercise and the consequential down-stream effects on insulin action (Lee et al., 2015; Motahari-
Tabari et al., 2015). 
Aside from the benefits to glucose metabolism, aerobic exercise has also been found to have a 
positive influence on endothelial function, ROS and inflammatory processes (Yokoyama et al., 
2004; Nojima et al., 2008; Iyalomhe et al., 2015). An exercise program of moderate intensity and 
conducted over a period of three weeks in older men and women, was found to be sufficient to 
significantly reduce arterial stiffness, an indirect marker of endothelial function (Yokoyama et al., 
2004). However, it was noted that within two days following the cessation of the exercise program, 
the improvements were not present, which suggests that in individuals suffering with T2DM, 
endothelial function can only be improved with constant exercise, possibly due to the damage 
caused by the consistent hyperglycaemia. The relationship between exercise intensity and oxidative 
stress has also been well-documented, with high intensity exercise causing higher levels of 
oxidative stress (Goto et al., 2003). Moderate intensity exercise, however, has been found to reduce 
ROS in type 2 diabetics, with a 12 month exercise program in older adults (men and women) 
showing significant reductions in urinary markers associated with oxidative stress (Nojima et al., 
2008). Chronic inflammation, which accompanies T2DM, is indirectly related to oxidative stress, 
and a recent study by Iyalomhe et al.(2015) found that a six-month exercise training program in 
older men and women of moderate intensity, significantly reduced the production of pro-
inflammatory cytokines, with a subsequent increase in anti-inflammatory molecules, as well as up-
regulation of the genes associated with neural growth and repair. 
The popularity of high intensity interval training (HIIT) for the management of body weight has 
been well documented, however, its use in T2DM patients is scarcely reported (Earnest, 2008; 
Terada et al., 2013; Cockcroft et al., 2015). Terada et al. (2013) found that compared to the more 
traditional moderate exercise intensity regimes, a HIIT program in older men and women was a 
feasible and effective treatment strategy in the management of T2DM. These findings were 
corroborated by three other studies where HIIT resulted in improvements in glucose metabolism, 
insulin sensitivity and cardiovascular functioning (Earnest, 2008; Drigny et al., 2013; Cockcroft et 
al., 2015). These improvements are related to cardiovascular adaptations (Drigny et al., 2013), 
improvements in mitochondrial enzyme functioning and an increase in beta oxidation (Earnest, 
2008; Cockcroft et al., 2015). 
Peripheral neuropathy is one of the most common complications associated with T2DM as alluded 
to in an above section.  Dixit et al. (2014) found that after eight weeks of moderate intensity 
exercise, there was significant improvement in nerve conduction velocity in a group of older men 
and women. The practical benefits thereof were reported by Morrison et al. (2014), where a 12 
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week exercise program for patients with peripheral neuropathy, and of a similar age group as the 
above-mentioned study, resulted in improvements in balance and reaction time, and favourable 
changes in gait directly related to fall risk. These improvements were linked to improvements in 
postural control and proprioceptive improvements (Morrison et al., 2014), with the improvements 
in nerve conduction velocity being attributed to improvements in the action of NO on the 
endothelium and a decrease in the production of protein kinase C (Dixit et al., 2014). 
A ground-breaking study has recently published data which could explain why certain individuals 
with T2DM respond to exercise programs, while others do not, even when they are matched 
(Stephens et al., 2015). The difference appears to be genetic in nature, with a form of “exercise 
resistance” found in the transcriptional profile of skeletal muscle in non-responders (Stephens et al., 
2015). Muscle fuel metabolism is what differentiates those who respond, versus those who don’t, 
therefore, dietary modifications may be of more benefit in these individuals. Furthermore, gene 
therapy may be indicated in future cases where all forms of traditional treatment options are 
exhausted (Stephens et al., 2015). 
2.7.2.2. Resistance Exercise and the Management of T2DM 
There is a paucity of data with respect to resistance exercise and the effects it has in managing 
T2DM outcomes, with aerobic exercise being researched far more often (Morais et al., 2011; Yang 
et al., 2014). The effects of both acute and chronic resistance training on blood pressure in T2DM 
patients have been studied extensively over the last decade, with conflicting results, although a 
number of authors suggest that methodological differences are to blame. However, it seems that 
resistance exercise exerts beneficial effects on both SBP and DBP, although not to the same extent 
as aerobic training (Morais et al., 2011; Figueira et al., 2014). There is contradictory evidence with 
respect to the effect of resistance training (RT) on insulin sensitivity, with some studies indicating 
that RT improves insulin sensitivity (Earnest et al., 2014; Abouassi et al., 2015), while others 
indicate that it has little or no effect (Jorge et al., 2011; Yang et al., 2014). Contrary to this, the 
effect that RT has on glycaemic control is reasonably clear cut, with a number of authors reporting 
decreases in HbA1c, fasting plasma glucose and a better glucose tolerance (Maiorana et al., 2002; 
Sigal et al., 2007; Church et al., 2010). Similarly to blood pressure though, while resistance 
exercise appears to exert beneficial effects on these parameters, the magnitude of the effect is still 
greater with aerobic training (Sénéchal et al., 2014; Yang et al., 2014). Finally, resistance exercise 
has been found, in some cases, to improve the lipid profile of T2DM patients by up-regulating lipid 
metabolism.  
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As was the case with a number of the above-mentioned outcomes, results are conflicting and more 
research into the effects of resistance exercise on T2DM parameters are needed (Gavin et al., 2010; 
Jorge et al., 2011). These conflicting results seem to be due mostly to methodological differences, 
with large discrepancies in the intensity of exercise, the duration of the program and the overall-
make up of the exercise sessions. However, irrespective of these differences, it appears that 
resistance training can be successful in managing the glycaemic parameters of T2DM. 
2.7.2.3. Combination Exercise and the Management of T2DM 
Recent research into the management of T2DM through exercise has shifted away from a unimodal 
exercise philosophy (only aerobic or resistance exercise) to one of combination exercise, with a 
number of studies showing promising results (Balducci et al., 2010; Figueira et al., 2014; Ades et 
al., 2015). However, one of the potential drawbacks to combination exercise as reported by Earnest 
et al. (2014), is that the amount of time required to exercise is substantially more and may influence 
adherence to a structured exercise program.  
Similarly to what was found with both aerobic and resistance exercise, combination exercise 
training has been found to have beneficial effects on endothelial function, and a subsequent 
improvement in both systolic and diastolic blood pressure. While the magnitude of the difference is 
in some cases greater than in either aerobic or resistance training alone, there are still conflicting 
reports, with some authors showing almost no change (Maiorana et al., 2001; Jorge et al., 2011; 
Figueira et al., 2014). Once again, the conflicting reports seem to be due to the large 
methodological differences with respect to program design and duration, with no standardised 
programs set for combination exercise in T2DM individuals.  
 Combination exercise was found to significantly improve insulin signalling in skeletal muscle by 
up-regulating IRS-1 expression (Jorge et al., 2011). The effect of combination exercise on insulin 
sensitivity is detailed in a study by AbouAssi et al. (2015), where it was found that an eight month 
combination (resistance and aerobic) training program was significantly more effective than either 
aerobic or resistance training alone. With respect to glycaemic control and lipid metabolism, 
combination exercise was found to be more effective than either aerobic or resistance training in 
isolation, which is hypothesised to occur due to the synergistic action of both training modalities 
(Balducci et al., 2010; Balducci et al., 2015; Ades et al., 2015). Furthermore, cardiovascular fitness, 
as measured by VO2max or time to exhaustion, was found to improve to a greater extent with 
combination exercise compared to either aerobic or resistance exercise alone (Maiorana et al., 2002; 
Earnest et al., 2014). 
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2.7.2.4. Role of Dietary Control in the Management of T2DM 
Dietary management of T2DM is a contentious issue and has been debated extensively by 
researchers over the last 50 years (Feinman et al., 2014; Moosheer et al., 2014; Campbell & Rains, 
2015). The first line of defence in dietary control has commonly been to reduce carbohydrate intake 
and is the most commonly used strategy in individuals recently diagnosed with T2DM today 
(Feinman et al., 2014). However, a number of additional strategies have been implemented over the 
years, either in combination with a low carbohydrate diet, or as a stand-alone treatment (Barnard et 
al., 2009; Hussain et al., 2012; Campbell & Rains, 2015). A study by Von Bibra et al. (2014) that 
investigated the effects of a low-carbohydrate/high-protein (LC/HP) diet on cardiac function and 
metabolic outcomes in older adults with T2DM, indicated that a LC/HP diet had a significant 
positive impact on cardiac function, insulin resistance and the risk of developing cardiovascular and 
metabolic complications.  
The effect of a high protein diet on glycaemic control, anthropometric outcomes and cardiovascular 
risk was reported in two studies conducted in older men and women by Moosheer et al. (2014) and 
Campbell & Rains (2015), where it was found that a high protein diet, supplemented with 
polyunsaturated fatty acids (PUFAs), significantly reduced HbA1c, waist circumference and fat 
mass, as well as inflammatory markers associated with CVD. Similar findings were reported by 
Jelinek et al. (2013) in an animal-model study, where a high-fat diet supplemented by fish oil 
resulted in significant improvements in glycaemic control and a reduction in inflammatory 
cytokines related to CVD risk. The use of the Mediterranean diet in the treatment regime of T2DM 
is not new, with a number of studies showing improvements in glycaemic control, insulin resistance 
and cardiovascular risk (Esposito et al., 2010; Itsiopoulos et al., 2011; Salas-Salvadó et al., 2011; 
Grosso et al., 2014).  
Of interest, is the timing of meals, and when the most calorie intensive meal is eaten. Jakubowicz et 
al. (2015) reported significantly better glycaemic control and insulin sensitivity in individuals who 
ate a high-energy breakfast versus a high-energy supper. What was of further importance is that 
those who missed breakfast on a regular basis had a higher cardiovascular risk and poorer 
glycaemic control (Mekary et al., 2012; Reutrakul et al., 2014). 
2.7.2.5. Lifestyle Interventions and the Management of T2DM 
While there are a multitude of studies on lifestyle programs for the prevention of T2DM, 
comprehensive lifestyle programs for the management of individuals diagnosed with T2DM are few 
and far between, with only a handful of studies published to date (Aguiar et al., 2014; Blackford et 
al., 2015). Lifestyle programs are multi-faceted in nature and usually consist of exercise, dietary 
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and behavioural change components (Aguiar et al., 2014). Most of the published studies indicate 
that the long-term benefits of lifestyle programs are sustained when compared to only exercise or 
diet-based programs, although in some cases the short-term improvements are comparable (Aguiar 
et al., 2014; Evert & Riddell, 2015). That being said, improvements in glycaemic control, body 
composition, insulin sensitivity and lipid metabolism have been reported in a number of 
comprehensive lifestyle programs (Andrews et al., 2011; Aguiar et al., 2014; Blackford et al., 2015; 
Evert & Riddell, 2015). In a four-month comprehensive intervention consisting of group exercise 
sessions as well as dietary advice and counselling, participants in the experimental group reported a 
clinically and statistically significant decrease in HbA1c, as well as improvement in a number of 
dietary behaviours related to favourable T2DM outcomes such as regular fruit and vegetable 
consumption, and the sparse consumption of refined carbohydrates (Speer et al., 2008). In a slightly 
longer six-month study by (Vadstrup et al., 2011), a comprehensive lifestyle intervention resulted in 
significant improvements in HRQoL as well as the individuals perception of their health, which are 
important in the overall management of T2DM. A multi-centre study by Wing et al. (2010) added 
further evidence in support of comprehensive lifestyle intervention programs, with data collected 
over a four year period reporting statistically significant improvements in body weight, glycaemic 
control and lipid metabolism, as well as cardiovascular fitness, when compared to participants who 
made use of traditional care modalities.  
2.8. Management Strategies for T2DM 
Three chief management strategies have been identified in research, each with their own positives 
and drawbacks, and are discussed in further details below. 
2.8.1. Telephonic/Correspondence Interventions 
With the advent of technology, and the need for health professionals to reach more individuals to 
try and mitigate the increased incidence of T2DM, telephone-linked, or telecare interventions have 
been implemented globally (Coberley et al., 2007; Walker et al., 2011; Saffari et al., 2014; Kaur et 
al., 2015). The cost-effectiveness of these interventions has been extensively studied, with a number 
of authors suggesting that telephone-based programs are effective in reducing healthcare costs, and 
costs to the individual concerned, without compromising on the quality of care (Gordon et al., 
2014; McGloin et al., 2015). Most studies related to telephonic interventions have examined the 
effects on glycaemic control and other haematological variables.  Kaur et al. (2015) found that 
weekly telephonic consultations, together with regular clinic visits resulted in significant 
improvements in HbA1c as well as HDL-C compared to those participants who didn’t receive 
telephonic consultations. Furthermore, this group also reported a higher HRQoL with respect to the 
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physical functioning domains. This finding was corroborated by Huang et al. (2015) who found 
similar improvements in HbA1c, as well as a reduction in fasting glucose and glucose tolerance 
following a meal.  
The use of text messaging was investigated in a recent study, and was found to be as effective as a 
traditional telephonic intervention with respect to a reduction in HbA1c (Saffari et al., 2014). 
Furthermore, when telephonic interventions were compared to print media such as manuals, 
booklets, etc., a significant reduction in HbA1c and an improvement in self-care activities were 
found in a low-income community, suggesting that the feedback given by telephonic interventions 
are more beneficial (Walker et al., 2011). While the authors did not explicitly state what the 
possible reasoning was for this finding, it is plausible that the personal contact, together with the 
opportunity to ask questions or voice concerns, gave individuals with T2DM more confidence to 
adhere to self-care activities and healthy lifestyle behaviours.  
The use of telephonic reinforcement following a structured program has been investigated over the 
last few years, with a number of studies reporting that while the reinforcement did not infer any 
additional benefits over and above the changes seen as a result of the initial program, the 
improvements were maintained at a follow up period some 12 – 18 months following the program 
(Lorig et al., 2008; Dunbar et al., 2010).  
2.8.2. Health Professional-Led Interventions 
Healthcare programs or intervention strategies conducted by a group of health professionals or 
healthcare providers, are the most common form of intervention strategy, although not always the 
most effective (Smith et al., 2011; Daly et al., 2014; Edelman et al., 2015). The impact of 
professional led interventions on glycaemic control and other metabolic measures is well 
documented, with a recent study by Tomioka et al. (2014) in elderly men and women showing 
significant improvements in HbA1c, lower lipid levels and lower blood pressure. Interestingly, 
these findings were not corroborated by Edelman et al. (2015), where only small and insignificant 
improvements were found in a similar study population. A study by Smith et al. (2011) in a multi-
ethnic population of older adults found improvements in a number of areas related to diabetes 
management including blood pressure and cholesterol, with the program being led by primary care 
workers. A similar study conducted in an older Yemeni population found comparable results, in 
addition to improvements in fasting blood glucose (Babelgaith et al., 2015). 
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2.8.3. Community-Led Interventions 
Recently, the advent of community- or peer-led interventions have taken centre stage as the medical 
professionals are no longer able to maintain the required level of care relative to the increase in the 
number of sick individuals. A recent cost-effectiveness study by Brown et al. (2012) found that 
lifestyle intervention programs implemented by community health workers (CHW) was extremely 
cost-effective in a community with low SES. Improvements in HbA1c seems to be mostly reported 
in the literature, with improvements in blood pressure and lipid profile being reported less 
frequently (Lorig et al., 2009; Castillo et al., 2010; Welch et al., 2011; Simmons et al., 2015). In 
addition to improvements in haematological parameters, a recent study in a low-income and elderly 
Hispanic population by Koniak-Griffin et al. (2015) found a significant improvement in levels of 
physical activity, waist circumference and dietary habits. Similar findings were reported in a 6-
week study by Melkus et al. (2004), where appropriately trained CHW delivered an educational 
program to 25 community members. Statistically significant improvements in glycemic control, 
BMI and emotional distress related to T2DM were reported. A 12-week dance and peer support 
program achieved similar results, with improvements in HbA1c, body fat percentage and blood 
pressure being substantially greater compared to the participants in the study who received the 
traditional method of care for T2DM (Murrock et al., 2009). An extensive 24 month program 
carried out by CHW with the explicit goal of reducing body weight in elderly patients with T2DM, 
was found to have wider-reaching effects, with decreased body weight, waist circumference and 
BMI reported, as well as improvements in metabolic control (Katula et al., 2013). Interestingly, a 
much shorter study of six months resulted in similar changes, in addition to improvements in 
diabetes self-care activities, all of which are essential to adequate management of T2DM (Assah et 
al., 2015). A similar study by Spencer et al. (2011) reported that a six month CHW intervention 
program resulted in a significant improvement in HbA1c, in addition to definitive modifications in 
behaviour towards better management and knowledge of T2DM. A culturally-tailored educational 
intervention conducted by CHW over a period of 12-months showed great promise, with the 
intervention group significantly improving their glycaemic control and blood lipid levels, as well as 
their quality of life and overall self-efficacy (Kim et al., 2015). 
2.9. Conclusion 
Despite the extensive research into T2DM there are still a number of unanswered questions and 
controversy surrounding the pathophysiology and management of the disease. This is especially 
evident in communities of low socio-economic status where further research needs to be conducted. 
The use of comprehensive, community-based lifestyle interventions have been identified as a 
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possible solution to the increasing prevalence of T2DM by empowering communities to manage 
their disease, in conjunction with the primary healthcare providers. What is abundantly clear 
however is that if nothing is done to curb this global challenge, the ramifications thereof will 
continue for generations to come. 
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3.1. Study Design 
This study followed an experimental randomised case-control study design. Three testing sessions 
comprised this study, namely a pre-testing session before the start of the intervention, the post-
intervention testing session, and finally a retention testing session. The time period between each of 
the testing sessions was 10 weeks. (Figure 3.1). The 10-week intervention period consisted of 
structured group exercise sessions, group dietary advice and group motivational interviewing 
conducted by clinical psychologists, which was determined to be a sufficient intervention duration 
based on studies with similar methodologies (Melkus et al., 2004; Kim et al., 2009). 
 
Figure 3.1.  Schematic of study design with the time between the respective sessions shown in 
weeks. 
3.2. Participants 
The target study population was a group of adults in a low-socioeconomic community in 
Cloetesville in Stellenbosch. Participants were recruited through the local media outlets, the 
Cloetesville community clinic, local churches via word of mouth, and flyers that were distributed 
within the community (Appendix A). All volunteers underwent a comprehensive pre-participation 
screening to determine their eligibility to participate in the study. Volunteers who qualified to 
participate in the study were requested to provide a medical clearance form from their primary 
physician (Appendix B), which had to be completed before any testing was conducted. All 
participants were informed of the purpose of the study in their preferred home language (English 
and/or Afrikaans), and gave full consent to participate in the study. A total of 45 individuals 
volunteered to participate in the study and were randomised into an experimental (n = 24) and 
control (n = 21) group. Randomisation was conducted by assigning a number to each participant 
and then randomly drawing the numbers out of a concealed box. A total of 43 participants 
completed the study, of which 23 were in the experimental group and 20 were in the control group. 
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3.3. Inclusion and Exclusion Criteria 
Participants were included in the study if they were diagnosed with type 2 diabetes mellitus 
(T2DM) for at least six months prior to enrolment in the study. Participants were required to be 
over 18 years of age, and classified as sedentary according to the criteria outlined by the American 
College of Sports Medicine (Table 3.1). Participants were excluded from the study if they presented 
with any pathologies that would prevent them from participating in any of the intervention sessions, 
if they had been following an individualised diet plan prescribed by a registered dietician for three 
months or longer, or if they were intending to, or confirmed to undergo, any surgical procedure 
during the intervention period. Furthermore, if participants attended less than 60 % of the respective 
intervention sessions, their data was excluded from analyses. 
 
Table 3.1. Definition of sedentary lifestyle, adapted from ACSM’s Guidelines for Exercise 
Testing and Prescription (American College of Sports Medicine, 2014). 
Atherosclerotic Cardiovascular Disease (CVD) Risk Factors and Defining Criteria 
Sedentary Lifestyle 
Not participating in at least 30 minutes of moderate intensity, 
physical activity (40 % - 60 % VO2R) on at least three days of 
the week for at least three months. 
 
3.4. Place of Study 
All testing and intervention sessions took place at the Vrye Gereformeerde Kerk (VGK) in 
Cloetesville, Western Cape, South Africa. Cloetesville was chosen as the preferred place for the 
study to be conducted due to the high incidence of T2DM in the region, and due to its classification 
as a low socio-economic status (SES) community, which was determined by the average monthly 
income of employed individuals, the highest level of education, and access to basic services 
(Bureau for Economic Research, 2013). Blood sample analyses were performed by PathCare 
pathology laboratories in Stellenbosch, South Africa, by a registered nurse and/or phlebotomist. For 
testing, participants were required to make three visits to the VGK Church. For the intervention 
period, participants were required to make 50 visits to the VGK Church, over a 10-week period. 
These 50 visits comprised of 30 exercise sessions with a registered biokineticist, 10 motivational 
interviewing sessions with a qualified community psychologist, and 10 dietary counselling sessions 
with a registered dietician. 
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3.5. Measurements and Instrumentation  
The physical measurements included standing height, body mass, body composition, resting blood 
pressure, resting heart rate, random blood glucose, total serum cholesterol as well as glycated 
haemoglobin (HbA1c). Quality of life was measured through the Short Form 36 (SF-36) 
questionnaire (Appendix E), and the Diabetes-39 questionnaire (Appendix F). Additional 
questionnaires on the participants’ dietary (Appendix G) and health professional usage habits 
(Appendix H), as well as family support (Appendix I) were also included. 
3.5.1. Anthropometrical Measurements 
All anthropometrical measurements were taken by an ISAK level 2 qualified anthropometrist, 
ensuring consistency and reliability of the measurements at every testing session. 
3.5.1.1. Standing Height (Stature) 
Standing height was measured according to the guidelines outlined by the International Society for 
the Advancement of Kinanthropometry (ISAK). Participants were instructed to wear loose-fitting, 
light-weight clothing, and to be barefoot. A sliding steel stadiometer (Siber-Hegner GPM, 
Switzerland) was used to obtain height, with participants standing upright, with their feet together, 
and heels, buttocks, upper back, and posterior aspect of the head touching the stadiometer. 
Participants were then placed in the Frankfort plane/position with the notch above the tragus of the 
ear (Tragion), and the lower edge of the eye socket (Orbitale), being in the same horizontal plane. 
Participants were then instructed to inhale maximally while the headboard was lowered to the 
highest point of the skull (Vertex). Measurements were taken to the nearest 0.1 centimetre (cm). 
3.5.1.2. Body Mass 
Body mass was also measured according to the guidelines outlined by ISAK. Participants wore 
loose-fitting, light-weight clothing and were barefoot. A Safeway household scale, checked for 
accuracy before each measurement with a 5 kilogram (kg) plate, was used, and participants were 
instructed to stand in the middle of the scale, weight-evenly distributed, and looking straight ahead 
for the entire duration of the measurement. Measurements of body mass were taken to the nearest 
0.1 kilogram (kg). 
3.5.1.3. Body Composition 
Body composition was measured by skinfold thickness via the use of a skinfold calliper (get info on 
calliper), which was calibrated according to the manufacturers protocol. The sum of skinfolds was 
then converted to body fat percentage by the formula developed by Yuhasz in 1974. This formula is 
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recognised as the gold standard by ISAK and is the reason for its use in this study. The formulas, 
different for men and women, are detailed in Equation 3.1 and Equation 3.2 below. 
𝐵𝑜𝑑𝑦 𝐹𝑎𝑡 % = (0.1051 × [Σ(𝑇𝑟 + 𝑆𝑆 + 𝑆𝑆𝑝 + 𝐴 + 𝑇ℎ + 𝐶)] + 2.585 
Equation 3.1.  Equation developed by Yuhasz (1974) to calculate body fat percentage in men, 
where Tr is triceps skinfold, SS is subscapular skinfold, SSp is supraspinale 
skinfold, A is abdominal skinfold, Th is anterior thigh skinfold, and C is medial 
calf skinfold. 
𝐵𝑜𝑑𝑦 𝐹𝑎𝑡 % = (0.1548 × [Σ(𝑇𝑟 + 𝑆𝑆 + 𝑆𝑆𝑝 + 𝐴 + 𝑇ℎ + 𝐶)] + 3.580 
Equation 3.2.  Equation developed by Yuhasz (1974) to calculate body fat percentage in women, 
where Tr is triceps skinfold, SS is subscapular skinfold, SSp is supraspinale 
skinfold, A is abdominal skinfold, Th is anterior thigh skinfold, and C is medial 
calf skinfold. 
All skinfolds were taken according to ISAK guidelines, on the right side of the body, and 
measurements were repeated twice. If the difference between two measurements of the same 
skinfold site exceeded two millimetres (mm), then the measurement was repeated for a third time. 
Prior to any skinfolds being measured, the various anatomical landmarks were marked with the use 
of a permanent marker. Each of these respective landmarks are explained in further detail together 
with their associated skinfold site. 
3.5.1.3.1. Biceps Skinfold 
The Acromiale ® landmark is the most lateral aspect of the acromion border on the scapula and is 
the first anatomical landmark necessary. The second landmark is the Radiale ®, and is the point at 
the most proximal and lateral border of the head of the radius bone in the forearm. A horizontal line 
is made midway between these two landmarks, known as the Mid-acromiale-radiale ®, with both 
the biceps and triceps skinfold making use of this landmark. The biceps skinfold is a vertical 
skinfold made parallel to the long axis of the arm, and at the most anterior aspect of the biceps at 
Mid-acromiale-radiale ® level. 
3.5.1.3.2. Triceps Skinfold 
The triceps skinfold is a vertical skinfold made parallel to the long axis of the arm, at the most 
posterior aspect of the triceps brachii, at Mid-acromiale-radiale ® level. 
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3.5.1.3.3. Subscapular Skinfold 
The Subscapular ® landmark is located by palpating the tip of the most inferior angle of the 
scapula. From this point, the subscapular skinfold site is marked two centimetres laterally and 
diagonally at an angle of 45 degrees. The subscapular skinfold is taken with the natural fold of the 
skin. 
3.5.1.3.4. Supraspinale Skinfold 
The Supraspinale ® skinfold site is determined by the intersection of the horizontal line from the 
Iliocristale ®, taken at the most lateral aspect of the iliac crest, and the line between the anterior 
axillary border and the Iliospinale ®, the most inferior aspect of the anterior superior iliac spine 
(ASIS), where the Sartorius muscle has its insertion point. The skinfold is taken with the natural 
fold of the skin, as in the case of the subscapular skinfold. 
3.5.1.3.5. Abdominal Skinfold 
The abdominal skinfold site is located five centimetres to the right of the centre of the navel 
(omphalion), with the skinfold itself being a vertical skinfold. 
3.5.1.3.6. Anterior Thigh Skinfold 
The anterior thigh skinfold site is located midway between the Inguinal fold ® and the most 
anterior and superior aspect of the patella (Anterior patella ®). This skinfold is taken with the 
person seated, and the knee bent at 90 degrees. The vertical skinfold is taken parallel to the long 
axis of the limb. 
3.5.1.3.7. Medial Calf Skinfold 
The medial calf skinfold is taken at the most medial aspect of the calf, at the level where the 
greatest circumference is measured. It is a vertical fold taken parallel to the long axis of the lower 
limb, with the foot placed on a raised platform. 
3.5.2. Cardiovascular Measurements 
Resting measurements of blood pressure and heart rate were obtained after the participants had been 
allowed to sit, at rest with feet flat on the floor, for five minutes. All cardiovascular measurements 
were taken according to the guidelines recommended by the American College of Sport Medicine 
(American College of Sports Medicine, 2014) and by a fully qualified biokineticist with five years 
of clinical experience, ensuring consistency and reliability of the measurements. 
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3.5.2.1. Blood Pressure 
Resting systolic blood pressure (SBP) and diastolic blood pressure (DBP) was measured with a 
hand-held aneroid sphygmomanometer (Just Sports, South Africa), which had been calibrated prior 
to its first use by the manufacturers. An adult size cuff was used (27.5 – 26.5 centimetre upper arm 
circumference) and positioned to ensure that at least 80 percent of the upper arm was encircled by 
the bladder of the cuff. The head of the stethoscope (Hi-Care, South Africa) was placed in the 
antecubital space of the elbow joint, while the cuff was inflated. The pressure was released at a rate 
of 2 – 5 millimetres mercury (mmHg), with the first and last Korotkoff sounds being used to 
determine the participants’ systolic and diastolic blood pressures, respectively. Resting blood 
pressure was measured twice, with a two-minute gap between readings. The average of the two 
measurements was used as the final reading. In addition to the resting blood pressure 
measurements, blood pressure was also measured at the termination of the six-minute walk test 
(6MWT), to determine whether the participant presented with the expected haemodynamic response 
at the end of the exercise bout as outline by the ACSM (American College of Sports Medicine, 
2014). Measurements of blood pressure were taken to the nearest 1 mmHg. 
3.5.2.2. Heart Rate 
Resting heart rate was measured via palpation of the radial artery on the lateral aspect of the 
forearm, while the forearm was supinated. The radial pulse was measured for 60 seconds with the 
participant seated and with both feet flat on the floor. Heart rate was also measured throughout the 
duration of the 6MWT via an electronic heart rate monitor and receiver (Suunto Team System, 
Vantaa, Finland). Heart rate measurements were measured in beats per minute (bpm). 
3.5.3. Haematological Measurements 
3.5.3.1. Random Blood Glucose 
To obtain a measurement of random blood glucose, a finger prick test was used to draw a small 
amount of blood needed for analysis. The ring finger of the participants’ non-dominant hand was 
cleaned with an alcohol swab (Dura-Surge, South Africa) to remove any dirt or substances that 
could have affected the accuracy of the results. A single-use Haemolance plus lancet (HaeMedic, 
Poland) was then used to puncture the skin to a depth of 1.8 mm and draw blood. The first sample 
of blood was wiped away using cotton wool, as is common practice for finger prick tests, with the 
second sample of approximately 10 𝜇𝐿 being drawn into a micro cuvette via capillary action. This 
sample was analysed using a Glucose 201+ analyser (Hemocue, Sweden). In order to ensure 
accuracy of the measurements, the analyser performed an internal self-calibration procedure prior to 
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each measurement, as outlined in the manufacturers protocol. All random blood glucose 
measurements were recorded with mmol.L
-1
 as the unit of measurement. Due to the logistical 
difficulties with obtaining fasting blood glucose measurements, the time at which the participants 
random blood glucose was tested, was fixed for each testing session in an attempt to standardise the 
measurements. I.e. If person A’s blood glucose was tested at 09h00 at the pre-testing session, it was 
tested at 09h00 at the post-testing and retention testing sessions. 
3.5.3.2. Total Serum Cholesterol (TSC) 
The same procedure described above for obtaining a blood sample for random blood glucose was 
used to obtain a blood sample for the analysis of total serum cholesterol. Approximately 15 𝜇𝐿 of 
blood was drawn and placed on the required area on the Accutrend ® cholesterol testing strips 
(Roche Diagnostics, Germany) to ensure that the reading was accurate. The blood sample was 
analysed using an Accutrend ® Plus multifunction analyser (Roche Diagnostics, Mannheim, 
Germany) and all measurements were expressed in mmol.L
-1
. In order to ensure accuracy of the 
measurements, the analyser performed an internal self-calibration procedure prior to each 
measurement, as outlined in the manufacturers protocol. 
3.5.3.3. Glycated Haemoglobin (HbA1c) 
All measurements for glycated haemoglobin (HbA1c) took place at the PathCare laboratory in 
Stellenbosch under the guidance of a registered nurse or phlebotomist. Blood was collected in 4 mL 
Ethylenediaminetetraacetic acid (EDTA) tubes to prevent coagulation of the blood sample. During 
analysis, 1 mL of blood was washed three times with 8 mL saline solution, followed by 
centrifugation at 15 000 rpm for 10 minutes. The sediment was then further analysed to give HbA1c 
as a percentage of total haemoglobin present, and rated according to their level, namely, normal (3.9 
% - 6.1 %), low (< 3.9 %) or high (> 6.2 %) (Zemlin et al., 2015). 
3.5.4. Questionnaires 
Participants were required to complete a total of five questionnaires (in their preferred language). 
There was no time limit imposed to complete the questionnaires, and if they were unsure of any of 
the questions being asked, it was rephrased by the researcher until it was established the question 
was properly understood. 
3.5.4.1. Short Form 36 (SF-36) 
The SF-36 was first developed by Ware & Sherbourne (1992) as a measure of health-related quality 
of life, and how a specific disease or a condition has an effect thereon. It is comprised of 36 
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questions, which are split into eight domains, namely, physical functioning, role limitations due to 
physical challenges and shortcomings, social functioning, body pain, overall mental health, role 
limitations as a result of emotional problems, vitality, as well as overall perception of health. Each 
domain is scored from zero to 100, with a higher score indicating a higher quality of life. In a 
number of different chronic disease populations, it has been demonstrated that the SF-36 is a valid 
and reliable measurement tool, even when translated from English to another foreign language 
(Jenkinson et al., 1993; Aaronson et al., 1998; Alonso et al., 1998; Failde & Ramos, 2000; Martin 
et al., 2011). The English version of the SF-36 can be seen in Appendix E. To assess the reliability 
of the SF-36, a reliability analysis was performed, with Cronbach’s alpha being used as a 
determining factor. Across the various domains of the SF-36, the Cronbach’s alpha scores varied 
from 0.53 to 0.91 (average of 0.76), indicating an acceptable to high reliability. 
3.5.4.2. Diabetes-39 
The Diabetes-39 (D-39) questionnaire is a health-related quality of life questionnaire that examines 
five areas that are traditionally affected by an individual with diabetes, as well as their perceived 
quality of life and perceived disease severity. The five areas are energy and mobility, sexual 
functioning, anxiety and worry, social burdens and diabetes control and management. Each of the 
39 questions is ranked on a seven point Likert scale, with one representing “not affected at all”, and 
seven representing “severely affected”. It has been shown to be a valid questionnaire and correlates 
well with more generalised health-related quality of life questionnaires such as the SF-36 (r = 0.71) 
(Boyer & Earp, 1997). Similarly to the SF-36, the Diabetes-39 questionnaire has been reproduced in 
foreign languages, without compromising its reliability (Khader et al., 2008). The English version 
of the Diabtes-39 questionnaire can be seen in Appendix F. A reliability analysis was performed on 
all the various domains of the D-39, with Cronbach alpha scores ranging from 0.79 to 0.95, 
indicating a high degree of reliability. 
3.5.4.3. Eating Habits 
The eating habits questionnaire (Appendix G) was developed by the researcher for use in this study, 
and included a number of questions regarding the frequency of eating, the detailed content of meal 
times, as well as questions regarding lifestyle behaviours such as smoking and alcohol 
consumption. A number of the questions were derived from studies conducted by Van Dam et al. 
(2002), Pisani et al. (1997) and Buzzard et al. (2001), which were all found to be reasonably 
reliable and valid (r = 0.71 ; r = 0.73 ; r = 0.59). The questionnaire was evaluated according to 
eating times and frequency, the content of the various meal times, as well as the lifestyle habits of 
the participants. 
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3.5.4.4. Health Professional Usage 
The health professionals’ usage questionnaire (Appendix H) was also developed by the researcher 
for use in this study and was based on similar questionnaires developed by Rim et al. (2011) and 
Schweikert et al. (2008), both of which were shown to have reasonable reliability and validity (r = 
0.65 ; r = 0.70). The questionnaire was designed to determine the frequency of participants’ use of 
various health professionals, whether or not they went for regular check-ups, and the location of 
where the participants consulted with their primary healthcare provider. 
3.5.4.5. Modified Diabetes Family Behaviour Scale (DFBS) 
The Diabetes Family Behaviour Scale (DFBS) was originally developed to assess familial support 
for children with type 1 diabetes mellitus (T1DM) (McKelvey et al., 1993). The original document 
was modified to make it more appropriate for adults with T2DM, and the English version can be 
seen in Appendix I. The DFBS is scored according to two subscales: the guidance-control subscale 
and the warmth-caring subscale. Participants answered questions on a five-point scale, and when 
the scores of the two subscales were totalled, a higher score indicated greater familial support. Due 
to the questionnaire being adapted from the original, a reliability analysis was conducted with 
Cronbach’s alpha scores being utilised to determine the internal consistency of the questionnaire. 
Overall the Cronbach’s alpha scores for the two subscales were 0.60, thereby resulting in acceptable 
internal consistency. 
3.5.5. Functional Measurements 
3.5.5.1. Six Minute Walk Test (6MWT) 
The six-minute walk test (6MWT) has been validated on a number of occasions as an accurate 
measure of determining functional capacity and overall exercise ability in diabetic populations 
(Lambers et al., 2008; Geirsdottir et al., 2012; Tuttle et al., 2012; Awotidebe et al., 2014). It has 
also been shown that impairments in the components of physical fitness, which are related to health 
(muscle strength and endurance, cardiorespiratory endurance), will result in an inferior performance 
on the 6MWT, thereby indirectly testing these components (Bade et al., 2012; Özgen et al., 2015). 
For this study, the participants were instructed to walk as fast as they could, without running, 
between two cones set five meters apart. The total distance walked in the six minutes was calculated 
by multiplying the number of laps with the distance between the cones. Participants were allowed to 
rest if necessary, although the time continued. All participants wore an electronic heart rate monitor 
(Suunto Team System, Vantaa, Finland) which measured their heart rate continuously throughout 
the test. Furthermore, participants were asked to provide a rating of perceived exertion (RPE) score 
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(Borg scale) at three minutes and at the termination of the test. An upper limit of 75 percent of the 
participants’ maximum heart rate (HRmax) was set as a termination criterion for the test, in addition 
to the standardised termination criteria outlined by the American College of Sports Medicine (Table 
3.2). The participant’s target heart rate (75 percent of HRmax) was calculated using the Karvonen 
formula (Equation 3.3). 
𝑇𝐻𝑅 = [(220 − 𝑎𝑔𝑒 − 𝑅𝐻𝑅) ×  𝐼] + 𝑅𝐻𝑅 
Equation 3.3.  Karvonen formula used to calculate target heart rate (THR) as a specific intensity 
(I), where RHR is resting heart rate. 
In cases where the participant were taking medication that could affect their haemodynamic 
response (e.g. β-blockers), an RPE of 7 or 8 was noted as the end point as these scores 
corresponded with approximately 75 percent of the HRmax (American College of Sports Medicine, 
2014). Blood pressure and heart rate were measured immediately at termination of the test, as well 
as three minutes after termination to ensure a normal haemodynamic recovery following a bout of 
exercise. 
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Table 3.2.  General indications for stopping an exercise test, adapted from ACSM’s 
Guidelines for Exercise Testing and Prescription (American College of Sports 
Medicine, 2014). 
Onset of angina or angina-like symptoms 
Drop in systolic blood pressure (SBP) of ≥ 10 mmHg with an increase in work rate or if SBP 
decreases below the value obtained in the same position prior to testing 
Excessive rise in blood pressure: systolic pressure > 250 mmHg and/or diastolic pressure > 115 
mmHg 
Shortness of breath, wheezing, leg cramps or claudication 
Signs of poor perfusion: light-headedness, confusion, ataxia, pallor, cyanosis, nausea, or cold and 
clammy skin 
Failure of heart rate to increase with increased exercise intensity 
Noticeable changes in heart rhythm by palpation or auscultation 
Subject requests to stop 
Physical or verbal manifestations of severe fatigue 
Failure of the testing equipment 
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3.6. Experimental Procedures 
3.6.1. Testing Sessions 
There were a total of three testing sessions that each participant attended, which varied in duration 
between 60 and 90 minutes. Before the start of each testing session, the participants were guided 
through the session in their preferred language, and any concerns or questions were addressed. The 
study documents (informed consent, questionnaires, etc.) were presented to the participants in their 
preferred language to eliminate any language related bias. 
3.6.1.1. Testing Session One 
During this testing session, the participant provided a comprehensive medical history, including a 
list of their current medications, frequency of use and dosage (Appendix D). The informed consent 
form (Appendix C) was also explained at this time, and any questions or concerns that arose were 
addressed before being signed. Participants’ anthropometrical measurements of standing height, 
body mass, and skinfold thickness were obtained. Furthermore, resting systolic (SBP) and diastolic 
blood pressure (DBP), and resting heart rate (HR) were taken as measures of cardiovascular 
functioning. A finger prick test allowed for the measurement of blood glucose and total serum 
cholesterol (TSC). Following these measurements, participants were required to complete the six-
minute walk test (6MWT). A number of questionnaires were provided to the participants following 
the physical testing and included the Short Form 36 (SF-36), Diabetes-39 Questionnaire, eating 
habits questionnaire, health professionals’ usage questionnaire, and the Diabetes Family Behaviour 
Scale (DFBS). At the end of the testing session, participants were provided with a request form for 
PathCare pathology laboratories for blood-work analysis. Participants were instructed to fast at 
least eight hours prior to their blood test (Gaudet-Savard et al., 2007). A pre-prepared SMS was 
sent to participants the evening before and the morning of their schedule PathCare testing 
appointments to ensure that they were in a completely fasted state for the blood tests. 
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3.6.1.2. Testing Session Two 
During this testing session, participants were required to undergo the same procedures as outlined in 
testing session one. However, an additional response form was added to the documents in order to 
obtain feedback from the participants on the respective intervention sessions so that the necessary 
changes could be made to the program going forward (e.g. what they enjoyed or didn’t enjoy in the 
sessions, what could be done differently or better, etc.) (Appendix K). Furthermore, the participants 
were provided with a post-intervention guide (Appendix L) incorporating all the aspects of the 
intervention program (three exercise programs, dietary guidelines and advice from the 
psychologists). 
3.6.1.3. Testing Session Three 
The last testing session took place 10 weeks after testing session two. The same procedures as 
outlined in testing session one and two were performed. 
3.6.2. Intervention Sessions 
The intervention program consisted of exercise, dietary and psychological sessions. The exercise 
sessions occurred three times a week, at two different time periods (one morning session and one 
evening session), and lasted between 30 and 60 minutes. The dietary and psychological sessions 
occurred once a week and at two different time slots (one morning session and one evening 
session), and lasted 45 to 60 minutes, respectively. All of the intervention sessions were conducted 
in groups. Participants were allowed to change the times that they attended the respective sessions 
according to their schedules, however, they were not allowed to attend more than three exercise 
sessions, or more than one of the dietary and psychological intervention sessions, per week. 
3.6.2.1. Exercise Intervention Sessions 
The exercise sessions consisted of a progressive, whole body, exercise program that lasted for 10 
weeks. A detailed breakdown of what occurred in each of the exercise sessions (per week) can be 
found in Appendix J, although a summarised example of one day, with progressions is displayed in 
Table 3.3 below. The exercise sessions were made increasingly difficult every week, and consisted 
of both aerobic and resistance exercises, as well as exercises for balance and proprioception. Each 
exercise session was preceded by a warm-up of approximately five minutes and ended with a cool-
down stretch of the respective muscles, of approximately five minutes. In order to ensure that the 
exercise sessions were progressive in nature, the RPE scores, based on the category-ratio Borg scale 
(Borg, 1982) were obtained from each participant at the end of each exercise session. 
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Table 3.3.  Example of an exercise session, with progressions for the following session 
included. 
Exercise Sets/Reps or Time Progression 
Fast feet over rope (fwd, sdw, fwd) 35 seconds each Increase time by 10 seconds 
Tri-Directional Torso Rotation with 
Discus 
2 x 20 
(10 per side) 
Increase reps per side by 2 
Sit-to-stand with isometric abduction 
(with band) 
2 x 15 Increase reps by 2 or add in hold 
at the halfway point 
Sumo Squats 2 x 10 Increase reps by 2 
Fast feet over rope (fwd, sdw, fwd) 35 seconds each Increase time by 10 seconds 
Lunges 2 x 6 Increase reps by 2 
Half Seated Holds (Hold for 15s) 
2 x 6 Increase reps by 2 or time by 5 
seconds 
Fast feet over rope (fwd, sdw, fwd) 35 seconds each Increase time by 10 seconds 
Calf Raises and Calf Raise Holds with 
Bounces 
2 x 10 
Increase reps by 2 
Stork Stand/Single Leg Balance 2 x 25 seconds Increase time by 10 seconds 
3.6.2.2. Dietary Intervention Sessions 
The dietary intervention sessions consisted of group discussions led by a qualified dietician, 
specialising in T2DM, on a number of topics relating to nutritional management of T2DM, which 
have shown to be successful in the past (Kontogianni et al., 2012). The session breakdown for the 
10-week intervention period is indicated in Table 3.4 below. Within the topics covered there were 
discussions on the following, which are pertinent to the study: The preferred switch from white-
bread to low-GI bread, the reduction in consumption of carbohydrates, especially multiple 
carbohydrates during one meal, the use of extra sugar or sweetener in food or beverages, and the 
increased consumption of the correct type of vegetables. 
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Table 3.4.  The main topics of the dietary intervention sessions. 
Week Number Topics Covered 
1 
Basics of diabetes 
Goals for the program 
2 Different food groups and how they are digested 
3 
When/What to eat for snacks 
Portion sizes 
4 Specifics of a diabetic diet (Part one) 
5 Specific of a diabetic diet (Part two) 
6 The Glycaemic Index (GI) 
7 Alcohol and diabetes 
8 Quiz on previous week’s sessions 
9 Monitoring of blood sugar levels 
10 Medication and diet 
 
3.6.2.3. Psychology Intervention Sessions 
Each of the psychological sessions was conducted in the form of a psychological technique known 
as the motivational interviewing (MI), and were presented by clinical psychology masters students 
who were appropriately trained in the technique. The purpose of motivational interviewing is to 
encourage the participants to utilise intrinsic motivation to elicit a change in behaviour, and is a 
collaborative and person-centred approach (Miller & Rollnick, 2009). The benefits of this approach 
were demonstrated in recent research by Li et al. (2014). Each of the sessions covered a number of 
topics, including motivating factors to change, relapse and its challenges, coping styles and support 
systems, eating habits at social functions, and setting personal and health-related goals. The 
sessions were conducted in groups of approximately five to six people and involved a discussion on 
each of the relevant topics, in line with the MI techniques, and all participants were encouraged to 
contribute and to be as open and honest as possible. 
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3.7. Ethics 
This study proposal was approved by the Ethics Committee for Human Research (Humanoria), 
Stellenbosch University (HS1029/2014). Participants were read the informed consent in their 
preferred language, and were given the opportunity to read the informed consent in their own time. 
A signed copy of the informed consent was given to each of the participants at the second testing 
session. Furthermore, participants were made aware of the risks associated with the testing sessions, 
intervention sessions or both (in the case of the experimental group). These include, discomfort as a 
result of the finger prick and venopuncture by PathCare, and discomfort and dizziness following a 
bout of exercise. The safety, privacy and interest of the participants were always maintained as the 
highest priority during the testing and intervention sessions. Furthermore, the researcher is a 
registered biokineticist with the Health Professionals Council of South Africa (BK0020109) and 
was fully qualified to perform the pre-test screenings. 
3.8. Statistical Analyses 
Statistical analysis of the data was performed using Statistica
®
 (Version 10, Statsoft, USA). 
Descriptive statistics were reported as means (?̅?) and standard deviations (± SD), unless otherwise 
stated. A multivariate analysis of variance (MANOVA) was used to analyse the data of the two 
groups across the various testing periods, with a Bonferroni post-test being used to determine 
between-group statistical significance, which was set at p ≤ 0.05. Furthermore, in cases where the 
same construct was tested by multiple measures, a Šidák correction was performed in order to 
eliminate the likelihood of a type 1 error. A Chi squared test was used to analyse the questionnaire 
data that were reported as a percentage of observed frequencies. Cohen’s effect sizes (ES) were also 
calculated to provide information on the practical significance of the results with an ES of 0 – 0.15, 
0.16 – 0.40, 0.50 – 0.75, 0.76 – 1.10 and 1.11 – 1.45, being considered a negligible, small, 
moderate, large and very large practical effect, respectively (Thalheimer & Cook, 2002). 
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The sections below are representative of the changes that occurred between the experimental and 
control groups over the pre-testing, post-testing and retention testing sessions, and encompass all of 
the outcome variables outlined in the methodology chapter. All data are expressed as means (?̅?) and 
standard deviations (± SD), unless stated otherwise. In the graphs, the error bars for the control 
group are represented by the dotted line (            ), whereas the error bars for the experimental group 
are represented by the solid line (              ).  
4.1. Participants 
Forty-five participants volunteered to participate in the study following screening to ensure that 
they met the inclusion and exclusion criteria. Participants were randomised into either an 
experimental or control group. Two participants, one each from the control and experimental group, 
were unable to complete the study, and their data have been removed from the final analysis. The 
remaining 43 participants (25 women and 18 men) completed the study and all attended more than 
60 % of the respective intervention sessions. The baseline descriptive statistics of the participants 
are outlined in Table 4.1 below, with the only statistically significant differences between the 
groups being standing height and total serum cholesterol. 
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Table 4.1.  Baseline physical characteristics (mean ± SD) for the experimental (EXP) and 
control (CON) groups. 
Characteristic 
Experimental (EXP) Control (CON) 
p-value 
Mean ± SD Range Mean ± SD Range 
Age (years) 61.3 ± 12.1 33 – 74 57.6 ± 12.3 40 – 80 > 0.05 
Height (cm) 156.9 ± 10.2 143 – 175 164.2 ± 8.8 149 – 175 0.02 * 
Body Mass (kg) 84.5 ± 19.0 55 – 133 89.3 ± 22.2 52 – 133 > 0.05 
BMI (kg.m
-2
) 33.8 ± 7.5 23 – 53 34.4 ± 9.7 20 – 53 > 0.05 
Body Fat (%) 31.8 ± 14.1 11 – 60  29.5 ± 15.3 11 – 53  > 0.05 
SBP (mmHg) 138.8 ± 21.8 100 – 190  143.9 ± 20.0 110 – 190  > 0.05 
DBP (mmHg) 76.3 ± 12.0 58 – 110  82.8 ± 15.1 62 – 110  > 0.05 
BGlc (mmol.L
-1
) 14.3 ± 4.3 5 – 22  13.4 ± 5.0 6 – 22  > 0.05 
TSC (mmol.L
-1
) 4.97 ± 1.2 4 – 9 5.71 ± 1.1 5 – 9  0.02 * 
HbA1c (%) 8.82 ± 2.1 6 – 14  9.47 ± 2.3 6 – 14  > 0.05 
* (p < 0.05). BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; BGlc, blood glucose; TSC, total 
serum cholesterol; HbA1c, glycated haemoglobin. 
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4.2. Anthropometric Variables 
4.2.1. Body Mass Index 
Figure 4.1 shows the differences in body mass index (BMI) between the experimental and control 
groups over the three testing sessions. No significant differences were observed throughout the 
intervention or retention period between groups, and there was no statistically significant interaction 
effect (group x time). The difference between the two groups at post-testing (Post) was not 
statistically significant (p > 0.05), nor practically significant (ES = 0.01, Table 4.2). The difference 
between the pre-testing (PreT) and the retention (Reten) testing in the experimental group was 8.75 
%, with this change not being statistically significant (p > 0.05). 
4.2.2. Body Fat Percentage 
There were no statistically significant differences in body fat percentage between the two groups 
over time (p > 0.05), and no statistically significant interaction effect (p > 0.05) (Figure 4.2). The 
control group showed almost no change in body fat percentage from the pre-testing session (PreT) 
to the post-testing session, with an overall change of 0.8 % body fat, which was not statistically 
significant (p > 0.05). The experimental group, however, showed a statistically significant drop in 
body fat percentage of 3.4% (p < 0.001) from PreT to post-testing, and a 3.7 % decrease from PreT 
to the retention testing session (p < 0.001). While there was a decrease of 0.3 % from post-testing to 
retention testing in the experimental group, this difference was not statistically significant (p > 
Figure 4.1.  Changes in body mass index (BMI) over the three testing periods. PreT, pre-
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0.05). Furthermore, there were no statistically, nor practically significant differences (Table 4.2) 
between the groups at any of the testing sessions (p > 0.05). 
Table 4.2.  Effect sizes (ES) related to differences in anthropometric measurements between 
the two groups at the pre-testing session (PreT) and post-testing session. 
Testing 
Phase 




BMI - 0.22 - 0.96 - 0.53 S 
Body Fat % 0.24 - 0.50 - 0.99 S 
Post 
BMI 0.01 - 0.61 - 0.64 N 
Body Fat % 0.08 - 0.55 - 0.71 N 
PreT, pre-testing ; Post, post-testing ; N, negligible ; S, small. 
 
Figure 4.2. Changes in body fat percentage over the three testing periods. PreT, pre-testing; 
Post, post-testing; Reten, retention testing. ***, p < 0.001; b, statistically 
significant difference between PreT and Post (p < 0.05) for experimental group; 
d, statistically significant difference between PreT and Reten for the 
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4.3. Cardiovascular Variables 
4.3.1. Systolic Blood Pressure 
Changes in systolic blood pressure (SBP) between the two groups over the course of the study can 
be seen in Figure 4.3 below. There were no statistically significant differences between the two 
groups over time (p > 0.05), nor was there a statistically significant interaction effect (p > 0.05). 
Between the pre-testing (PreT) session and the post-testing session, the control group on average 
had a four percent higher SBP. There was an approximate 2.0 mmHg increase in SBP in both 
groups at post-testing, signifying only a minor change from the pre-testing session (PreT), with no 
statistically significant or practically significant (Table 4.3) differences between the groups (p > 
0.05). When comparing the retention testing session to both PreT and post-testing, there was a 
decrease of 2.40 % (3.3 mmHg) and 3.81 % (5.3 mmHg), respectively, neither of which were 






Figure 4.3.  Changes in systolic blood pressure over the three testing periods. PreT, pre-
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4.3.2. Diastolic Blood Pressure 
The changes in diastolic blood pressure (DBP) for the two groups are shown in Figure 4.4 below, 
and show that the control group had on average a seven percent higher DBP than the experimental 
group over the first two testing sessions, although there were no statistically significant differences 
between the groups over time (p > 0.05), or any interaction effect (p > 0.05). The experimental 
group displayed statistically significant reductions in DBP of 5.4 % (4.2 mmHg) and 6.5 % (5.0 
mmHg) at post-testing (p = 0.04) and retention (p = 0.03), respectively, when compared to PreT. 
This is further confirmed by the moderate practically significant difference between the control and 





Figure 4.4.  Changes in diastolic blood pressure over the three testing periods. PreT, pre-
testing; Post, post-testing; Reten, retention testing.*, p < 0.05; b, statistically 
significant difference between PreT and Post in experimental group (p < 0.05); 
d, statistically significant difference between PreT and Reten for the 
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Table 4.3.  Effect sizes (ES) related to differences in systolic blood pressure (SBP) and 
diastolic blood pressure (DBP) between the two groups at the pre-testing session 
(PreT) and post-testing session. 
Testing 
Phase 




SBP - 0.33 - 1.08 ; 0.41 S 
DBP - 0.24 - 0.99 ; 0.50 S 
Post 
SBP - 0.30 - 0.94 ; 0.33 S 
DBP - 0.64 - 1.28 ; 0.01 M 
PreT, pre-testing ; Post, post-testing ; SBP, systolic blood pressure ; DBP, diastolic blood pressure ; S, small ; M, moderate. 
 
4.4. Haematological Variables 
Due to their being two outcome variables related to blood glucose levels, a Šidák p-value 
adjustment was made, with the level of statistical significance for random blood glucose and 
glycated haemoglobin (HbA1c), being set at p < 0.03. 
4.4.1. Random Blood Glucose 
Figure 4.5 displays the change in random blood glucose over the three testing occasions with 
statistically significant differences between and within the groups, as well as a statistically 
significant interaction effect (p = 0.02). An increase of 14.1 % in blood glucose from the pre-testing 
session (PreT) to post-testing was reported in the control group although this increase was not found 
to be statistically significant (p > 0.03). On the other hand, there was a 12.8 % decrease from PreT 
to post-testing, and a further 4.97 % decrease from post-testing to retention testing in the 
experimental group, neither of which was statistically significant (p > 0.03). Similarly to this, the 
cumulative decrease of approximately 18.0 % from PreT to the retention testing session in the 
experimental group, was also not found to be statistically significant (p > 0.03). When examining 
the differences between the two groups, a statistically significant difference of 20.0 % was found at 
post-testing (p = 0.03) and this difference was also of moderate practical significance (ES = - 0.70, 
Table 4.4). 
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4.4.2. Total Serum Cholesterol 
Changes over the three testing sessions can be seen in Figure 4.6. There were statistically 
significant differences between the two groups over time, although no interaction effect was found 
(p > 0.05). The differences between the two groups at the pre-testing session (PreT) and post-testing 
were statistically significant (PreT, p = 0.02; Post, p < 0.001), with the difference of the greatest 
magnitude being at post-testing, namely a substantial difference of 23 %. These differences were 
also found to be of large and very large practical significance (PreT, ES = - 0.83; Post, ES = - 1.11), 
respectively, and are displayed in Table 4.4. Both groups saw an increase in their total serum 
cholesterol (TSC) from PreT to post-testing, although neither of the differences were statistically 
significant (p > 0.05). On average, the control group had a 19.9 % higher total serum cholesterol 
measurement than the experimental group. TSC levels increased from post-testing to the retention 
testing session in the experimental group by 0.83 %, and by 2.74% from PreT, with neither of these 




































Figure 4.5.  Changes in random blood glucose over the three testing periods. PreT, pre-
testing; Post, post-testing; Reten, retention testing. *, p < 0.03; a, statistically 
significant difference between experimental and control group (p < 0.03). 
a * 
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4.4.3. Glycated Haemoglobin 
The final haematological variable measured was glycated haemoglobin (HbA1c), with differences 
between the two groups displayed in Figure 4.7. In this instance, there was a statistically significant 
interaction effect (p = 0.01), with differences between and within the groups being observed over 
time. The difference between the two groups at post-testing was 1.38 %, which was found to be 
statistically significant (p = 0.03) and practically significant (ES = - 0.64, Table 4.4). Statistically 
significant differences were also found between the pre-testing session (PreT) and post-testing in 
the experimental group (p = 0.01), as well as between PreT and the retention testing session (p = 
0.02). Despite the 1.07 % increase in HbA1c from PreT to post-testing in the control group, the 









































Figure 4.6.  Changes in total serum cholesterol over the three testing periods. PreT, pre-
testing; Post, post-testing; Reten, retention testing.*, p < 0.05; ***, p < 0.001; a, 
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Table 4.4. Effect sizes (ES) related to differences in the haematological variables between 
the two groups at the pre-testing session (PreT) and post-testing session. 
Testing 
Phase 




BGlc 0.18 - 0.57 ; 0.92 S 
TSC - 0.83 - 1.60 ; - 0.06 L 
HbA1c 0.12 - 0.62 ; 0.86 N 
Post 
BGlc - 0.70 - 1.34 ; - 0.05 L 
TSC - 1.11 - 1.78 ; - 0.44 VL 
HbA1c - 0.64 - 1.28 ; 0.003 L 
PreT, pre-testing ; Post, post-testing ; BGlc, blood glucose ; TSC, total serum cholesterol ; HbA1c, glycated haemoglobin ; N, 






















Figure 4.7. Changes in glycated haemoglobin (HbA1c) over the three testing periods. PreT, 
pre-testing; Post, post-testing; Reten, retention testing. *, p < 0.05; a, 
statistically significant difference between experimental and control group (p < 
0.05); b, statistically significant difference between PreT and Post in the 
experimental group (p < 0.05); d, statistically significant difference between 
PreT and Reten (p < 0.05). 
b * d * 
a * 
b, d 
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4.5. Functional Capacity Variable 
4.5.1. Six Minute Walk Test (6MWT) 
Differences between the two groups, and changes over the three testing occasions are displayed in 
Figure 4.8 below. There were no statistically significant differences (p > 0.05) between the groups 
over time, and no interaction effect. At the pre-testing session (PreT), both groups walked almost 
identical distances, with the control group walking 60 cm, or 0.2 % further. Both groups increased 
the total distance walked in six minutes at post-testing, with no statistically significant difference (p 
> 0.05) found between the two groups, although there was a small practically significant difference 
(ES = 0.38, Table 4.5). Statistically significant differences were found, however, when PreT (p = 
0.0001) was compared to post-testing in the experimental group. Compared to post-testing, a slight 
decrease in the total distance walked of 3.89 % (14.7 m) was reported at the retention-testing 
occasion in the experimental group, with the difference not being statistically significant (p > 0.05). 
Despite the decrease compared to post-testing, the total distance walked at retention testing was still 































Figure 4.8.  Changes in total distance walked in the six minute walk test (6MWT) over the 
three testing periods. PreT, pre-testing; Post, post-testing; Reten, retention 
testing. *, p < 0.05; ***, p < 0.001; b, statistically significant difference 
between PreT and Post in the experimental group (p < 0.05); d, statistically 
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Table 4.5.  Effect sizes (ES) related to differences in the distance walked during the six 
minute walk test (6MWT) between the two groups at the pre-testing session 
(PreT) and post-testing session. 
Testing 
Phase 
Variable ES 95% CI 
Qualitative 
Outcome 
PreT 6MWT - 0.006 - 0.75 ; 0.74 N 
Post 6MWT 0.38 - 0.25 ; 1.02 S 
PreT, pre-testing ; Post, post-testing ; 6MWT, six minute walk test ; N, negligible ; S, small. 
 
4.6. Health Related Quality of Life Questionnaires 
Due to their being two questionnaires which objectively measured health-related quality of life 
(HRQoL), a Šidák p-value adjustment was made, with the level of statistical significance for each 
of the different domains of the two questionnaires, being set at p < 0.03. 
4.6.1. Short-Form 36 (SF-36) 
The SF-36 is a non-disease specific health-related quality of life (HRQoL) questionnaire and is 
scored according to the following domains which can be seen in Figure 4.9 to Figure 4.10 below: 
physical functioning, limitations in physical role functioning, bodily pain, social role functioning, 
mental health, limitations in emotional role functioning, vitality and general health perceptions. 
Each domain is scored from zero to 100, with zero being the least favourable outcome (i.e. HRQoL 
in the specific domain being scored is affected to the most severe extent), and 100 being the most 
favourable outcome (i.e. HRQoL in the specific domain being scored is not affected at all). 
4.6.1.1. Physical Functioning 
Changes in physical functioning scores between the two groups over the three testing occasions can 
be seen in Figure 4.9 below. There were statistically significant differences between and within the 
groups over time, as well as a statistically significant interaction effect (p < 0.001). When the two 
groups were compared at post-testing, it was found that the experimental group scored substantially 
higher (34.3 %) than the control group, a difference that was found to be statistically significant (p 
= 0.008), as well as having a large practical significance (ES = 0.90, Table 4.6). Furthermore, the 
difference between post-testing and PreT (37.5%) in the experimental group was found to be 
statistically significant (p < 0.001). The change in physical functioning score between post-testing 
and the retention-testing occasion in the experimental group was hardly noticeable (0.18 %), 
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however, the difference between PreT and the retention-testing occasion was far more substantial. 
The difference of 27.4 % was found to be statistically significant (p < 0.001). 
4.6.1.2. Limitations in Physical Role Functioning 
Similarly to physical functioning, there were statistically significant differences between and within 
the groups over time, as well as a statistically significant interaction effect (p = 0.002) (Figure 4.9). 
Once again, the control group scored on average 3.61 % higher than the experimental group at the 
pre-testing session (PreT), with the difference not being statistically significant (p > 0.03). At post-
testing, the 23.6 % difference in score between the experimental and control group was found to be 
statistically significant (p = 0.01), as well as having a large practically significant difference (ES = 
0.94, Table 4.6). Furthermore, within the experimental group, the difference between post-testing 
and PreT (19.6 %) was statistically significant (p = 0.005). Similar to what was seen in the above 
domain, there was a slight decrease (3.53 %) in physical role functioning score from post-testing to 
the retention testing session in the experimental group, although this difference was not statistically 
significant (p > 0.03). When the retention testing session is compared to PreT, the difference of 13.3 
% was not statistically significant (p > 0.03). 
4.6.1.3. Bodily Pain 
As depicted in Figure 4.9, there were no statistically significant differences between the two groups 
over time (p > 0.03) and no interaction effect. The control group scored 13.8 % higher (and 
therefore a better outcome) than the experimental group at the second pre-testing occasion (PreT), 
which was not statistically significant (p > 0.03) or practically significant (Table 4.6). Both groups 
scored similarly at post-testing, and although there was an increase in score from PreT to post-
testing of 10.6 % in the experimental group, it was not statistically significant (p > 0.03). Once 
again, it was found that at the retention-testing occasion, there was a change in bodily pain score of 
7.51 % when compared to post-testing in the experimental group, a difference that was not 
statistically significant (p > 0.03). When compared to PreT, the difference of 17.3 % was not found 
to be statistically significant (p > 0.03). 
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Figure 4.9.  Changes in scores for the physical parameters of the short form-36 (SF-36) questionnaire, over the three testing periods. PreT, pre-
testing; Post, post-testing; Reten, retention testing. The table inserts to the right of the graph indicates the statistically significant 
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4.6.1.4. Social Role Functioning 
Changes in social role functioning score between the two groups and across the three testing 
occasions, is graphically represented in Figure 4.10 below. There were no statistically significant 
differences between the two groups over time (p > 0.03) and no interaction effect present. The 
difference between the two groups at the pre-testing session (PreT) was 9.1 % and although this 
difference was not statistically significant (p > 0.03), it was of moderate practical significance (ES 
= - 0.41, Table 4.6). At post-testing, the difference between the experimental and control group was 
14.7 %, which was not statistically significant (p > 0.03), although it was a difference of moderate 
practical significance (ES = 0.65). The social role functioning score was highest at the retention 
testing occasion with differences of 13.4 % and 6.50 % when compared to PreT and post-testing, 
respectively. Neither of these differences was statistically significant (p > 0.03). 
4.6.1.5. Mental Health 
Figure 4.10 below is a graphical representation of the changes that occurred with respect to mental 
health between the two groups over the three testing sessions. There were statistically significant 
differences between and within the groups over time, although no interaction effect was found. 
Both the experimental and the control group had almost identical scores at the pre-testing session 
(PreT), with a non-significant overall difference (p > 0.03). At post-testing, the experimental group 
had a 14.1 % higher score compared to the control group, a difference that was not statistically 
significant (p > 0.03), although was of moderate practical significance (ES = 0.70, Table 4.6). At 
the retention-testing occasion, the mental health score decreased significantly (p = 0.03) when 
compared to post-testing in the experimental group, with a difference of 9.62 %. When compared to 
PreT, the score at the retention testing session was 4.99 % lower, although the difference was not 
statistically significant (p > 0.03). 
4.6.1.6. Limitations in Emotional Role Functioning 
The change in scores related to limitations in emotional role functioning between the two groups, 
over the three different testing occasions, is displayed in Figure 4.10 below. There were no 
statistically significant differences between the two groups over time (p > 0.03), nor any interaction 
effect. The difference between the two groups at the pre-testing session (PreT) was a mere 2.9 %, 
which was not statistically significant (p > 0.03). Contrary to what was found at PreT, at post-
testing the experimental group scored 6.5 % higher than the control group, although this difference 
was not statistically significant (p > 0.03) and was only of small practical significance (ES = 0.26, 
Table 4.6). Similarly to what was seen in a number of the above-mentioned domains, the difference 
between post-testing and PreT in the experimental group was statistically significant, and 13.4 % in 
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magnitude (p = 0.02). While there was an 8.82 % decrease in the retention testing score compared 
to post-testing, the score was still 5.04 % higher than PreT, with neither of these differences being 
statistically significant (p > 0.03). 
4.6.1.7. Vitality 
Figure 4.10 below is a graphical representation of the changes in vitality scores between the two 
groups over the three testing occasions. There were statistically significant differences between and 
within the two groups over time, although no interaction effect was found. Both the experimental 
and control group scored similarly at the pre-testing session (PreT), with the experimental group 
scoring 3.68 % higher than the control group, a non-statistically significant difference (p > 0.03). At 
post-testing, the 24.5 % difference between the experimental and control group was statistically 
significant (p = 0.004), as well as being of large practical significance (ES = 0.96, Table 4.6). 
Furthermore, the 15.1 % difference between post-testing and PreT in the experimental group was 
also statistically significant (p = 0.008). Contrary to what was seen in a number of the above-
mentioned domains, there was a substantial decrease in vitality score from post-testing to the 
retention-testing occasion in the experimental group, with the score being only slightly higher than 
PreT (1.09 %). The decrease of 12.2 % between post-testing and the retention-testing occasion was 
statistically significant (p = 0.02). 
4.6.1.8. General Health Perceptions 
Changes in general health perceptions scores between the two groups, and across the three testing 
occasions, are displayed in Figure 4.10 below. Similarly to the vitality domain, there were 
statistically significant differences between and within the two groups over time, although no 
interaction effect. There was a marginal difference (1.02 %) between the two groups at the pre-
testing session (PreT), which was not statistically significant (p > 0.03). At post-testing however, 
the 24.8 % difference between the two groups was statistically significant (p = 0.004), and of large 
practical significance (ES = 0.86, Table 4.6). Similarly to what was reported above, the difference 
between post-testing and PreT (23.4 %) in the experimental group was statistically significant (p < 
0.001). Scores at the retention-testing session were slightly lower when compared to post-testing in 
the experimental group, although the difference of 3.71 % was not statistically significant (p > 
0.03). There was a statistically significant difference, however, between PreT (15.9 %, p = 0.02) 
and the retention-testing occasion. 
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Figure 4.10.  Changes in scores for the psychological parameters of the short form-36 (SF-36) questionnaire, over the three testing periods.  PreT, 
pre-testing; Post, post-testing; Reten, retention testing. The table inserts to the right of the graph indicates the statistically significant 
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Table 4.6.  Effect sizes (ES) related to differences in the SF-36 domains between the two 
groups at the pre-testing session (PreT) and post-testing session. 
Testing 
Phase 






- 0.29 - 0.89 ; 0.32 S 
Role Physical - 0.12 - 0.72 ; 0.48 N 
Role Social - 0.41 - 1.02 ; 0.20 M 
Body Pain - 0.40 - 1.00 ; 0.21 S 
Mental Health 0.05 - 0.55 ; 0.65 N 
Role Emotional - 0.09 - 0.69 ; 0.51 N 
Vitality 0.14 - 0.46 ; 0.74 N 
Health 
Perception 




0.90 0.27 ; 1.53 L 
Role Physical 0.94 0.31 ; 1.57 L 
Role Social 0.65 0.04 ; 1.27 M 
Body Pain 0.08 - 0.52 ; 0.68 N 
Mental Health 0.70 0.09 ; 1.32 M 
Role Emotional 0.26 - 0.35 ; 0.86 S 
Vitality 0.96 0.33 ; 1.59 L 
Health 
Perception 
0.86 0.23 ; 1.48 L 
PreT, pre-testing ; Post, post-testing ; N, negligible ; S, small ; M, moderate ; L, large. 
 
4.6.2. Diabetes-39 Questionnaire (D-39) 
The D-39 is a disease-specific health-related quality of life (HRQoL) questionnaire designed for use 
in diabetic populations. Similarly to the SF-36, it is scored according to a number of categories or 
domains that are relevant to a person suffering from diabetes and are graphically represented in 
Figure 4.11 to Figure 4.12. The domains of diabetes specific HRQoL that are measured through 
this questionnaire are: energy and mobility, sexual functioning, diabetes management and control, 
anxiety and worry, social burdens, perceived quality of life and perceived diabetes severity. The 
lower the score, the less affected their HRQoL is, with a higher score indicating the persons 
HRQoL being affected to a greater extent. 
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4.6.2.1. Energy and Mobility 
Figure 4.11 indicates the changes in energy and mobility, as determined by the D-39, over the three 
testing occasions and between the two groups. For this domain there were statistically significant 
differences between and within the two groups over time, and a statistically significant interaction 
effect (p = 0.003). At the pre-testing session (PreT), the control group scored 10.0 % higher than the 
experimental group, although this difference was not statistically significant (p > 0.03) and only 
showed a small degree of practical significance (ES = - 0.31, Table 4.7). At post-testing however, 
the experimental group scored 33.9 % lower than the control group, indicating an improvement in 
HRQoL related to energy and mobility, which was statistically significant (p < 0.001), as well as 
being a very large practically significant difference (ES = - 1.33). While the control group showed a 
general trend towards a lower score, and therefore a lower impact on their energy and mobility as a 
result of diabetes, the decrease was not statistically (p > 0.03), nor practically significant. On the 
contrary, the experimental group displayed a substantial 28.5% drop from PreT to post-testing, 
which was statistically significant (p < 0.001). There was a slight increase in score for the 
experimental group from post-testing to the retention testing session of 7.40 %, indicating that their 
HRQoL was once again being affected by their levels of energy and mobility, but the change was 
not statistically significant (p > 0.03). However, the 22.8 % difference between PreT and retention 
testing was statistically significant (p = 0.003). 
4.6.2.2. Sexual Functioning 
The changes in scores with respect to the sexual functioning domain of the D-39 over the three 
testing occasions can be seen in Figure 4.11. There were no statistically significant differences 
between the two groups over time (p > 0.03) and no interaction effect. At the pre-testing session 
(PreT), both the experimental and control group had similar scores, with the experimental group 
scoring 6.56 % higher, thereby indicating that their sexual functioning had a greater impact on their 
HRQoL. This difference was neither statistically nor practically significant (p > 0.03). The 
difference between the two groups at post-testing was 17.1 %, where the HRQoL of the 
experimental group was less affected by sexual function. This difference was not statistically 
significant (p > 0.03) and only of small practical significance (ES = - 0.27, Table 4.7). However, the 
difference between PreT and post-testing in the experimental group was statistically significant (p = 
0.02), with a substantially improved HRQoL with respect to sexual functioning. The scores at the 
retention-testing occasion were almost identical to the score at post-testing, with the only 
statistically significant difference being found between PreT and retention testing (p = 0.03), where 
once again there was an improved HRQoL with respect to sexual functioning. 
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4.6.2.3. Diabetes Management and Control 
Figure 4.11 below shows the changes in diabetes management and control scores between the two 
groups over the three testing occasions. Statistically significant differences between and within the 
groups were found over time (p < 0.03), although no interaction effect was found. The control 
group scored 8.1 % higher than the experimental group at the pre-testing session (PreT), indicating 
a greater impact of their HRQoL, although this difference was not statistically significant (p > 0.05) 
and only of small practical significance (ES = - 0.19, Table 4.7). Statistically significant differences 
between the two groups were, however, observed at post-testing, with a 25.2 % difference between 
the two groups (p = 0.004), which also resulted in a large practically significant difference (ES = - 
0.85). Compared to PreT, the experimental group had a statistically significant change at post-
testing of 16.2 % (p = 0.01). As has been a general trend for most of the above-mentioned domains, 
there was a slight increase in the score from post-testing to the retention testing session in the 
experimental group (2.47 %), although this difference was not statistically significant (p > 0.03). 
The 14.1 % decrease in score when compared to PreT was also not statistically significant (p > 
0.03). 
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Figure 4.11.  Changes in scores for the physical parameters of the diabetes-39 questionnaire (D-39) over the three testing periods. PreT, pre-
testing; Post, post-testing; Reten, retention testing. The table inserts to the right of the graph indicates the statistically significant 
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4.6.2.4. Social Burdens 
The changes in social burdens score between the experimental and control group across the three 
testing occasions is displayed in Figure 4.12 below. Statistically significant differences between 
and within the groups were found over time, however, no statistically significant interaction effect 
was found (p > 0.03). Similar to what has been observed in other D-39 domains, the control group 
scored 2.94 % higher than the experimental group in the pre-testing session (PreT), indicating that 
social burdens affected their HRQoL to a greater degree. This difference was not statistically or 
practically significant (p > 0.03). When the two groups were compared at post-testing, the 
difference of 33.1 % was statistically significant (p = 0.003), as well as having a large practical 
significance (ES = - 0.92, Table 4.7). Furthermore, the reduction in score from PreT to post-testing 
(21.7 %) in the experimental group, was also statistically significant (p = 0.01). At the retention-
testing occasion it was found that the social burdens score increased marginally (4.27 %) when 
compared to post-testing in the experimental group, but was still 18.2 % lower than PreT; a 
difference that was not statistically significant (p > 0.03). 
4.6.2.5. Anxiety and Worry 
Figure 4.12 graphically depicts the change in score with respect to the anxiety and worry domain of 
the D-39, over the three testing occasions. There were no statistically significant differences found 
between and within the groups over time, nor any statistically significant interaction effect (p > 
0.03). The control group scored 12.7 % higher than the experimental group at the pre-testing 
session (PreT), once again indicating that anxiety and worry affected their HRQoL to a greater 
degree. This difference was of small practical significance (ES = - 0.33, Table 4.7), although not 
statistically significant  (p > 0.03). The difference between the two groups at post-testing (29.4 %), 
however, was statistically significant (p = 0.006). Aside from the statistically significant difference, 
there was also a moderate practically significant difference between the two groups (ES = - 0.74). 
The experimental group furthermore displayed a statistically significant difference between post-
testing and PreT (p = 0.006), with a 20.6 % reduction in score. There was a non-statistically 
significant (p > 0.03) increase of 5.49 % from post-testing to the retention-testing occasion in the 
experimental group. Despite this increase, the anxiety and worry score at retention testing was still 
15.9 % lower than PreT, which was not statistically significant (p > 0.03). 
4.6.2.6. Perceived Quality of Life 
Changes in perceived quality of life (QoL) scores between the two groups across the three testing 
occasions are displayed in Figure 4.12 below. Statistically significant differences were found 
between and within the groups over time, with a significant interaction effect (p = 0.02). At post-
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testing, the experimental group had a 22.7 % lower score than the control group, indicating that 
perceived quality of life affected their HRQoL to a lesser extent than the control group. This 
difference was found to be statistically significant (p = 0.02), as well as being of large practical 
significance (ES = - 0.82, Table 4.7). A statistically significant difference (22.7 %) was observed in 
the experimental group when the PreT (p = 0.008) score was compared to the post-testing score. 
When comparing the retention testing scores against the two preceding testing sessions in the 
experimental group, it was found that there was a non-significant (p > 0.03) 18.8 % increase 
compared to post-testing, and a non-significant (p > 0.03) 4.79 % decrease compared to PreT. 
4.6.2.7. Perceived Diabetes Severity 
Figure 4.12 below is a graphical representation of the changes in perceived diabetes severity score 
between the two groups over the course of the three testing occasions. Statistically significant 
differences between and within the groups over time were found, although on this occasion, no 
statistically significant interaction effect was reported (p > 0.03). The control group scored 6.83 % 
higher than the experimental group at the pre-testing session (PreT), a difference that was not 
statistically significant (p > 0.03), but was of small practical significance (ES = - 0.21, Table 4.7), 
and indicated that perceived diabetes severity affected their HRQoL to a greater degree than the 
experimental group. At post-testing, however, the difference of 20.4 % between the experimental 
and control group, was statistically significant (p = 0.03) and of moderate practical significance (ES 
= - 0.60). The decrease in score of 22.2 % from PreT to post-testing in the experimental group was 
statistically significant (p = 0.002). Once again, a similar pattern to the above-mentioned domains 
was found, with their being a slight, and not statistically significant (p > 0.03) 9.34 % increase in 
score from post-testing to the retention testing session in the experimental group. When compared 
to PreT, the retention testing occasion score was 14.2 % lower, which was not a statistically 
significant difference (p > 0.03). 
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Figure 4.12.  Changes in scores for the psychological parameters of the diabetes-39 questionnaire (D-39) over the three testing periods. PreT, pre-
testing; Post, post-testing; Reten, retention testing. The table insert to the right of the graph indicates the statistically significant 
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Table 4.7.  Effect sizes (ES) related to differences in the D-39 domains between the two 
groups at the pre-testing session (PreT) and post-testing session. 
Testing 
Phase 






- 0.30 - 1.05 ; 0.44 S 
Sexual 
Functioning 
0.09 - 0.65 ; 0.83 N 
Anxiety & 
Worry 
- 0.33 - 1.08 ; 0.42 S 




- 0.19 - 0.94 ; 0.55 S 








- 1.33 - 2.03 ; - 0.64 VL 
Sexual 
Functioning 
- 0.27 - 0.90 ; 0.36 S 
Anxiety & 
Worry 
- 0.74 - 1.39 ; - 0.09 M 




- 0.85 - 1.50 ; - 0.19 L 




- 0.60 - 1.24 ; 0.04 M 
PreT, pre-testing ; Post, post-testing ; QoL, quality of life ; N, negligible ; S, small ; M, moderate ; L, large ; VL, very large. 
 
4.7. Social Support Questionnaire 
The Diabetes Family Behaviour Scale (DFBS), adapted for this study, was used to assess the degree 
of familial social support the participants received throughout the duration of the study. The DFBS 
is scored according to two subscales, namely the Guidance-Control subscale, and the Warmth-
Caring subscale, with higher scores indicative of greater familial support. 
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4.7.1. Guidance-Control DFBS Subscale 
Changes in the guidance-control scores between the two groups and across the three testing 
occasions are displayed in Figure 4.13 below. There were no statistically significant differences 
between or within the groups over time (p > 0.05) and no interaction effect. The groups scored 
almost exactly the same for the pre-testing session (PreT), with the difference of 0.75 % not being 
statistically significant (p > 0.05) or practically significant. At post-testing, the control group scored 
2.2 % higher than the experimental group, a difference that was neither statistically significant (p > 
0.05), nor practically significant (Table 4.8). When compared to the retention-testing occasion, 
there were once again no statistically significant differences (p > 0.05), although the guidance-
control subscale score for the experimental group was highest at this testing session, with 
differences of 1.07 % and 2.27 % when compared to PreT and post-testing, respectively. 
4.7.2. Warmth-Caring DFBS Subscale 
Figure 4.13 below is a graphical representation of the changes in warmth-caring scores between the 
experimental and control group over the three testing occasions. There were no statistically 
significant differences between or within the groups over time, and no interaction effect. The 
control group scored 1.3 % higher than the experimental group at the pre-testing session (PreT), 
although this difference was not statistically significant (p > 0.05) or practically significant. At post-
testing, the magnitude of the difference between the two groups was larger (4.4 %), although this 
difference was not statistically significant (p > 0.05). The difference was, however, of small 
practical significance (ES = - 0.38, Table 4.8). When evaluating the warmth-caring subscale score 
at the retention testing session for the experimental group, once again no statistically significant 
differences were found compared to previous scores (p > 0.05), although the scores were highest 
during this testing period. The differences were a marginal 1.71 % and 0.09 % compared to PreT 
and post-testing, respectively 
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Figure 4.13. Changes in guidance-control and warmth-caring subscale scores from the diabetes family behaviour scale (DFBS), over the three 
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Table 4.8.  Effect sizes (ES) related to differences in the DFBS Subscales between the two 
groups at the pre-testing session (PreT) and post-testing session. 
Testing 
Phase 






0.03 - 0.71 ; 0.78 N 
Warmth - 
Caring 




- 0.11 - 0.74 ; 0.52 N 
Warmth - 
Caring 
- 0.38 - 1.01 ; 0.25 S 
PreT, pre-testing ; Post, post-testing ; N, negligible ; S, small. 
4.8. Dietary Outcomes 
4.8.1. Eating Times 
There were a number of statistically significant differences between the experimental and control 
group with respect to eating times. For the most part, both groups ate at four occasions during the 
day (combination of breakfast, lunch, supper and snacks), with the experimental group reporting 
this eating pattern more frequently (73.6 %) compared to the control group (65.8 %). This figure 
increased to 85.7 % in the experimental group when the retention testing data was factored in. The 
remaining 26.4 % (14.3 % with retention data included) and 35.3 % in the experimental and control 
group, respectively, only reported eating on three occasions during the day (combination of 
breakfast, lunch, supper and snacks). Supper (Figure 4.14c) was the only constant between the two 
groups, with 100% of the experimental and control group reporting that they ate at supper time. 
Breakfast (Figure 4.14a) and lunch (Figure 4.14b) had similar frequencies, with snacks (Figure 
4.14d) being consumed the least (76.9 % in the experimental group and 79.7 % in the control 
group) as displayed in Figure 4.14 below. However, the incidence of participants in the 
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4.8.2. Food Content 
When looking at food content, the areas that were highlighted as clinically relevant for diabetics 
was sugar usage, the type of bread that was consumed, whether complex carbohydrates were eaten 
together during a single meal, and the frequency at which vegetables and/or salad were consumed 
per week.  
With respect to extra sugar or sweeteners being used (Figure 4.15), the control group exhibited 
higher usage during the pre-testing session (PreT) compared to the experimental group, although 
the differences between the two groups was not statistically significant (p > 0.05). At post-testing, 
however, the 57.1 % difference between the two groups was statistically significant (p = 0.002). 
Furthermore, the experimental group exhibited a drop of 47.6 % in the use of extra sugar or 
sweeteners from PreT to post-testing, which was statistically significant (p = 0.003). However, 
there was no change in the number of participants who made use of extra sugar or sweeteners 
between post-testing and the retention testing session. The statistically significant difference of 47.6 
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(c) (d) 
Figure 4.14.  Differences between the experimental and control group at (a) breakfast, (b) 
lunch, (c) supper, and (d) snacks. PreT, pre-testing; Post, post-testing; Reten, 
retention testing. 
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The three types of bread consumed were white bread, brown bread and low glycaemic index (GI) / 
whole-wheat bread, with the differences being displayed in Figure 4.16 below. White bread (Figure 
4.16a) was the most commonly eaten bread by the control group across the first two testing 
occasions (61.2 %), whereas the experimental group most commonly ate low GI bread (Figure 
4.16c) (52.4 %). None of the participants in the control group reported eating low GI bread, with 
brown bread (Figure 4.28b) only being eaten 38.8 % of the time. Statistically significant differences 
between the groups were found at the first two testing sessions with respect to white bread 
consumption (p = 0.02, PreT ; p < 0.001, Post), with the complete cessation of white bread 
consumption by the experimental group at post-testing and retention testing resulting in a 
statistically significant difference when compared to PreT (p = 0.04). While there was a difference 
of approximately one percent between the experimental and control group with respect to brown 
bread consumption, the difference was not statistically significant (p > 0.05). Considering the 
control group did not consume low GI or whole-wheat bread, the differences between the two 

























Figure 4.15.  Differences between the two groups with respect to extra sugar and/or 
sweetener being used across the three testing occasions. PreT, pre-testing; Post, 
post-testing; Reten, retention testing. **, p < 0.01; a, statistically significant 
difference between experimental and control group (p < 0.05); b, statistically 
significant difference between PreT and Post in the experimental group (p < 
0.05); d, statistically significant difference between PreT and Reten in the 
experimental group (p < 0.05). 
b ** d ** 
a ** b, d 
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Post). The increase in consumption of the experimental group between PreT and post-testing, was 
however, not statistically significant (p > 0.05). The experimental group reduced their low GI bread 
consumption at retention testing by 19.1 % when compared to post-testing, with a concomitant 
increase of the same magnitude in brown bread consumption. Neither of these changes was found to 
be statistically significant (p > 0.05). 
 
Figure 4.17 depicts the differences between the two groups with respect to the consumption of 
complex carbohydrates together during one sitting, across the three different testing occasions. 
Complex carbohydrates most commonly reported were rice, potatoes, maize meal and pasta. The 
control group consumed complex carbohydrates more frequently than the experimental group at the 












































































Figure 4.16.  Differences between the experimental and control group with respect to (a) 
white bread consumption, (b) brown bread consumption, and (c) low GI or 
whole-wheat bread consumption. PreT, pre-testing; Post, post-testing; Reten, 
retention testing. *, p < 0.05; ***, p < 0.001; a, statistically significant 
difference between experimental and control group (p < 0.05); b, statistically 
significant difference between PreT and Post in the experimental group (p < 
0.05); d, statistically significant difference between PreT and Reten in the 
experimental group (p < 0.05)  
(a) (b) 
(c) 
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However, at post-testing there was a substantial difference of 89.0 % between the two groups, 
which was statistically significant (p < 0.001). Furthermore, the 81.0 % reduction from PreT to 
post-testing in the experimental group, was also statistically significant (p < 0.001, PreT). At the 
retention-testing session, there was a small increase of 2.38 % from post-testing; however, this was 
still substantially lower than the reported incidence at PreT, with the difference of 78.6 % being 
statistically significant (p < 0.001). 
 
The frequency of vegetable and/or salad consumption per week for both groups across the three 
testing occasions is displayed in Figure 4.18. There were statistically significant differences 
between and within the groups over time, as well as a statistically significant interaction effect (p < 
0.001). Marginal differences in consumption between the two groups were observed at the pre-
testing session (PreT), with the experimental group on average, consuming vegetables and/or salads 
2.7 times per week, compared to 2.4 times per week for the control group, a difference of 5.7 %. 


































Figure 4.17.  Differences between the experimental and control group with respect to the 
consumption of complex carbohydrates together during a single sitting, across 
the three testing occasions. PreT, pre-testing; Post, post-testing; Reten, retention 
testing. ***, p < 0.001; a, statistically significant difference between 
experimental and control group (p < 0.05);  b, statistically significant difference 
between PreT and Post in the experimental group (p < 0.05); d, statistically 
significant difference between PreT and Reten in the experimental group (p < 
0.05). 
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groups at post-testing was (p < 0.001). In this case the experimental group on average consumed 
vegetables and/or salads five times a week, compared to 2.4 times a week for the control group, a 
difference of 52.0 %. Furthermore, the 47.0 % increase from PreT to post-testing in the 
experimental group was also statistically significant (p < 0.001). A similar pattern was observed at 
the retention-testing occasion in the experimental group, with a large statistically significant 
difference when compared to PreT (44.6 %, p < 0.001). While there was a decrease of 4.29 % 
compared to post-testing, the difference between the two testing occasions was not statistically 
significant (p > 0.05). 
 
When examining the total monthly food expenses (Figure 4.19), between the two groups across the 
three testing occasions, no statistically significant differences were found between the groups over 
time (p > 0.05), and no interaction effect was observed. At the pre-testing session (PreT), the 
control group had an average monthly expenditure of R 1 480.00, which was 9.81 % higher than the 
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Figure 4.18.  Differences between the experimental and control group with respect to the 
number of times per week vegetables and/or salad are consumed, across the 
three testing occasions.  PreT, pre-testing; Post, post-testing; Reten, retention 
testing. ***, p < 0.001; a, statistically significant difference between 
experimental and control group (p < 0.05); b, statistically significant difference 
between PreT and Post in the experimental group (p < 0.05); d, statistically 
significant difference between PreT and Reten in the experimental group (p < 
0.05). 
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0.05). At post-testing, the experimental group had a 7.53 % (R 108.70) higher monthly expenditure, 
whereas the control group had a 3.62 % (R 53.53) lower monthly expenditure, with this difference 
not being statistically significant (p > 0.05). When looking at the differences within the groups 
between the first two testing sessions, a statistically significant difference between PreT and post-
testing (p = 0.03) was found in the experimental group. However, no statistically significant 
difference was found between PreT and post-testing in the control group (p > 0.05). Monthly 
expenditure increased only marginally (R 6.52) for the experimental group at the retention testing 
session compared to post-testing, which was not statistically significant (p > 0.05). However, the 
difference of 7.94 % (R 115.22) between PreT and the retention-testing occasion was statistically 




































b * d * b, d 
Figure 4.19.  Differences in monthly expenditure on food between the experimental and 
control group across the three testing occasions. PreT, pre-testing; Post, post-
testing; Reten, retention testing. *, p < 0.05; b, statistically significant difference 
between PreT and Post in the experimental group (p < 0.05); d, statistically 
significant difference between PreT and Reten in the experimental group (p < 
0.05). 
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4.8.3. Lifestyle Habits 
The smoking and drinking behaviours of the two groups formed the basis for the lifestyle habits 
analysis. On average, 19.4 % of the control group and 14.3 % of the experimental group indicated 
that they were regular smokers, with no statistically significant change (p > 0.05) in smoking 
behaviour observed in either group across the three testing occasions. The control group did, 
however, report a decreased number of smokers (6.25 %) at post-testing compared to the pre-testing 
session (PreT) as seen in Figure 4.20 below. 
 
The differences between the experimental and control group with respect to drinking behaviour are 
graphically represented in Figure 4.21 to Figure 4.25 below. For the first two testing sessions, there 
was a greater number of control group participants (22.5 %) who consumed alcoholic beverages 
(Figure 4.21) compared to the experimental group (14.3 %), although this difference was not 
statistically significant (p > 0.05). Compared to PreT, the experimental group displayed no change 
in the number of drinkers, whereas the control group displayed a slight increase (5.0 %) at post-
testing, with the difference not being statistically significant (p > 0.05). Interestingly, at the 
retention testing session, there was a decrease of 7.14 % in the number of participants who 
consumed alcoholic beverages when compared to both post-testing and PreT. This decrease was not 

























Figure 4.20.  Differences in the number of smokers between the experimental and control 
group across the three testing occasions. PreT, pre-testing; Post, post-testing; 
Reten, retention testing. 
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The differences between the type of alcohol consumed by both groups is displayed in Figure 4.22 
below. The control group (Figure 4.22a) had a reasonably even distribution, with wine and beer 
being the most common type of drink consumed. Conversely, almost two thirds of the experimental 
group (Figure 4.22b) preferred spirits as their drink of choice, with wine being the next popular 
choice, and beer being the least consumed alcoholic beverage.  
When looking at the quantity of alcohol consumed per week between the two groups (Figure 4.23), 
no statistically significant differences between the groups were found, and no interaction effect was 
reported (p > 0.05). At the pre-testing session (PreT), the experimental group reported a 6.30 % 
higher alcohol intake than the control group which was not statistically significant (p > 0.05). In 
contrast to this, at post-testing, the experimental group decreased their alcohol consumption by 25 
%, a non-statistically significant difference (p > 0.05). The control group did not change the 
quantity of alcohol consumed and were found to consume 20 % more alcohol than the experimental 
group at this testing period. A further reduction in the quantity of alcohol consumed by the 
experimental group was seen at the retention testing session, with non-statistically significant 
differences of 65 % and 50 % from PreT and post-testing, respectively. 
With respect to the frequency of alcohol consumed per week (Figure 4.24), no statistically 
significant differences between the groups were found, and no interaction effect was reported (p > 
0.05). The control group engaged in drinking 42.9 % more frequently than the experimental group 
at the pre-testing session (PreT), a difference that was not statistically significant (p > 0.05). The 
control group reported a lower drinking frequency at post-testing when compared to PreT, with the 
decrease of 21.4 % not statistically significant (p > 0.05). The experimental group on the other hand 
did not change the frequency at which they consumed alcohol per week, although they did report a 
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Figure 4.21.  The frequency of participants in the experimental and control group who 
consumed alcoholic beverages across the three testing occasions. PreT, pre-













Figure 4.22.  Differences in the type of alcoholic beverages consumed between the (a) control 
and (b) experimental group. 
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Figure 4.23.  Differences in the quantity of alcohol consumed per week between the 
experimental and control group, across the three testing occasions. PreT, pre-















































Figure 4.24.  Differences in the frequency of alcohol consumed per week between the 
experimental and control group, across the three testing occasions. PreT, pre-
testing; Post, post-testing; Reten, retention testing. 
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Figure 4.25 depicts the differences in monthly expenditure on alcohol and/or smoking products 
between the two groups. No statistically significant differences between the two groups were found 
over time (p > 0.05). On average the control group spent 33.3% more per month (R 100.00) than the 
experimental group, although this difference was not statistically significant (p > 0.05). There was 
no difference between the groups at post-testing compared to the pre-testing session (PreT).  
Taken as a percentage relative to monthly food expenditure, the control group devoted 20.6 % of 
their funds towards alcohol and smoking products, with the experimental group apportioning 14.4 
% of their funds towards alcohol and smoking products. The experimental group decreased their 
monthly spend on smoking and/or drinking activities by 50 % (R 100.00) at the retention testing 
session compared to post-testing and PreT, a difference that was not statistically significant (p > 
0.05). However, when taken as a percentage of monthly food spend, only 6.90 % of their funds 

















































Figure 4.25.  Differences in monthly expenditure on alcohol and/or smoking products 
between the experimental and control group across the three testing occasions. 
PreT, pre-testing; Post, post-testing; Reten, retention testing. 
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4.9. Health Professional Usage Outcomes 
4.9.1. Location of Primary Healthcare Provider 
Three locations were reported as places where the participants would visit their primary healthcare 
provider, namely, state hospital, community clinic, or private practice. Figure 4.26 shows the 
differences between the two groups with respect to the above-mentioned locations. The control 
group (Figure 4.26a) most often consulted with their primary healthcare provider in private practice 
settings (63.0 %), both within and outside the community, with the community clinic being used by 
just under one quarter of the control participants. State hospital visits to consult with the 
participants’ primary healthcare provider were the least favoured option. In contrast, the 
experimental group (Figure 4.26b) used both the community clinic (54 %) and private practice (46 
%), in almost equal proportions, to consult with their primary healthcare providers, with none of the 
participants making use of the state hospitals for regular consultations. 
 
Figure 4.27 below shows the different modes of transport used by the control (Figure 4.27a) and 
experimental (Figure 4.27b) group to travel to their respective primary healthcare provider. Almost 
two thirds of the control group made use of a vehicle (private or public transport) as their preferred 
mode of transport, with the remaining third walking to the location of their primary healthcare 
provider. The experimental group, however, favoured walking to the location of their primary 




Hosptial Visit Clinic Visit Private Visit
54% 
46% 
Hosptial Visit Clinic Visit Private Visit
(a) (b) 
Figure 4.26.  Differences in location for consulting with the primary healthcare provider 
between the (a) control and (b) experimental group. 
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The differences between the two groups with respect to the distance needed to travel to consult with 
the primary healthcare provider are displayed in Figure 4.28 below. The control group (Figure 
4.28a) most often only had to travel five kilometres or less to reach the location of their primary 
healthcare provider, with 20.0 % of the participants travelling between six and 20 kilometres. Only 
a small proportion of participants travelled more than 20 kilometres to visit their primary healthcare 
provider. Similar proportions were found in the experimental group (Figure 4.28b), where almost 
three quarters of the participants were required to travel five kilometres or less, and only 28.0 % 
were required to travel between six and 20 kilometres. 
 
4.9.2. Use of Primary Healthcare Provider 
The number of visits to the primary healthcare provider per year for the two groups is displayed in 
Figure 4.29 below. The control group (Figure 4.29a) consulted with their primary healthcare 
provider far less frequently than the experimental group (Figure 4.29b), with only 44.0 % of the 









Figure 4.27.  Differences in mode of transport to travel to the primary healthcare provider 








< 5 km Btwn 6-20 km > 20 km
(b) 
Figure 4.28.  Differences in distances required to travel to the primary healthcare provider 
between the (a) control and (b) experimental group. 
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comparison, 65.0 % of the experimental group visited their primary healthcare provider between 
two and five times per year, with six percent of the participants in the experimental group having 
monthly check-ups. Of concern is the 56.0 % and 29.0 % of the participants in the control and 
experimental group, respectively, who consulted with their primary healthcare provider once, or 
sometimes less, per year. 
 
Figure 4.30 further illustrates this point, where the number of participants who go for regular 
check-ups with their primary healthcare provider or other healthcare professional (nurse, etc), is 
surprising low in the control group. At the pre-testing session (PreT), the experimental group 
reported going for regular check-ups 17.6 % more frequently than the control group, a difference 
that was not statistically significant (p > 0.05). However, the difference of 81.3 % between the 
experimental and control group at post-testing, was statistically significant (p = 0.003). 
Encouragingly, the number of participants who reported regular check-ups at the retention-testing 

















< 1 p/y 2 - 5 p/y 6 - 12 p/y
(b) 
Figure 4.29.  Differences in the number of visits per year to the primary healthcare provider 
between the (a) control and (b) experimental group. 
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Figure 4.30.  Differences between the experimental and control group with respect to regular 
check-ups with their primary healthcare provider and/or other healthcare 
professionals, across the three testing occasions. PreT, pre-testing; Post, post-
testing; Reten, retention testing. **, p < 0.01; a, statistically significant 
difference between experimental and control group (p < 0.05). 
a ** 
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The main objective of this study was to determine the effectiveness of a community-based, 10-week 
lifestyle intervention on the physiological, psychological and health-related outcomes in adults 
suffering from T2DM in a low SES community. Furthermore, this study sought to determine 
whether a post-intervention guide containing information related to the different aspects of the 
study, was able to maintain the changes seen during the intervention period. 
In the South African context, there are only a handful of studies conducted in low-socioeconomic 
communities, and only two community-based studies with similar methodologies to the current 
study, although not nearly as comprehensive in nature. This study is the first comprehensive 
lifestyle intervention in a low SES community in South Africa and will hopefully form the 
framework upon which further studies can be built. This study will also provide further insight into 
the barriers that exist to the development of and carrying out of comprehensive lifestyle 
intervention programs, specifically with respect to accounting for confounding variables, 
integrating the program with the primary healthcare sector and ensuring that each of the dimensions 
of the program work synergistically. The use of combination exercise in this specific community, 
with the focus on whole-body exercise is additionally an area that has not been extensively explored 
in low SES communities, despite the advantageous benefits over either aerobic or resistance 
exercise on their own, and is where the current study is contributing significantly to the paucity of 
data. 
There were a number of encouraging findings in the study, with improvements seen in most of the 
physiological outcome variables, as well as a comprehensive improvement in HRQoL. 
Furthermore, there seemed to be an improvement in dietary habits, although minimal change to 
other potentially harmful lifestyle behaviours was observed. The use of the post-intervention guide 
and its ability to maintain the changes seen following the intervention was unclear and requires 
further investigation. 
5.2. Descriptive Characteristics at Baseline 
There are a multitude of studies that have been conducted over the last 30 years examining all the 
components of T2DM, and the management thereof. While there is a wide age-range of participants 
in T2DM studies, dependent on the specific goals of the study, the average age in recent studies 
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involving physical activity interventions, dietary interventions, or both is 57.2 ± 3.5 years 
(Itsiopoulos et al., 2011; Yang & Oh, 2013; Ades et al., 2015; Hosseinpour-Niazi et al., 2015; 
Motahari-Tabari et al., 2015), which is similar to the average age of this study of 59.5 ± 12.2 years. 
This is to be expected considering that T2DM is traditionally considered an adult-onset disease, 
although there is sufficient evidence to believe that this is changing, with the average age of onset 
for T2DM set to decrease substantially over the next decade if nothing is done to prevent it 
(Thunander et al., 2008; Craig, 2009; De Onis et al., 2010). While no specific information on 
income or education was explicitly asked from participants in the current study, 63 % of the 
participants were retired and receiving the state pension of approximately R 1 500 per month as 
their only form of income. Furthermore, 14 % of the remaining participants were nearing the age of 
retirement and would also be relying on the state pension as an income in the foreseeable future. 
The total income of approximately R 17 000 per year would place the majority of the participants in 
the low SES category. A number of other studies have found that annual income for low SES is 
approximately $ 15 000 per family (Krishnan et al., 2010; Piccolo et al., 2015) or approximately $ 
1250 per month, placing the participants in this study well below the low socio-economic standard 
of living in the USA. 
5.3. Outcome Parameters 
5.3.1. Anthropometric Outcomes 
The anthropometric profile of T2DM patients is of particular importance due to the link of android 
obesity with an increased risk of developing diabetes, and the complications that arise thereof (Fox 
et al., 2007; American College of Sports Medicine, 2014). The average BMI of the participants in 
this study was 31.1 ± 8.6, which according to the ACSM, would classify them as obese (American 
College of Sports Medicine, 2014). Once again, the average BMI in related studies was similar to 
that of the present study, with only a marginally higher measurement of 32.3 ± 3.6 (Savoca et al., 
2004; Lambers et al., 2008; Geirsdottir et al., 2012; Yang & Oh, 2013; Ades et al., 2015; Motahari-
Tabari et al., 2015). There is a well-established relationship between obesity and T2DM, which is 
why the high BMI measurements do not come as a surprise (Tuei et al., 2010; McKenney & Short, 
2011; Wu et al., 2014; Costanzo et al., 2015; Wang et al., 2015). 
Body fat percentage is not always reported in studies involving physical activity and/or diet as a 
treatment or intervention method, however, in the cases where it was reported, the average body fat 
percentage was 33.0 ± 5.3 % (Maiorana et al., 2002; Geirsdottir et al., 2012; Ades et al., 2015; 
Emerenziani et al., 2015; Sari-Sarraf et al., 2015), which was slightly higher than the average body 
fat percentage of 30.7 ± 14.7 % of the participants in this study. 
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There was a slight decrease in BMI for both the experimental and control group over the 10-week 
period, although this difference was not statistically significant. There was, however, a substantial 
decrease of 3.4 % body fat in the experimental group (< 0.05). These findings are supported by 
Ades et al. (2015) who, in a group of obese/overweight individuals found a significant reduction in 
BMI and body fat percentage (3.5 %) following a six month weight loss program. Unfortunately, 
this study did not have a control group for comparison, however, in a similar, albeit slightly shorter 
study by Sari-Sarraf et al. (2015), they found the experimental group had a significant reduction in 
BMI and body fat percentage (3.1 %), with minimal changes in the control group for both BMI and 
body fat percentage. These changes in body fat percentage were similar to what was found in the 
current study of 10 weeks, providing evidence that a combination exercise program of reasonably 
short duration is effective in managing anthropometric outcomes. There were, however, distinct 
methodological differences between the two above-mentioned studies and the present study with 
respect to both the exercise and dietary programs. The exercise program of the current study 
continually progressed the exercises from week to week, whereas the studies by (Ades et al., 2015) 
and (Sari-Sarraf et al., 2015), used a set intensity for the duration of the intervention period. 
Furthermore, while the study by Ades et al. (2015) made use of a similar dietary intervention, none 
was used by Sari-Sarraf et al. (2015). 
A 12 month study by Balducci et al. (2004) reported similar findings to the above-mentioned 
studies, with a combined aerobic and resistance training program resulting in a 10 % decrease in 
BMI and fat mass, respectively. Considering the exercise program methodology was similar to the 
current study, their results are probably due to the longer duration of their program. A six month 
home-based exercise program elicited similar results to the above-mentioned authors, with the 
intervention resulting in a significant decrease in BMI, although no information was provided with 
respect to changes in body fat percentage (Yang & Oh, 2013). In a recent study by Emerenziani et 
al. (2015), it was found that a 12-week aerobic exercise program resulted in a significant decrease 
in BMI and body fat percentage (2.0 %) in the experimental group and no change in the control 
group. Despite the experimental period being longer than the current study, the drop in body fat 
percentage was smaller, and could be as a result of the sole use of aerobic exercise as a training 
modality at a continuous intensity that may have been lower than the current study, the slightly 
older age of the participants in the study (67 years versus 60 years), or the lower baseline body fat 
percentage of the participants. These findings were corroborated by another recent study where 
there was a steady decrease in BMI over an eight week period during which an aerobic exercise 
program was presented, while the control group had minimal changes, even tending towards an 
increase (Motahari-Tabari et al., 2015). This study did not explicitly measure body fat percentage, 
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however, considering the study population were obese, a decrease in waist circumference together 
with a decrease in BMI could suggest that there was a certain degree of fat mass loss as a result of 
the intervention (Meeuwsen et al., 2010).  
Contrary to these findings, Maiorana et al. (2002) found that following an eight week combined 
exercise program, there was no change in BMI in either the experimental or control group. 
However, there was a decrease in body fat percentage in the experimental group, which suggests 
that there was a concomitant increase in fat free mass to compensate. Considering that the absolute 
weight of fat free mass is higher than fat mass, this is a plausible reason for this finding. Another 
study which had similar findings was conducted by Tessier et al. (2000) and found no change in 
BMI following a 16-week progressive aerobic exercise program in either group, with no data on 
body fat percentage being reported. There are a number of plausible reasons for this finding. Firstly, 
it has been reported by Stephens et al. (2015) that individuals with T2DM exhibit a genetic 
predisposition towards a term known as “exercise resistance”, whereby physical activity does not 
result in improvements in T2DM management and control. Muscle fuel metabolism is what 
differentiates those who respond, versus those who don’t, therefore, dietary modifications may be 
of more benefit in these individuals. Secondly, the participants in this study were on multiple 
pharmacological agents for the management of their T2DM, with most of these participants being 
on these agents for three years or more. One of the well-established side-effects of certain 
medications is weight gain, and could explain why the BMI did not change, despite the increase in 
energy expenditure brought about by the exercise program (Neumiller & Setter, 2009; Harper et al., 
2013; He et al., 2015). Finally, the possibility exists that the participants could have increased their 
food consumption due to the exercise sessions, with no data reported on dietary changes by the 
authors.  
Aside from the effects of physical activity on anthropometric outcomes, dietary changes have been 
reported to impact on BMI and body fat percentage, in the absence of, and in conjunction with 
physical activity. Hosseinpour-Niazi et al. (2015) found that simply by substituting certain food 
types (substitution of red meat with legumes), eight weeks was sufficient to cause a decrease in 
BMI and waist circumference, which was not seen in the control group. The principle of 
substituting food groups was similar to what was observed in this study, and was part of the dietary 
intervention, with changes in the quality of carbohydrate consumed (e.g. substituting white bread 
for low GI bread, which causes a more sustained glycaemic response) possibly accounting for some 
of the changes in anthropometric outcomes. Encouraging research published earlier, found that after 
only three weeks of either a low-carbohydrate or low-fat diet, there was a marked reduction in BMI 
and waist circumference, although the low-carbohydrate diet seemed to be more effective (Von 
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Bibra et al., 2014). Considering that the participants in this study were not prescribed a specific 
diet, it is difficult to directly compare these results to this study. Nevertheless the decrease in 
multiple carbohydrates being eaten in one meal, as well as a decrease in the use of extra sugar and 
sweeteners from the current study could account for the changes in body composition. With this 
consideration in mind, the decrease in body fat percentage, which is strongly associated with waist 
circumference (Meeuwsen et al., 2010), shows that the exercise and diet intervention affected 
change. 
A large percentage of studies investigating diet-related changes on T2DM outcomes are conducted 
over six months to one year, which is substantially longer than the current study, and could account 
for some of the differences seen between the present study and previous studies of longer duration. 
Andrews et al. (2011) examined the effects of a six-month program of diet only, a combination of 
diet and exercise and usual care given by healthcare professionals. It was found that diet alone and 
the combination of diet and exercise, both resulted in decreases in BMI, as well as decreases in 
resistance measured by bioelectrical impedance (BIA), while negligible differences were found 
between the diet only and combination group. BIA works on the principle that a micro-current 
emitted, will experience impedance based on the size and type of the various tissues it passes 
through, with lower levels of impedance indicating a greater degree of fat free mass, and higher 
levels of impedance indicating a greater degree of fat mass (Ryo et al., 2005; Huang et al., 2015; 
Mehlig et al., 2015).  
The negligible differences between the diet only group, and combination group could be due to a 
number of reasons. Firstly, the intensity of the activity may not have been high enough to elicit a 
response, with walking being used as the modality. Secondly, it is plausible that the participants 
increased their food intake in response to exercise participation, which would negate the caloric 
deficit that may have been present. Finally, most of the participants were at the early stages of 
disease progression, therefore the magnitude of improvement possible would be less. While the 
dietary components were similar between the current study and the study by Andrews et al. (2011), 
the exercise components were vastly different, which makes the two studies difficult to compare. 
However, the benefits of a combination intervention over usual care are comparable and illustrate 
the potential these types of programs have in managing T2DM. Kontogianni et al. (2012) found that 
a 12-month dietary intervention consisting of a reduction in sugars, saturated fat and refined foods, 
together with an increase in vegetable intake, resulted in a substantial decrease in BMI and a small 
decrease in waist circumference.  
The similarities in the findings between the two studies is more than likely because the dietary 
component of the current study included similar dietary advice, with participants being encouraged 
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to reduce sugar intake, minimise the frequency at which they ate multiple carbohydrates during one 
meal, moderate portion sizes and increase the consumption of vegetables and healthy fats. Another 
long-term study conducted over 12 months by Pedersen et al. (2014), investigated the difference 
between a high-protein and standard-protein diet on a number of anthropometric and metabolic 
markers. Both the high- and standard-protein diets resulted in a decrease in BMI and body fat 
percentage, although the high-protein diet resulted in a greater, yet not significant reduction. The 
reasoning behind these types of diets is that protein, like fat, gives higher levels of satiety, and 
therefore an individual is more prone to decrease their food intake in subsequent meals, resulting in 
an energy deficiency and ultimately weight loss (Johnston et al., 2004). Dietary protein in the form 
of fish and some vegetables were consumed in greater amounts following the 10-week intervention 
in this study which would confirm the findings of the study by Pedersen et al. (2014). A recent 
study conducted in a resource limited setting in South Africa found that, following a six-month 
program of dietary advice, BMI was moderately lower than at baseline, although was not 
maintained at the 12 month follow-up, suggesting that constant support and a structured program is 
necessary to maintain changes in anthropometric outcomes (Muchiri et al., 2015). The findings of 
the present study contradict this, with an improvement in BMI being reported at the follow-up 
period 10-weeks after the intervention program 
It is possible that the longer time period between the cessation of the intervention and the follow-up 
in the study by (Muchiri et al. (2015) could account for the failure to maintain the changes. 
Furthermore, the participants in the current study received a post-intervention guide to assist them 
with making healthy dietary choices, which the participants in the study by Muchiri et al. (2015) 
did not. 
Mora-Rodriguez et al. (2014) found that following a four-month aerobic training program and in 
the absence of any further training (detraining) for one month, the improvements seen in insulin 
resistance and cardiorespiratory fitness fell to almost baseline levels, with only some blood pressure 
and body composition variables being maintained. Being cognoscente of these findings, it is clear 
that the results of this study (further decreases in BMI and body fat percentage) demonstrate that the 
participants remained active, albeit at a lower level than during the intervention, for the 10-week 
period following the completion of the program. This study highlights the importance of continued 
participation in physical activity, and healthy lifestyle behaviours, even after the cessation of a 
structured program. 
It is also likely that the combination exercise program in the current study played a role. As 
mentioned previously, combination exercise incorporating both upper and lower body exercises, 
results in significant improvements in anthropometric outcomes by increasing the uptake of glucose 
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in the blood stream, thereby improving the sensitivity of insulin, as well as decreasing the 
likelihood of the storage of fat. Furthermore, improvements in dietary habits in combination with 
exercise would result in lower levels of ROS and less damage to pancreatic β-cells, thereby 
increasing serum insulin levels. 
5.3.2. Cardiovascular Outcomes 
Hypertension in most cases precedes the diagnosis of T2DM, although in some cases it may occur 
secondary to disease progression. The average systolic and diastolic blood pressure for this study 
population was 141.4 ± 20.9 mmHg and 79.6 ± 13.6 mmHg, respectively, with all of the 
participants being diagnosed with hypertension prior to participation in the study. While the range 
of blood pressure measurements in related studies varies greatly, the average SBP was 137.9 ± 18.7 
mmHg, while the average DBP was 82.6 ± 9.0 mmHg (Geirsdottir et al., 2012; Kontogianni et al., 
2012; Von Bibra et al., 2014; Ades et al., 2015; Muchiri et al., 2015; Sari-Sarraf et al., 2015). The 
ACSM recommends that SBP be lower than 120 mmHg and DBP lower than 80 mmHg under ideal 
circumstances. According to ACSM criteria, the participants in this study would be classified as 
having stage one hypertension, while the overall study population would be classified as pre-
hypertensive (American College of Sports Medicine, 2014). 
There was a slight, but not significant increase in systolic blood pressure (SBP) over the 10-week 
intervention period in both groups, combined with a decrease in diastolic blood pressure (DBP), 
which was significant in the experimental group compared to baseline. The general trend among 
almost all exercise- and diet-based intervention studies is that there is a reduction in SBP and DBP 
of varying degrees. 
The increase in SBP following the intervention is an unexpected result, with no other study 
supporting this finding. There are two plausible reasons for this finding. Firstly, it is possible that 
the participants were not consistent with adhering to their anti-hypertensive medication, particularly 
on the day of post-testing, which has been previously reported (Saleh et al., 2014). Secondly, it is 
possible that due to the participants’ walking to the testing sessions, the five-minute rest period 
provided before taking the individual’s resting blood pressure was not sufficient time to allow for 
the blood pressure to normalise. While the guidelines provided by the ACSM suggest that five 
minutes is sufficient (American College of Sports Medicine, 2014), it is possible that due to all of 
the participants having diagnosed hypertension, their SBP and DBP would be elevated to a greater 
degree after a bout of walking, than someone who was normotensive. The only study that found no 
change in blood pressure was by Edelman et al. (2015), where neither SBP nor DBP changed 
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following a 24 month behavioural intervention led by nurses, although the methodology and study 
design was vastly different to the current study and therefore makes it difficult to directly compare.  
The statistically significant decrease in DBP in this study is corroborated by a number of authors. A 
recent study involving aerobic training over a 16-week period reported an almost 15 % decrease in 
DBP with a smaller, but still significant decrease in SBP (Sari-Sarraf et al., 2015). Similar findings 
were reported in a six month study conducted by Ades et al. (2015), where there was a non-
significant decrease in SBP, but a significant decrease in DBP (6.0 mmHg) following a exercise 
intervention aimed at weight loss, and was conducted in a group of elderly men and women. The 
concomitant decreases in body weight, fat mass and serum lipids, as well as an improvement in 
glycaemic control could all account for this improvement in blood pressure, due to their direct 
effect on vascular function (Selwyn et al., 1997; Goldstein & Scalia, 2004). Despite the duration of 
the current study being slightly shorter than the above-mentioned studies, the mechanisms 
responsible for the lower DBP found in this study would be similar, with the additional anti-
inflammatory benefits provided by healthy dietary choices. 
In a longer 12-month intensive exercise program, Balducci et al. (2010) reported decreases in SBP 
and DBP compared to baseline in both the control and experimental groups, although the magnitude 
of the decrease was greater in the experimental group for both SBP and DBP. In this instance, 
changes to anthropometrical outcomes were only seen in the experimental group, which could 
account for the difference between the groups. However, both groups also experienced an 
improvement in VO2max, and thus central adaptations such as improvements in mitochondrial 
enzyme activity, or a decrease in pre-load, could further account for the reduction in SBP and DBP 
in both groups (Balducci et al., 2010). An earlier study by the same author, which also employed a 
12-month combination aerobic and resistance exercise program, found similar results, with a 
clinically significant improvement of SBP and DBP by 5 mmHg and 4 mmHg, respectively in the 
experimental group (Balducci et al., 2004).  
Although there was no change in SBP in this study, the decrease in DBP of 4.2 mmHg in this study 
was comparable to the study by Balducci et al. (2004), and achieved in a shorter time period. A 
plausible reason for the more rapid decrease in DBP could be linked to the concomitant dietary 
intervention that was included in this study, where a 12-week dietary intervention study by 
Sasakabe et al. (2015) providing evidence of this. A study comparing the effects of aerobic, 
resistance and combined exercise found that following a 12-week intervention period, all three 
exercise modalities, as well as the control group, reported decreases in SBP and DBP (6.3 mmHg 
decrease on average) that were statistically significant (Jorge et al., 2011). The authors did not 
explicitly measure dietary control, therefore it is possible that both the experimental and control 
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group made changes to their eating habits (e.g. reduced carbohydrate, increased vegetable 
consumption) which would have affected vascular function, and therefore their blood pressure. 
Furthermore, either adherence or non-adherence to medication could have influence the blood 
pressure measurements in the study by Jorge et al. (2011) and was combatted in the current study 
by requesting participants to not change their medication schedule unless medically advised to by 
their primary healthcare provider. Geirsdottir et al. (2012) found that a 12-week resistance training 
program resulted in reductions in SBP and DBP (2.9 mmHg), which were comparable to healthy 
elderly individuals. The decrease in this study was slightly higher than the abovementioned study 
and may be due to the combined effect of aerobic and resistance exercise on vascular function. 
Similarly to exercise interventions, dietary interventions have been equally successful in reducing 
both SBP and DBP over a period of time by reducing plasma glucose levels, which was seen in this 
study. A 12-week study by Sasakabe et al. (2015), reported decreases in SBP and DBP (3.9 mmHg) 
that were both statistically significant and were as a result of adopting a low-carbohydrate diet. 
These findings are comparable to the current study, although it must be noted that these findings 
were from a diet-only intervention, whereas the present study made use of both dietary and exercise 
interventions. In another 12-week study that examined the impact of a traditional Mediterranean 
diet on blood pressure, there was no change in SBP and only a slight decrease in DBP (Itsiopoulos 
et al., 2011). However, these results should be interpreted with caution, as the baseline blood 
pressures of the participants indicated that they were not classified as hypertensive (< 140/90 
mmHg). In a similar, albeit shorter study to Sasakabe et al. (2015), a three week low-carbohydrate 
diet was found to significantly decrease SBP and DBP when compared to a low-fat diet, with a 
subsequent improvement in cardiac function (Von Bibra et al., 2014). Kontogianni et al. (2012) 
reported similar findings, whereby reducing sugar, refined carbohydrate and saturated fat intake 
resulted in a significant decrease in SBP, but no change in DBP following a year of the specific 
diet.  
These findings are contrary to what was found in the present study and could be due to the inclusion 
of exercise in the current study. On the other hand, a study conducted in a resource-limited setting 
found that, while there were improvements in SBP and DBP following a six-month nutritional 
education program, neither SBP nor DBP were maintained at the six month follow up, with levels 
returning to baseline values (Muchiri et al., 2015). This is contrary to what was found in the present 
study, with decreases in both SBP and DBP being reported at the follow-up testing which occurred 
10-weeks following the post-testing session. Continued involvement in some form of exercise, as 
well as health dietary behaviours, were more than likely responsible for these findings. 
Stellenbosch University  https://scholar.sun.ac.za
102 | P a g e  
 
5.3.3. Haematological Outcomes 
Considering that a large part of the pathology of T2DM arises due to sustained levels of elevated 
blood glucose (hyperglycaemia), it was deemed necessary to include three blood tests as part of the 
outcome variables, with glycated haemoglobin (HbA1c) being one of the most important indicators 
of blood glucose levels over a period of 10 to 12 weeks. 
Fasting blood glucose is most often used as a measure of glycaemic control in conjunction with 
HbA1c. The range of blood glucose values among the participants in this study was large and could 
have been influenced by a number of factors such as treatment regime, time when tested, and diet. 
On average, fasting blood glucose in related studies was on average 7.9 ± 1.5 mmol.L
-1
 (Maiorana 
et al., 2002; Lambers et al., 2008; Geirsdottir et al., 2012; Kontogianni et al., 2012; Von Bibra et 
al., 2014; Ades et al., 2015), which considering that participants were diagnosed diabetics and  for 
the most part on medication, is surprisingly high. This again highlights the need for more research 
into adequate management of the disease.  
In resource-limited settings, it is not uncommon for random blood glucose to be used as a measure 
of glycaemic control and it has been shown to correlate well with HbA1c (Gill et al., 1994; 
Rasmussen et al., 2014). Furthermore, recent studies have indicated that the use of random blood 
glucose testing may be superior to predicting T2DM than the traditional methods and should be 
included as part of pre-diabetic screening (Kowall et al., 2013; Bowen et al., 2015). The average 
value in these studies was 7.0 ± 1.2 mmol.L
-1
, which is substantially lower than the average of 13.9 
± 4.6 mmol.L
-1
 which was found in the current study. Possible reasons for such a large disparity in 
the measurements could be related to medication adherence, inadequate medication dosage due to 
disease progression that is not picked up by the primary healthcare provider, or the time of day the 
measurements were taken.  
When examining HbA1c, however, there is a large degree of uniformity, partly due to the 
standardised procedures and methods for collecting and analysing the blood samples.  Similarly to a 
number of the above-mentioned variables, there is a large degree of variation in the HbA1c 
measurements, which could be as a result of the study populations observed. When looking at 
similar studies to the current one, the average HbA1c was found to be 8.3 ± 1.2 % which is 
substantially higher than the usual clinical treatment target of 7.0 % (Peer et al., 2014). Once again, 
the average HbA1c in this study was substantially higher (9.1 ± 2.2 %), although this is to be 
expected considering the high blood glucose levels. This finding also suggests that despite being on 
hyperglycaemic medication, the T2DM in this study population was still not under control. 
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Total serum cholesterol was found to be 7.7 ± 1.2 mmol.L
-1
 on average for a number of related 
studies (Maiorana et al., 2002; Lambers et al., 2008; Von Bibra et al., 2014; Ades et al., 2015; 
Emerenziani et al., 2015; Hosseinpour-Niazi et al., 2015). This is substantially higher than the 
guidelines of the ACSM which suggest that total serum cholesterol should be under 5.20 mmol.L
-1
 
in order to reduce cardiovascular risk (American College of Sports Medicine, 2014). This high level 
could be explained by the findings of Taskinen & Borén (2015) who suggested that long-term 
T2DM results in unfavourable changes in lipid profiles. The total serum cholesterol measurement in 
the current study was substantially lower than the average of previous studies and the measurement 
of 5.3 ± 1.1 mmol.L
-1
 was only marginally higher than the ACSM guidelines. 
In the current study, reductions in random blood glucose and HbA1c, of which the latter was 
statistically significant, and an increase in TSC were reported in the experimental group following 
the intervention. In contrast to the experimental group, there were increases in HbA1c, TSC and 
random blood glucose in the control group. 
Most studies report either a decrease or no change in the respective variables over time, therefore 
the increase in cholesterol in the experimental group is surprising, although it could be explained by 
the development of dyslipidaemia found in T2DM patients (Taskinen & Borén, 2015). The 
decreases in HbA1c and glucose were confirmed in a recent study by Ades et al. (2015), where 
HbA1c was 0.6 % lower following a six month intervention, and fasting glucose decreased by over 
20 %. These differences were similar to what was found in this study, albeit with a shorter 
intervention period. The mechanism behind this decrease is linked to the effect of exercise on 
GLUT-4 translocation, and therefore a decrease in serum glucose levels. Over time, consistently 
lower blood glucose levels would translate into a lower HbA1c. Considering that the individuals in 
both the study by Ades et al. (2015) and this study, exercised three times a week for approximately 
60 minutes, this mechanism of action is highly probable.  
A 12-month intensive exercise program elicited almost identical results with a substantial decrease 
in HbA1c, fasting glucose and cholesterol values, highlighting the positive effect that exercise has 
on glycaemic and lipid control (Balducci et al., 2010). The longer time period could account for the 
larger magnitude of the improvements observed in this study, in addition to the individualised 
exercise sessions these participants received. In the present study, the exercise sessions were 
conducted in groups which has been shown to be less effective than individualised exercise sessions 
(Perri et al., 1997), although there evidence contrary to this is presented by Church et al. (2010) 
who found that group exercise was more beneficial than individual exercise.  
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The time period needed to achieve glycaemic control, or at least clinical improvements in 
glycaemic control, is widely debated and is dependent on a number of factors such as disease 
severity, the presence of other co-morbidities, and medication adherence to name a few. However, 
Sari-Sarraf et al. (2015) found that eight weeks of training resulted in statistically significant 
changes in fasting plasma glucose, and by 16 weeks, the change in the eight week period was not 
significantly less, therefore strengthening the notion that extended programs are not always 
necessary to achieve glycaemic control. The findings of the present study, however, are contrary to 
this, in that both blood glucose and HbA1c decreased further following the 10-week period after the 
cessation of the structured program. A possible reason for this finding is that the exercise program 
by Sari-Sarraf et al. (2015) was not incremental in nature, with the same intensity of exercise in the 
first week and sixteenth week. This was not the case in the current study, and the constant need to 
adapt to the increased exercise demands may have resulted in the further improvements seen in this 
study. A noteworthy finding of the study by Sari-Sarraf et al. (2015) is that the decrease in fasting 
plasma glucose was accompanied by a decrease in insulin resistance and plasma insulin levels, a 
clear indication of the physiological changes induced by regular participation in exercise.  
The general consensus regarding changes to haematological parameters seems to be that all modes 
of exercise (aerobic, resistance or a combination of the two) result in improvements in HbA1c, 
fasting plasma glucose and total serum cholesterol, confirmed in a 12-week study by Jorge et al. 
(2011). HbA1c and fasting plasma glucose improved the most in the resistance training group, 
whereas total serum cholesterol improved the most in the aerobic training group. The magnitude of 
the differences was smaller in the combination exercise group, although still significant, and could 
be due to the reduced volume and specificity of training when compared to the aerobic and 
resistance training groups. With the exception of total serum cholesterol, the findings of the current 
study suggest that combination exercise is effective in decreasing HbA1c and blood glucose levels. 
These findings were similar to what was reported by Balducci et al. (2004), who found that a 12-
month combination exercise program resulted in significant reductions in HbA1c, total serum 
cholesterol, LDL-C and triglycerides, with a significant increase reported in HDL-C. The longer 
duration of the study by Balducci et al. (2004) is a plausible reason for the significant 
improvements seen in lipid metabolism, which weren’t found in the present study. These 
improvements in lipid metabolism are linked to decreases in central adiposity, which may take 
longer than the 10-week intervention period used in the present study. In a significantly shorter 
study of four months, which also made use of combination training, similar findings to that of 
Balducci et al. (2004) were reported, although the magnitude of the changes were not as large, and 
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there was no apparent change in HDL-C (Cauza et al., 2006). This finding provides further 
evidence that changes in HDL-C may only occur after prolonged participation in physical activity.  
Conflicting evidence with regards to resistance training and its impact on glycaemic control was 
highlighted by Geirsdottir et al. (2012) where a 12-week resistance training program resulted in a 
slight increase in both HbA1c and fasting plasma glucose. This was an anomaly, which could be 
explained by dietary behaviours or a reduced adherence to medication in the T2DM participants. 
Further evidence that this finding was an anomaly was reported by Cauza et al. (2005) who found 
that four months of resistance training resulted in a 1.2 % decrease in HbA1c, which was not found 
with endurance training of the same duration. Furthermore, there were improvements in insulin 
sensitivity and serum lipid levels, most notably a decrease in TSC, LDL-C and triglycerides. 
Considering that the present study made use of combination training techniques, these findings only 
partially support the results seen in the current study. 
The role of diet in glycaemic control and lipid metabolism cannot be underestimated, and was 
clearly demonstrated by Sasakabe et al. (2015). They found that by adopting a low carbohydrate 
diet for three months, significant decreases were found in HbA1c and fasting blood glucose. While 
the total serum cholesterol was not reported, there was a decrease in LDL-C and a significant 
increase in HDL-C, which is indicative of an improvement in health status and decreased 
cardiovascular risk. These findings were corroborated in the present study, with the decrease in 
carbohydrates consumed together, and an increase in the frequency of vegetable consumption 
possibly accounting for these improvements. This in agreement with a substantially shorter three-
week study by Von Bibra et al. (2014) where a low-carbohydrate/high-protein diet resulted in 
comparable changes in HbA1c, fasting glucose and cholesterol.  
Specific diets, which were not employed in the present study, seem to result in favourable changes 
in a shorter period of time when compared to dietary advice, although the exact difference remains 
unknown. In another study of three month duration, using the Mediterranean diet as the treatment 
diet of choice, reductions in HbA1c and fasting blood glucose were reported, although the changes 
were not statistically significant (Itsiopoulos et al., 2011). These results may indicate that the use of 
a low-carbohydrate diet initially to achieve glycaemic control might be a more prudent approach, 
with a switch to a more balanced diet at a later stage for maintenance. Interestingly, a high protein 
diet, which was designed for weight-loss, resulted in significant decreases in HbA1c and fasting 
blood glucose at four months, although these decreases were not maintained at the 12-month testing 
period (Pedersen et al., 2014). This once again highlights the need to adapt the dietary behaviours 
accordingly as improvements in glycaemic control and lipid metabolism are seen (Pedersen et al., 
2014). This balanced diet is potentially the reason why the results in the present study were 
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maintained at the follow-up period. Andrews et al. (2011) found that both diet alone, and in 
combination with exercise, result in favourable improvements in glycaemic control and the 
magnitude of the difference between the two groups is minimal when the two groups were 
compared. This would suggest that diet plays a greater role in glycaemic control than exercise, 
although it must be noted that the participants in the study by Andrews et al. (2011) were newly 
diagnosed T2DM patients, and therefore may be more susceptible to dietary changes that an 
individual who had been suffering with T2DM for a longer period of time. 
When looking at the difference at a follow-up period at some point after the cessation of an 
intervention program, Lee et al. (2015) found that participants in both a structured aerobic training 
and a structured walking program were able to maintain their improvements in glycaemic control 
variables seen at post-testing, although the improvements in the walking group were more 
consistent. Considering that walking is a more convenient and less strenuous form of exercise, these 
results are understandable, especially considering that most individuals with T2DM are overweight 
or obese, and where running may predispose them to increased risk of injury. Two community or 
peer-led studies by Koniak-Griffin et al. (2015) and Pérez-Escamilla et al. (2015) found that 
glycaemic variables and serum lipid levels were maintained, and in some cases improved, at the 
follow-up periods when compared to their respective control groups. The strength of both studies 
lies in their comprehensive intervention design, which involved community health workers (CHW) 
making individual visits over the course of the follow-up period. While this was somewhat different 
to the present study, the support of fellow participants, which was advocated during the 
psychological arm of the intervention, may have contributed to the maintenance of the 
improvements at the follow-up testing session. Contrary to this, Houle et al. (2015) reported 
increased HbA1c levels at six and 12 months following a hospital-based intervention, which could 
be as a result of reduced levels of support following the intervention. 
5.3.4. Functional Outcomes 
There was an increase in the distance walked by both the control and experimental group following 
the 10-week intervention, although only the difference in the latter was found to be statistically 
significant. These improvements are likely to have occurred from a combination of increased 
muscle strength and improved cardiovascular capacity, which have been widely reported in the 
literature (Maiorana et al., 2002; Lambers et al., 2008; Balducci et al., 2010; Jorge et al., 2011; 
Geirsdottir et al., 2012; Earnest et al., 2014; Morrison et al., 2014; Ades et al., 2015). 
Increases in muscle strength were found in a number of studies where either combination or 
resistance training were used. In a 12-week resistance training program, absolute and relative (to 
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lean body mass) quadriceps strength was significantly increased, which led to an increase in the 
distance walked during a 6MWT (Geirsdottir et al., 2012). While the exercise program of the 
present study was not exclusively resistance training, many of the exercises included were targeting 
lower limb strength, which would include the quadriceps. It is therefore plausible that the findings 
of this study are comparable to the findings of the above-mentioned study, which would account for 
the increase in distance walked during the 6MWT. Similar findings were reported in a combination 
exercise program also conducted over 12-weeks where both upper and lower body strength 
improved, with a subsequent increase in distance walked during the six-minute walk test (Lambers 
et al., 2008). While it is unlikely that upper body strength would have contributed directly to the 
improvement in the 6MWT, it is possible that an increase in postural stability, in combination with 
the increased lower-body strength would have caused the improvement. This mechanism is also a 
plausible reason for the improvement in 6MWT distance walked in the present study, with a 
number of exercises included to improve core strength and postural stability, a hallmark of 
combination exercise programs.  
The contentious issue of whether or not resistance exercise influences cardiorespiratory fitness in 
T2DM patients was explored by two comprehensive studies by Jorge et al. (2011) and Yang et al. 
(2014), where aerobic, resistance and combination exercise were compared for their effects on these 
parameters. Both studies found that resistance exercise, while beneficial in other areas, did not 
result in any substantial improvement in aerobic capacity (VO2max). Aerobic training on the other 
hand, has been found to significantly improve walking speed (Morrison et al., 2014), VO2max 
(Emerenziani et al., 2015; Sari-Sarraf et al., 2015), functional exercise capacity (Tessier et al., 
2000) and leg strength (Sari-Sarraf et al., 2015), which all would ultimately lead to improved 
performance in the 6MWT. These findings corroborate what was found in the present study, and 
although VO2max wasn’t explicated measured, the estimate from the distance walked in the 6MWT 
would suggest that it did, together with an increase in walking speed. Combination exercise has 
demonstrated similar results to that of aerobic training, with Earnest et al. (2014) showing a 
significant improvement in VO2max and time to exhaustion during a VO2max test in elderly adults. 
Similar findings in an older adult population was reported by Ades et al. (2015), where a six-month 
exercise program designed for weight loss resulted in a 20 % improvement in VO2max. Structured 
exercise of moderate intensity was used by Ades et al. (2015), which was similar to the current 
study. Balducci et al. (2010) presented similar findings to Sari-Sarraf et al. (2015), where they 
found that a 12-month intensive exercise program in older adults improved upper and lower body 
strength, flexibility and VO2max. One of the benefits of the present study was the use of whole body, 
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combination exercise, which confers additional benefits in muscular strength and endurance, and 
subsequent performance, compared to isolated programs. 
Aside from the improvements in VO2max, an eight-week combination exercise program in older 
adults also resulted in significantly lower RPE values at set exercise workloads (Maiorana et al., 
2002). Once again, the present study reported similar findings, with the perceived level of work, or 
difficulty during the 6MWT being lower following the intervention than at baseline, indicating an 
improvement in strength and aerobic capacity.  
The mechanisms behind these findings are complex and involve the synergistic actions of a number 
of systems. Both aerobic and resistance exercise increase the levels of shear stress which ultimately 
results in increased NO production and improved vascular function (Delbin & Trask, 2014). 
Furthermore, muscle contraction promotes GLUT-4 translocation, which would aid in lowering 
serum glucose levels. Down-stream effects of this would ultimately result in improved insulin 
sensitivity, an increase in fatty acid metabolism, and a reduction in inflammatory cytokines and 
molecules, all contributing to a favourable outcome with respect to glycaemic control and T2DM 
disease management (Jorge et al., 2011; Yang et al., 2014) 
5.3.5. Dietary Habits Outcomes 
Dietary control for diabetics is of particular importance with a number of studies investigating the 
content of the food, frequency of eating and/or snacking, and time of day eating took place, and in 
some cases correlating it with the levels of HbA1c (Savoca et al., 2004; Mekary et al., 2012; 
Castro-Sánchez & Ávila-Ortíz, 2013; Hood et al., 2014). Furthermore, with recent reports emerging 
of skeletal muscle “exercise resistance” in T2DM, with muscle fuel metabolism differentiating 
between those who respond, versus those who don’t, dietary habits may play the most important 
role in T2DM disease management in these individuals (Stephens et al., 2015). 
A number of studies have shown that there is a strong resistance to changing dietary behaviours that 
may stem from cultural beliefs and practices (Hempler et al., 2015), as well as perceived goal 
difficulty and chances of attainment (Miller et al., 2012). There appears to be general consensus 
that the process of adopting changes in dietary behaviours is modelled on the trans-theoretical 
model (TTM) of behaviour change first introduced by Prochaska & DiClemente (1983). The five 
stages of behavioural change are pre-contemplation, contemplation, preparation, action and 
maintenance, and are fluid stages of indeterminate time. The likelihood of a person diagnosed with 
T2DM adhering to a diet has been shown to correlate well with the TTM behavioural stage they are 
in (Uggiero & Reene, 2003; Castro-Sánchez & Ávila-Ortíz, 2013; Knight et al., 2015). Miller et al. 
(2012) found that those people with a higher self-belief in change, and therefore at the latter stages 
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of the TTM, were more committed to the end goal, and perceived the goal to be substantially less 
difficult to achieve than those with a lower self-belief. These findings were confirmed to a certain 
degree by Knight et al. (2015) where it was found that the perceived barriers to dietary change were 
greater in the earlier stages in the TTM, with the barriers and actual goal of dietary change being 
less at the latter stages in the TTM. Interestingly, it was found that women were more likely to be in 
the last two stages of the TTM than men. A number of barriers to dietary adherence were identified 
by Hempler et al. (2015), which included a lack of social and familial support, low socio-economic 
status,  the affordability of the required food and lack of appropriate knowledge from community 
health-care workers. Binge eating is a further challenge associated with adherence to a healthy diet 
required for T2DM patients, with a strong correlation found between stage of TTM and the 
likelihood of engaging in binge eating behaviour (Herbozo et al., 2015). 
There is a certain degree of ambiguity in the knowledge that T2DM patients have regarding the role 
of carbohydrates in the dietary management of their disease, with a large percentage only attributing 
carbohydrate to sugar in its basic form, and reasoning that by decreasing sugar intake, you are 
effectively controlling your blood sugar (Breen et al., 2015). This could potentially account for the 
finding in this study that the control group did not significantly change their eating habits with 
respect to the type of bread consumed, or the consumption of complex carbohydrates together. The 
change in the experimental group towards a low-GI or whole-wheat bread consumption is 
consistent with what was found by England et al. (2014) where study participants decreased their 
consumption of white bread and high-energy food sources. These results indicated the beneficial 
effects of dietary advice on eating habits, as was the case with the present study. Furthermore, the 
ability of a non-specific dietary intervention to exact change over a period of time was highlighted 
by the continuation of healthy dietary behaviours, even after the cessation of a structured 
intervention. Similar findings were reported by Kontogianni et al. (2012) where the experimental 
group decreased their consumption of sugars, refined cereals and processed foods, while a 
concomitant increase in fruit and vegetables and high-fibre foods was seen. The findings of the 
present study are in concordance with the findings of the above-mentioned study, with the nature of 
the dietary interventions being very similar.  
There have been several studies that have reported the benefits of consuming low-GI or whole-grain 
products, which include improved insulin sensitivity and lower fasting plasma glucose, as well as 
decreasing the risk of developing T2DM by 30 % (Gil et al., 2011; Aune et al., 2013; Tucker et al., 
2014). These findings are similar to a study by Chandalia et al. (2000) who found that consumption 
of a high fibre diet resulted in 10 % improvement in glycaemic control, 12 % improvement in 
insulin sensitivity and an approximately nine percent decrease in serum lipid levels. The 
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improvements in glycaemic control were also reported by Buyken et al. (1998) which found that 
higher consumption of dietary fibre was associated with a decrease in HbA1c levels and therefore 
better glycaemic control. The present study reported similar findings, with consumption of low GI 
or brown bread, as well as increased consumption of vegetables accounting for the increased dietary 
fibre intake. The physiological manifestations of these dietary changes were evident in the 
decreased levels of blood glucose and HbA1c at the completion of the intervention. 
Similarly to what was seen in this study, where a large percentage of the study population 
consumed far more than the recommended number of starch servings per day, Medagama & 
Widanapathirana (2015) found that 70 % of their participants also consumed more than the 
recommended number of starch servings per day, which had a significant impact on the glycaemic 
response. Cultural beliefs and practices more than likely contributed to this finding in the present 
study as well as the study by Medagama & Widanapathirana (2015), where the staple food is 
comprised of starch. Furthermore, the relatively low cost of these foods predisposes an individual to 
consume them on a more regular basis and in larger quantities in order to achieve adequate levels of 
satiety. However, as has been demonstrated in the present study, the sustained consumption of large 
quantities of starch results in an unfavourable progression in T2DM and worsening glycaemic 
control.  
A recent meta-analysis by Wu et al. (2015) provided strong evidence that regular consumption of 
vegetables significantly reduces the risk of developing T2DM. It was therefore no surprise that at 
the start of the current study, participants consumed less than two servings of vegetables per day. 
This finding was also in agreement with that of Medagama & Widanapathirana (2015). The 
increased levels of vegetable and/or salad consumption in the current study is in line with a number 
of studies that are based on the Mediterranean or prudent diet, which is characterised by a higher 
vegetable and legume intake (Salas-Salvadó et al., 2011; Grosso et al., 2014; Zad et al., 2015). The 
present study reported a 52 % increase in vegetable consumption and most likely contributed to the 
improvements in glycaemic control being evident. 
The decrease in the quantity of alcohol consumption reported in this study would have some 
question as to whether or not this is beneficial, considering there are a number of studies that 
indicate moderate alcohol consumption is associated with a decreased risk of T2DM which is 
loosely linked to improved insulin sensitivity (Carlsson et al., 2000; Van de Wiel, 2004; Carlsson et 
al., 2005; Baliunas et al., 2009; Marques-Vidal et al., 2015). However, what is important to note is 
that spirits were most often consumed by the experimental group, with a significant association 
found between spirit and beer consumption and impaired glycaemic control, as well as risk for 
developing T2DM (Carlsson et al., 2000; Molsted et al., 2014; Marques-Vidal et al., 2015). 
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Therefore, by possibly changing the type of alcohol consumed, the experimental group would be 
reducing the likelihood of impaired glycaemic control as a result of spirit consumption. This finding 
is supported by Hausenblas et al., (2015) who found that additional supplementation with 
resveratrol, one of the chief active ingredients in red wine, was successful in reducing HbA1c and 
SBP in older adults with T2DM. 
5.3.6. Health-Related QoL Outcomes 
The relationship between glycaemic control and HRQoL is one that has been explored by a number 
of authors, with conflicting results being found. Kuznetsov et al. (2014) found that those individuals 
who had a lower HRQoL at a five-year follow-up, had a higher HbA1c measurement. This is a 
plausible reason for the findings of the present study, which reported a substantially lower HRQoL 
in the control group, with a concomitant increase in HbA1c, whereas the experimental group 
reported a significantly higher HRQoL, together with a decrease in HbA1c following the 
intervention. These findings were highlighted in a study by Lambers et al. (2008) where a 12-week 
combined exercise-training program in older adults showed that a decrease in HbA1c resulted in 
small improvements in HRQoL. A study by Guldbrand et al. (2014) had a number of similarities, 
where it was reported that a low-carbohydrate diet improved HRQoL after 12 months. The 
mechanism behind this finding is two-fold. Firstly, there was a reduction in body weight, with the 
decrease in weight resulting in an improvement in HRQoL. Secondly, there was an improvement in 
glycaemic function, which has previously been shown to correlate with increased HRQoL (Shah et 
al., 2015). Another similar study involving a low-calorie diet, with or without the addition of 
exercise, also reported an improvement in HRQoL that was once again attributable to weight loss 
(Snel et al., 2012). While there was no significant weight loss in the present study, there was a 
significant decrease in body fat percentage, which would most certainly have a positive impact on 
HRQoL. It is understandable that embarrassment of physical appearance negatively impacts on 
social interactions and activities of daily living, therefore a decrease in body fat percentage resulted 
in an improvement in social function, which in turn positively impacted on HRQoL.  
A ground-breaking study by Davis et al. (2012) found that both a low-carbohydrate and low-fat diet 
had beneficial effects on HRQoL, more specifically on energy and mobility, and sexual function, as 
assessed by the D-39 questionnaire. These findings were corroborated in the present study, albeit 
with dietary advice as opposed to a specific dietary plan. Furthermore, the effect of exercise cannot 
be negated, with improved vascular function as a result of exercise possibly accounting for the 
improvement in sexual function. However, it must be noted that higher consumption of vegetables 
and high-fibre food, together with a reduced intake of   refined foods and sugars, as was the case 
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with the present study, have been shown to also positively impact sexual function. The mechanism 
responsible for this improvement is linked with decreased levels of oxidative stress and a 
subsequent improvement in vascular function (Giugliano et al., 2010). 
The impact of social support, from family, peers and healthcare professionals on HRQoL has been 
extensively reported. Chew et al. (2015) and Stopford et al. (2013) found that higher levels of social 
support resulted in greater glycaemic control, which in turn resulted in an improved HRQoL. The 
results of the present study reported no change in the levels of familial support, however, the group 
sessions for all the various intervention arms would have resulted in a significant increase in peer 
support, which would have positively impacted on HRQoL. Stopford et al. (2013) suggested that 
social support from family and close friends exerts greater benefits that the social support from a 
healthcare professional due to the more frequent interaction with the individual. Conversely, Chew 
et al. (2015) suggested that support from a healthcare professional or external social support group 
would offer greater benefits. The findings of the present study support the findings by Chew et al. 
(2015) with a slight decrease in HRQoL observed at the follow-up, 10-weeks after the cessation of 
the study. While it is possible that the continuous interaction with the healthcare professionals 
resulted in an improvement in HRQoL, a more plausible reason for the decline could be linked to a 
change in the routine or structure that the participants had become accustomed to in the preceding 
10-weeks. Hilding et al. (2015) reported that higher levels of familial and social support, as well as 
social interaction, significantly decreased the risk of developing T2DM, however, it must be kept in 
mind that certain behaviours, while being socially active, may in turn increase the risk (e.g. high 
alcohol consumption, high refined food consumption, etc.). The role of spousal support is scarcely 
reported and is, to some extent, undervalued in the appropriate management of the disease. Choi et 
al. (2015) revealed the importance and beneficial effects of spousal support on quality of life, and 
highlighted the need for further research to be conducted in this area. 
HRQoL and self-care activities are strongly associated with one another, with high levels in one, 
resulting in high levels in the other, a phenomenon which has been described by a number of 
authors (Walker et al., 2014; Shayeghian et al., 2015). Recent studies have all indicated that lower 
levels of self-care, with presumably lower levels of HRQoL, have resulted in poorer glycaemic 
control (Shayeghian et al., 2015; Smalls et al., 2015), poorer adherence to diet, and greater diabetic-
related complications (Saleh et al., 2014). The findings of the present study support these findings, 
with fewer check-ups with healthcare professionals to monitor blood glucose levels, decreased 
ability to fulfil physical and emotional roles and overall difficulty with managing T2DM seen in the 
control group. Conversely, the experimental group reported improvements in all of the above-
mentioned areas, with a subsequent increase in HRQoL. Socio-economic status is another variable 
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that has been shown to indirectly impact on HRQoL through a number of different mechanisms; 
access to adequate care, self-efficacy and perceived stress being a few (Nejhad et al., 2013; Walker 
et al., 2014). This is an area that requires further research in the community investigated with the 
current study. 
Diabetes-related distress (DRD) is another factor that has a significant impact on HRQoL and is 
very often associated with poor self-care, low self-efficacy and poor glycaemic control (Karlsen & 
Bru, 2014; Co et al., 2015; Shallcross et al., 2015). Karlsen & Bru (2014) revealed that DRD may 
be more challenging to combat than initially thought, with social support being the greatest 
predictor of whether an improvement would occur or not, and specifically support from healthcare 
providers was of more benefit than from family and peers. However, it is important to note that in 
most cases, and as was seen in this study, T2DM patients don’t regularly visit either their primary 
or other health care provider(s), thereby highlighting the need for appropriate on-going support. A 
pilot study by Sabourin et al. (2011) did just that, with a very brief (six contact sessions) 
psychosocial intervention resulting in significantly lower DRD at the three-month follow-up 
session, which could have possibly translated into improved glycaemic control and HRQoL due to 
the link between DRD and HRQoL as described above. The present study made use of 10 
psychological support contact sessions, with significant improvements in perceived QoL and 
perceived diabetes severity being attributed to a better HRQoL, and therefore lower DRD.  
As alluded to in the previous paragraphs, HRQoL and glycaemic control go hand-in-hand, with a 
study by Co et al. (2015) confirming this, as well as suggesting that DRD is a mediator in the 
relationship between the two. The mechanism behind this mediated effect is thought to be related to 
the propensity of someone with DRD to engage in unfavourable lifestyle activities such as poor 
diet, low levels of physical activity and poor medication adherence, all of which would impact on 
physiological systems, thereby worsening glycaemic control and ultimately HRQoL. These 
findings, to a certain extent were confirmed by this study, with improvements in areas related to 
DRD as well as improved glycaemic control. 
Overall the findings of this study were in concordance with the literature, although the 
improvements in HRQoL in this study appear to be more comprehensive that what is traditionally 
found. There are a number of possible reasons for this conclusion. Firstly, the community within 
which the intervention took place is a very close-knit community and a sense of togetherness 
throughout the different aspects of the intervention could have substantially impacted on HRQoL. 
Secondly, there was an improvement in glycaemic control, as well as an improvement in a number 
of the anthropometric outcomes, with a number of anecdotal reports of participants being extremely 
satisfied with their external appearance. The increase in confidence and self-efficacy that 
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accompanies these findings could also have played a role in the improved HRQoL. Thirdly, the 
improvements in strength and cardiorespiratory capacity would have afforded the participants the 
ability to partake in activities that family or friends participated in, that they may not have been able 
to do before, thereby reinforcing once again a feeling of togetherness and social coherence, which 
has been shown to significantly impact on HRQoL (Nilsen et al., 2015). 
5.3.7. Health Professionals Usage Outcomes 
The findings of the current study showed that there was a small improvement in the number of 
people who regularly went for check-ups with their primary healthcare provider and/or associated 
healthcare provider, although of concern is the 56.0 % and 29.0 % of the participants in the control 
and experimental group, respectively, who consulted with their primary healthcare provider (doctor) 
once or less per year. There is, unfortunately, extremely limited data specifically looking at the use 
of primary care providers and the reasons for not consulting them on a regular basis. With that 
being said, Unger et al. (2011) went some way to shedding more light on this area by examining the 
pattern of primary care utilisation in urban and rural areas. One of the most important findings of 
their study was that those people living in an urban area most commonly made use of general 
practitioners (GPs) as their primary healthcare provider, with those in rural areas making use of 
allied health professionals, nurses and complementary and alternative medicine practitioners. 
Considering that the study population in the current study would be seen as urban, the findings 
seem to be in opposition to what is reported in the literature. However, the shortage of GPs in the 
area would have a significant impact on the participants’ choices, thereby driving them towards the 
use of nurses and other allied health professionals out of necessity.  
Sabale et al. (2015) painted a slightly different picture in that individuals with newly diagnosed 
T2DM generally made use of a GP for the first year of treatment, thereafter preferring to make use 
of nurses with diabetes-specific training. Given that the participants in the present study had been 
diagnosed with T2DM for longer than one year, the finding that participants chiefly made use of 
nurses for the management of their disease fits the result of Sabale et al. (2015). The use of nurses 
as an adjunct profession to treating T2DM was well-documented in a study by Lawton et al. (2005). 
The nurses’ approachability and sound technical knowledge base were highlighted by Lawton et al. 
(2005) and both these qualities was also confirmed by the participants in the current study. The use 
of complementary and alternative medicine (CAM) practitioners in the treatment of T2DM has been 
around for a number of years and was brought about due to the failings of the traditional healthcare 
system, or so-called “Westernised medicine” (Atwine et al., 2015; Kapongo et al., 2015). While no 
explicit findings have been reported, a number of patients are still reluctant to discuss the use of 
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CAM with their primary healthcare provider, due to the stigma attached to its use (Chao et al., 
2015). The disparity between patients and primary healthcare professionals with respect to patients’ 
perspectives on the management of their disease, the need to tightly control blood glucose levels 
and empowering patients to manage their disease, seem to be a number of the barriers identified 
(Clark & Hampson, 2003; Bhojani et al., 2013).  
On the other hand, a comprehensive and multi-disciplinary study by Fokkens et al. (2011) found 
that by developing a structured care program, involving GP’s, diabetes-specialised and practice 
nurses and dieticians, clinical outcomes related to disease management (HbA1c, BMI, SBP, DBP, 
etc.) were significantly better, and better maintained over time, than the usual care reported in most 
studies. These types of programs, where patients are more likely to reach their clinical goals, has 
significant economic implications, as well as health-related implications such as reduced risk of 
death from CVD, which could possibly encourage individuals suffering from T2DM to engage with 
their primary healthcare providers and allied health professionals on a more regular basis (Hunt et 
al., 2015). The framework of the present study was similar to that of Fokkens et al. (2011), whereby 
a collective of healthcare professionals (Biokineticist, dietician, clinical psychologists) working 
synergistically achieved the best possible  outcomes for the respective participants. 
The advent of community-based interventions or programs were developed to assist primary 
healthcare providers and allied healthcare professionals, as is depicted in a model developed by 
West (2014). It is a comprehensive multi-system model proposed to adequately address the 
management and prevention of T2DM. It involves the collaborative work of all levels of the 
healthcare system, as well as community engagement and input. Together the various stakeholders 
put strategies in place to evaluate measureable outcomes as set out in a guide published by the CDC 
regarding community disease management. Although there are a number of logistical and 
methodological challenges that need to be addressed in future studies, the results of community-
based interventions speak for themselves, with a number of extremely promising results.  
One of the first community-based studies was a randomised controlled trial by Lorig et al. (2009) 
which found that compared to usual care by primary healthcare providers, a peer-led diabetes self-
management program resulted in significant improvements in some health indicators 
(hypoglycaemic events) and health behaviours (healthy eating and glucose monitoring), which were 
maintained at 12 months. While the current study presents evidence that health-care led programs 
are definitely beneficial, the impact of programs delivered by peers cannot be underestimated. 
There is a significantly higher level of understanding with respect to the barriers that exist in the 
community and the plausible solutions to these barriers, in peer-led interventions compared to 
healthcare professional led interventions. Similar findings were reported by Klug et al. (2008) 
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where they found improvements in dietary and physical activity behaviours, as well as 
improvements in self-efficacy following a four-month peer-led program. The findings at the four- 
and eight-month follow-up were however inconclusive, with the authors recommending the need 
for further research in this area. 
While the two above-mentioned studies reported minimal changes in HbA1c and other glycaemic 
variables, studies by Castillo et al. (2010) and Assah et al. (2015) which were 10-weeks and six 
months in duration, respectively, both found improvements in HbA1c and SBP. Furthermore, Assah 
et al. (2015) also reported improvements in serum lipid levels and anthropometric outcomes (body 
fat percentage, BMI, waist circumference). In a substantially longer study of 24-months, split into 
two phases, Katula et al. (2013) found that a peer-led lifestyle intervention significantly improved 
all the anthropometric outcomes measured (body mass, BMI, waist circumference), as well as 
measures of glycaemic control (fasting plasma glucose and insulin, insulin resistance), when 
compared to usual care by primary healthcare providers. The intrinsic motivation and increased 
accountability, which is created through the use of peer-led interventions, would account for most 
of the improvements seen in the above-mentioned studies. Furthermore, by using appropriately 
trained people within the community to lead these programs, there is a decreased pressure on the 
primary and allied healthcare professionals in managing T2DM in the community. The next phase 
in this project will aim to achieve exactly this, by identifying and properly training individuals 
within the community, who will drive the program in collaboration with other allied health 
professionals (Biokineticist). 
5.4. Use of Post-Intervention Guide 
There has been no study conducted to date that has examined the effects of a post-intervention 
guide on maintaining the effects of a structured program over a long period of time. The theory 
behind the guide is that when participants are not involved in structured contact sessions with the 
respective health professionals, it provides an understandable reference to the various components 
of the program. Furthermore, it serves as a reminder to continue with the progress that was made 
during the intervention program, as well as motivating those in the household to indirectly assist 
with the management of their respective family members T2DM. The only two studies to make use 
of print media in an intervention were conducted by Walker et al. (2011) and Kim & Kang (2006). 
In the study by Walker et al. (2011), the study compared a telephone-based intervention to a 
information booklet, without any prior intervention program, therefore making it difficult to draw 
conclusions, although the study concluded that the telephone-intervention was more successful. In 
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contrast to this, the study by Kim & Kang (2006), found that web-based and print materials were 
equally effective in increasing physical activity levels, and improving glycaemic control. 
When compared to the outcome measures at the post-testing session, the post-intervention guide did 
not confer any additional benefits, nor was it able to successfully maintain the improvements 
achieved during the intervention program. There are a number of plausible reasons for this finding. 
Firstly, the post-intervention guide did not provide sufficient motivation and accountability, as is 
the case with contact sessions, therefore the participants could revert back to unfavourable activities 
without any verbal recourse or reinforcement. Secondly, the follow-up period was conducted at the 
beginning of winter, when the weather conditions were not as favourable when compared to the 
summer or autumn months. Inclement weather conditions may have negatively impacted on the 
likelihood of the participants exercising, especially if they had incorporated walking into their 
exercise regime. Thirdly, the participants may not have taken the opportunity to clarify any 
questions they may have had regarding the post-intervention guide, and decided to rather continue 
with their habitual behaviours, which may have resulted in unfavourable outcomes. 
Nevertheless it seems that the post-intervention guide may have helped the participants to do better 
at post-intervention compared to baseline. With the exception of BMI, SBP and TSC, all the 
remaining anthropometric, cardiovascular, haematological and functional outcome variables were 
still significantly better at the follow-up session compared to baseline. Furthermore, the physical 
components of HRQoL and general health perception were significantly higher than at baseline. 
Dietary and lifestyle behaviour changes were also significantly better at the follow-up session 
compared to baseline. While these improvements may not be directly attributable to the use of the 
post-intervention guide, it is plausible that having a frame of reference upon which to work assisted 
the participants with maintaining healthy lifestyle choices over the long-term.  
5.5. Research Objectives Hypotheses 
5.5.1. Objective One – A 10-week comprehensive lifestyle intervention will result 
 in significant changes in anthropometric, cardiovascular, haematological 
 and functional capacity outcome variables. 
There were statistically significant decreases in body fat percentage (p < 0.001), diastolic blood 
pressure (p = 0.04) and HbA1c (p = 0.01), together with a statistically significant improvement in 
the total distance walked during the 6MWT (p < 0.001). However, there were no significant 
changes in BMI, SBP, blood glucose or TSC. The findings of this study suggest that for individuals 
suffering from T2DM, a 10-week comprehensive lifestyle intervention can cause clinically 
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significant changes in anthropometric, cardiovascular, haematological and functional capacity 
variables, and therefore the hypothesis is partially accepted. 
5.5.2. Objective Two – A 10-week comprehensive lifestyle intervention will result 
 in significant changes in dietary habits and lifestyle behaviours. 
A significant reduction in the frequency of external sugar/sweetener usage (p = 0.03) and a 
reduction in the frequency of complex carbohydrates being eaten together in one sitting (p < 0.001) 
were two important findings. In addition, there was a significant increase in the frequency of 
vegetables and/or salad consumption on a weekly basis (p < 0.001), and a reduction in the 
consumption of white bread (p = 0.04). There was, however, no significant change in lifestyle 
behaviours related to smoking and drinking habits. The findings of this study suggest that in 
individuals suffering from T2DM, a 10-week comprehensive lifestyle intervention can cause 
significant changes in dietary habits, but not lifestyle behaviours, and therefore the hypothesis is 
partially accepted. 
5.5.3.  Objective Three – A 10-week comprehensive lifestyle intervention will result 
 in significant changes in health-related quality of life (HRQoL). 
Physical and psychological components related to HRQoL, both general and diabetes-specific, were 
substantially improved following the intervention period. With respect to the physical components, 
there was a significant improvement in physical functioning (p < 0.001), energy and mobility (p < 
0.001), sexual functioning (p = 0.02) and diabetes management and control (p = 0.01), with a 
decrease in the number of limitations in physical role functioning (p = 0.005). With respect to the 
psychological components, there was a significant improvement in vitality (p = 0.008), health 
perceptions (p < 0.001), anxiety and worry (p = 0.006), social burdens (p = 0.01), perceived quality 
of life (p = 0.008) and perceived diabetes severity (p = 0.002). There was furthermore, a decrease in 
the number of limitations in emotional role functioning (p = 0.02). No significant change was 
observed in the HRQoL domains of social functioning, body pain or overall mental health. The 
findings of this study suggest that in individuals suffering from T2DM, a 10-week comprehensive 
lifestyle intervention can cause significant changes in HRQoL, and therefore the hypothesis is 
partially accepted. 
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5.5.4. Objective Four – A 10-week comprehensive lifestyle intervention will result 
 in significant changes in health professional usage behaviour. 
The findings of this study indicated that there was no significant change in the number of people 
who regularly went for check-ups with their primary healthcare provider and/or associated 
healthcare provider, and therefore the hypothesis is rejected. 
5.5.5. Objective Five – A post-intervention guide provided following a 10-week 
 comprehensive lifestyle intervention will ensure that the significant 
 improvements obtained during the program, will be maintained. 
The results of this study showed that a post-intervention guide was not effective in maintaining the 
improvements seen following participation in a 10-week comprehensive lifestyle intervention., 
However, it must be noted that all of the measured outcome variables were still better at the follow-
up testing period  compared to baseline. Furthermore, there was no means to investigate whether the 
results at the retention-testing session was due to the use of the post-intervention guide. The 
hypothesis is therefore rejected.  
5.6. Conclusion  
With the increased prevalence of T2DM and its associated complications globally, progressively 
more research is being devoted to prevention and improvement of management of the disease. The 
findings of this study demonstrated that as little as 10 –weeks of a community-based program can 
improve glycaemic control, HRQoL and lifestyle habits, contributing to the improved management 
of the disease in the specific community. While the economic impact of this study was not 
measured, previous research infers that the improvements in disease management would result in 
lower levels of morbidity and T2DM associated complications and lower years lost to disability or 
death. The improvements seen in glycaemic control should result in reductions in the dosage and 
frequency of medications usage, carefully controlled by the participants’ primary healthcare 
providers, which in turn would lower the negative side effects associated with long-term medication 
usage. Furthermore, there is evidence to suggest that programs making use of both dietary and 
physical activity interventions achieve better long-term results. 
To date, no study has been published which has examined the use of supplementary materials such 
as a post-intervention guide, in an attempt to maintain the changes resulting from a structured 
intervention program. It is highly probable that these studies don’t yet exist due to the high costs 
associated with preparation of and manufacturing of the materials, especially in large-scale studies. 
The effect of post-intervention guides will need to be repeated in small-scale studies to determine 
Stellenbosch University  https://scholar.sun.ac.za
120 | P a g e  
 
their effectiveness before a decision can be made on their large-scale application. There are 
however, a number of studies that used a follow-up period or periods after the completion of the 
respective intervention. What is of interest is that the number of published studies with a follow-up 
period pale in comparison to the studies that do not. This is particularly worrying considering that 
individuals suffering with T2DM often find it difficult to make the necessary changes to improve 
disease management, or to maintain the changes following a program. Once again, it is probable 
that this lack of data is due to limited resources and logistical challenges with respect to participant 
retention, medication adherence and the development of complications related to T2DM. 
5.7. Study Limitations 
Due to the comprehensive nature of the study there were a number of limitations. Firstly, the 
sample size was small and may have, in some cases, affected the statistical power of the analyses. 
Through G-power analysis it was calculated that a sample size of 60 would have been required to 
detect statistically significant differences between the two groups. Recruitment of the participants 
from this area proved extremely difficult due to the novelty of the study in the region. However, 
with that being said, a number of intervention studies with T2DM participants found statistically 
and clinically significant results with far fewer participants (Melkus et al., 2004; Murrock et al., 
2009) Furthermore, there was a large degree of variability in some of the parameters related to 
HRQoL, as well as dietary and lifestyle habits. This could have been due to the validity and 
reliability of the self-developed questionnaires not being tested prior to their use, or the participants 
responding to questions based on what they perceived to be the correct answer, and not necessarily 
what was true in their case. Although participants were encouraged to answer as accurately and 
truthfully as possible, there are no tools that can control for the participants’ responses.  
In addition, there was no way to discriminate between the changes seen from the baseline to post-
testing, and the respective contributions of each of the intervention methods (exercise, diet and 
psychology), with future research needing to be conducted in order to identify which, if any of the 
three, plays the most important role. 
The use of the 6MWT as the only measurement of physical activity is a further limitation of this 
study, and although there is evidence to suggest that it indirectly assesses a number of the 
components of physical fitness, the use of an activity monitor, and additional testing in the form of 
the Seniors fitness test would have been preferable. 
No data was collected on participants’ exercise habits following the completion of the intervention, 
which could have explained some of the changes from post-testing to retention testing. The use of a 
physical activity questionnaire such as the EPIC physical activity questionnaire or global physical 
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activity questionnaire (GPAQ) would have been beneficial in this regard. It must be noted, that 
following 10-weeks of complete detraining, a number of the physiological variables would have 
returned to baseline levels (Narici et al., 2008), which provides some evidence that the participants 
would have continued with some form of structured exercise and appropriate lifestyle behaviours. 
Finally, not having two separate groups with respect to the post-intervention guide (one group who 
received the guide and another who did not), made drawing conclusions on its effectiveness very 
difficult, in addition to their being no published research in this area. Furthermore, the control group 
was not measured at the retention testing session, and while it is assumed that there would have 
been no statistically significant change, it would have been beneficial to test them. This is most 
certainly an area that requires further investigation considering that empowering individuals to 
manage their disease following a structured program, would allow community health workers to 
reach other people suffering from T2DM, thereby reducing overall prevalence of the disease. 
The field of research into the management of T2DM is vast and diverse, with a number of areas yet 
to be properly explored and reported in research. What is known, however, is that more 
investigation into community or peer-led comprehensive lifestyle interventions is necessary in order 
to adequately tackle the medical catastrophe that is T2DM. 
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Chapter 6 
Summary, Practical Application and Future Directions 
6.1. Summary 
With the prevalence of T2DM on the rise in communities with low SES there is a growing need for 
interventions driven by healthcare professionals within the community to continue to manage and 
prevent the medical catastrophe of T2DM from spreading further into a multi-generational disease. 
This study is the first comprehensive lifestyle intervention in a low SES community in the 
Stellenbosch region and South Africa and may assist in forming the framework upon which further 
low-cost and sustainable studies can be built, targeting T2DM and other prevalent NCDs. The 
results of this study demonstrate that a 10-week comprehensive lifestyle intervention program, 
incorporating physical activity, dietary advice and psychological behavioural change techniques, 
may significantly benefit T2DM related outcomes such as glycaemic control, HRQoL and lifestyle 
habits. 
Improvements in anthropometric, cardiovascular, haematological and functional outcomes were 
found to be clinically significant in the experimental group. Furthermore, the improvements in self-
care activities and diabetes-related distress add significant value, with higher levels of self-care 
being associated with better glycaemic control, and therefore better management of T2DM. By 
improving HRQoL, it significantly decreases the likelihood of unfavourable lifestyle behaviours 
such as binge eating and high levels of alcohol consumption, which themselves have been found to 
negatively impact of T2DM development and progression. 
Considering the cultural beliefs and practices of the low SES community where the study was based 
in, which is characterised by a diet high in sugar, refined carbohydrates and low vegetable 
consumption, significant improvements in dietary habits, as well as a decrease in the quantity of 
alcohol consumed, demonstrates that education and access to information play a significant role in 
managing T2DM. Both dietary and lifestyle behaviours were maintained at the follow-up period, 
which, in conjunction with the haematological findings, indicate that participants were able to bring 
their T2DM under control. 
The need for open and consistent communication and contact times between the patient with T2DM 
and healthcare professionals, whether it be their primary healthcare provider or allied health 
professionals, is essential to the proper management of T2DM. The more frequently the individual 
has their clinical status measured, the lower the incidence of diabetes-related complications and the 
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better an individual adheres to their medication schedule. This in combination, results in favourable 
outcomes and better management of the disease. 
Considering the limitations, this study has shown that 10-weeks of a structured and comprehensive 
lifestyle intervention delivered by a multidisciplinary team, has the potential to significantly 
improve clinical outcomes, as well as overall management of T2DM in a community with a low 
SES. 
6.2. Practical Application 
One of the most important practical applications from this study is that community-based programs 
may prove useful for implementation by local clinics to manage the patients with T2DM. 
Furthermore, the knowledge gained by participating in these types of programs allows for the 
individuals suffering with T2DM to make informed choices regarding exercise, dietary habits and 
lifestyle behaviours, leading to better management and control of T2DM. These improvements are 
critical to the adequate management of T2DM, as prolonged uncontrolled T2DM has been linked to 
the development of CVD and other diabetes-related complications such as peripheral neuropathy 
and cancer. By empowering individuals with T2DM to take responsibility for their health, it has the 
potential to spread to family members who may also have T2DM, as well as friends who may be 
suffering from the disease. The potential impact this knowledge could have on other chronic 
diseases cannot be discounted, with the benefits of exercise and dietary interventions on 
hypertension and hypercholesterolemia being well documented. The financial costs needed to cover 
the testing and execution of the program were extremely low, which enables the program, or 
programmes similar to the one described in this study to be repeated a number of times, ultimately 
to reach a larger proportion of community members suffering with T2DM, or other NCDs. 
Furthermore, considering that the program was conducted in a low SES community, the low cost 
factor increases the likelihood of the program being sustained over an extended period of time. In 
addition to this, the need for further study in this and other similar communities is evident, with the 
current study providing valuable information to potential researchers regarding the development 
and execution of multi-faceted lifestyle interventions. Finally, the barriers to participation in this 
study were not investigated. Once again, this provides the opportunity for research into this specific 
community with regard to what those barriers may be. By identifying those barriers, possible 
solutions can be sought, which could improve the participation in, and adherence to programs that 
target the prevention and management of chronic lifestyle diseases. 
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6.3. Future Directions 
Firstly, no study has previously differentiated between the three different intervention components 
(exercise, diet, psychology) and their individual contributions to change. This is especially 
important in a low SES community, where resources are limited and the need to optimise the 
programs at the lowest possible cost is necessary. By determining the relative contribution of each, 
future programs could be developed in relation to the overall benefit each component provides. 
Secondly, the impact of social support, especially in the follow-up period, should be investigated 
further considering that one of the barriers to positive lifestyle changes identified in the literature is 
low levels of social support. The success or impact  of a post-intervention guide was not conclusive 
due to interaction of several parameters. Potential future studies could benefit from evaluating the 
effect of these guides on control and management of T2DM, in addition to the use of telephonic 
contact as an assistive aide. In principle, should this method be found to be effective, it would allow 
for community health workers to reach other people suffering with T2DM, thereby reducing overall 
prevalence of the disease, as well as the overall incidence of diabetes-related complications. There 
are, however, a number of logistical challenges that need to be overcome such as language 
preferences, provision of a central location where individuals can exercise as a group, and on-going 
support structures should they be needed. Considering that the overall running costs of the program 
were extremely low, the possibility to incorporate the program as part of preventative and on-going 
management of T2DM in the public health sector must be explored. 
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Appendices 
Appendix A – Flyer 
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We are looking for men and women 
between the ages of 18 and 80 years to 
take part in a 10 week lifestyle 
intervention program to help better 
control their diabetes. 
 
Participation in this program is FREE of 
charge! 
 
If you are interested, call or message Bradley 
Fryer on 082 551 2318 or e-mail 
bfryer@sun.ac.za. 
 
Do you suffer from Type 2 
Diabetes?? 
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I,      , hereby give permission for (Name of Participant) to 
participate in the Type 2 Diabetes Lifestyle Intervention Program. Through consultation with 
him/her, I have no reason to believe that he/she will not be able to safely perform exercise of a 
moderate intensity (40-60% HRmax). This letter serves to clear (Name of Participant) for 
participation in the program. 
 
Doctor Name:       
Practice Number:      
Signature:       
 
  
Stellenbosch University  https://scholar.sun.ac.za
 174 | P a g e  
 






CONSENT TO PARTICIPATE IN RESEARCH 
 
The implementation of a community-based lifestyle intervention program for adults with type 2 
diabetes in Stellenbosch. 
You are asked to participate in a research study conducted by Bradley James Fryer (M Sport 
Science), from the Department of Sport Science at Stellenbosch University. The results will be used 
as part of a PhD dissertation. You were selected as a possible participant in this study because you 
are older than 18 years and have been diagnosed with non-insulin dependent diabetes mellitus 
(Type 2 Diabetes) for at least six months. 
 
PURPOSE OF THE STUDY 
The purpose of this study is to implement a community-based intervention for individuals with type 
2 diabetes in a socially disadvantaged community which can be managed and sustained by allied 
health professionals and local health care workers. 
 
PROCEDURES 
If you volunteer to participate in this study, we would ask you to do the following things: 
Following screening for eligibility to participate in the study, you will need to visit the doctor(s) 
located at the Cloetesville clinic to clear you for participation, which will not cost you anything. 
You will be required to make two visits to the local community centre/church hall within a space of 
4 weeks. Thereafter, you will make visits to the local community centre/church hall for the 
intervention period lasting a total of 10 weeks. The sessions will include teaching of lifestyle skills 
to manage your diabetes as well as advice on correct eating habits for your diabetes. You will also 
participate in an exercise session three times a week that will be about 60 minutes. 
During the first visit, the outline and aims of the study will be explained in full to you, as well as the 
informed consent. During this first pre-testing session, basic measurements of height, body mass, 
blood pressure and body fat percentage will be taken, as well as glucose and cholesterol. Secondly, 
you will be asked to complete a few questionnaires on how being diagnosed with diabetes has 
affected you. Lastly, you will perform a short exercise test to test your fitness levels. You will then 
be given a form which you must take to a Pathcare clinic for blood to be drawn in order to measure 
your glycated haemoglobin (HbA1c) levels. The testing procedures will take no longer than 90 
minutes to complete. These procedures will be repeated on three other occasions over the next 6 
months in order for us to assess your progress. The intervention will take place at the local 
community centre/church hall for under the guidance of the researcher and the assistance of allied-
health professionals. 
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POTENTIAL RISKS AND DISCOMFORTS 
During the testing sessions before the intervention begins, you will undergo a finger-prick test for 
blood glucose (sugar) and cholesterol. This may feel like a small sting and cause slight discomfort 
afterwards. You will also be required to give 5ml of blood so that your HbA1c levels (a blood 
marker for type 2 diabetes) can be measured. You will be performing moderate intensity exercise, 
therefore it is possible that you may experience some discomfort and dizziness following the 
exercise, and symptoms will be managed in this regard. You may also experience slight muscle 
soreness or fatigue 24- to 48-hours following exercise known as delayed onset muscle soreness 
(DOMS) which is a common side-effect following exercise and can be considered to be normal if it 
subsides over a 48-hour period. Some of the questions in the testing procedure(s) may be of a 
personal nature and all information will be kept strictly confidential. Furthermore, you may decide 
not to answer the question should you wish. 
 
POTENTIAL BENEFITS TO SUBJECTS AND/OR TO SOCIETY 
Participation in the study will help to improve with the management and control of your diabetes. It 
will also aid in the development of a structured and sustainable program for type two diabetics that 
could potentially be carried out as a community service initiative by the Stellenbosch Biokinetics 
Centre. It also has the potential to be carried out in other chronic disease population groups. 
 
PAYMENT FOR PARTICIPATION 
You will not receive any payment for participating in this study.  
 
CONFIDENTIALITY 
Any information that is obtained in connection with this study and that can be identified with you 
will remain confidential and will be disclosed only with your permission or as required by law. 
Confidentiality will be maintained by means of special coding system for each participant. Data will 
be stored on a two password protected servers which only the researcher will have access to. 
Results of the study will be published in a reputable journal with no personal information being 
published. Any data published will be general and non-specific to the subjects. 
 
PARTICIPATION AND WITHDRAWAL 
You can choose whether to be in this study or not.  If you volunteer to be in this study, you may 
withdraw at any time without consequences of any kind.  You may also refuse to answer any 
questions you don’t want to answer and still remain in the study. The investigator may withdraw 
you from this research if circumstances arise which warrant doing so.  These circumstances include 
but are not limited to: significant decline in your health or inability to complete all the tests. 
 
IDENTIFICATION OF INVESTIGATORS 
If you have any questions or concerns about the research, please feel free to contact Bradley Fryer 
(Researcher) on 0825512318 (day), 021 889 5031 (day), or via e-mail bradleyjfryer@gmail.com. 
Prof. Elmarie Terblanche (Supervisor) may also be contacted on 021 8082742 (day) or via e-mail 
on et2@sun.ac.za. In the case of emergency you can contact Bradley Fryer on 0825512318 or 
021 889 5031.  
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RIGHTS OF RESEARCH SUBJECTS 
You may withdraw your consent at any time and discontinue participation without penalty.  You are 
not waiving any legal claims, rights or remedies because of your participation in this research study.  
If you have questions regarding your rights as a research subject, contact Ms Maléne Fouché 
[mfouche@sun.ac.za; 021 808 4622] at the Division for Research Development. 
 
SIGNATURE OF RESEARCH SUBJECT OR LEGAL REPRESENTATIVE 
 
The information above was described to me by Bradley James Fryer in Afrikaans/English and I am 
in command of this language or it was satisfactorily translated to me.  I was given the opportunity to 
ask questions and these questions were answered to my satisfaction.  
 
I hereby consent voluntarily to participate in this study I have been given a copy of this form. 
 
________________________________________ 
Name of Subject/Participant 
________________________________________ 
Name of Legal Representative (if applicable) 
________________________________________   ______________ 
Signature of Subject/Participant or Legal Representative Date 
 
SIGNATURE OF INVESTIGATOR  
 
I declare that I explained the information given in this document to 
____________________________ and/or [his/her] representative ____________________. 
[He/she] was encouraged and given ample time to ask me any questions. This conversation was 
conducted in [Afrikaans/*English]. 
 
________________________________________  ______________ 
Signature of Investigator     Date 
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INITIAL SCREENING FORM 
 
Name:       Contact Number:    
Surname:      ID#:      
Address:      DOB:      
       Doctor:     
       Next of Kin:     
       Kin Cont #:     
 
History: 
             
             
             
             
             
 
Family History:     Personal History: 
Coronary Artery Disease    Coronary Artery Disease  
Myocardial Infarction     Myocardial Infarction 
Stroke       Stroke 
Diabetes      Diabetes 
Pulmonary Disease     Pulmonary Disease 
Other Cardiovascular Disease   Other Cardiovascular Disease 
Other Metabolic Disease    Other Metabolic Disease 
 
Current Activity Levels 
 
Type:       Duration:     
Frequency:      Intensity:     
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Medications: 
             
             
             
 
Any Musculoskeletal or Joint Problems: 
Yes:    No:   
Specify:            
 
Any Specific Eating Plan: 
Yes:    No:   
Specify and Duration:          
 
 
Signature of Researcher:     Date:     
 
Signature of Participant:     Date:     
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Appendix E – Short-Form 36 (SF-36) Questionnaire 
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Your Health and Well-Being 
 
 
This questionnaire asks for your views about your health. This information will 
help keep track of how you feel and how well you are able to do your usual 
activities.  Thank you for completing this survey! 
 
For each of the following questions, please mark an  in the one box that best 
describes your answer. 
 
1. In general, would you say your health is: 
Excellent Very good Good Fair Poor 
    




2. Compared to one week ago, how would you rate your health in general 
now? 
Much better 








one week ago 
Somewhat 
worse 
now than one 
week ago 
Much worse 
now than one 
week ago 
    
   1    2    3    4    5 
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3. The following questions are about activities you might do during a typical 











    
 a Vigorous activities, such as running, lifting  
heavy objects, participating in strenuous sports ......................  1 .............  2 .............  3 
 b Moderate activities, such as moving a table, pushing  
a vacuum cleaner, bowling, or playing golf .............................  1 .............  2 .............  3 
 c Lifting or carrying groceries ....................................................  1 .............  2 .............  3 
 d Climbing several flights of stairs .............................................  1 .............  2 .............  3 
 e Climbing one flight of stairs ....................................................  1 .............  2 .............  3 
 f Bending, kneeling, or stooping ................................................  1 .............  2 .............  3 
 g Walking more than a kilometre ...............................................  1 .............  2 .............  3 
 h Walking several hundred metres ..............................................  1 .............  2 .............  3 
 i Walking one hundred metres ...................................................  1 .............  2 .............  3 
 j Bathing or dressing yourself ....................................................  1 .............  2 .............  3 
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4. During the past week, how much of the time have you had any of the 
following problems with your work or other regular daily activities as a 
result of your physical health? 










     
 a Cut down on the amount of  
  time you spent on work or  
  other activities ..................................  1 ..............  2 ..............  3 ..............  4 ..............  5 
 b Accomplished less than you  
  would like ........................................  1 ..............  2 ..............  3 ..............  4 ..............  5 
 c Were limited in the kind of  
  work or other activities ....................  1 ..............  2 ..............  3 ..............  4 ..............  5 
 d Had difficulty performing the 
  work or other activities (for  
  example, it took extra effort) ...........  1 ..............  2 ..............  3 ..............  4 ..............  5 
 
 
5. During the past week, how much of the time have you had any of the 
following problems with your work or other regular daily activities as a 
result of any emotional problems (such as feeling depressed or anxious)? 










     
 a Cut down on the amount of  
  time you spent on work or  
  other activities ..................................  1 ..............  2 ..............  3 ..............  4 ..............  5 
 b Accomplished less than you  
  would like ........................................  1 ..............  2 ..............  3 ..............  4 ..............  5 
 c Did work or other activities 
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6. During the past week, to what extent has your physical health or emotional 
problems interfered with your normal social activities with family, friends, 
neighbours, or groups? 
Not at all Slightly Moderately Quite a bit Extremely 
    






7. How much bodily pain have you had during the past week? 
None Very mild Mild Moderate Severe Very severe 
     






8. During the past week, how much did pain interfere with your normal work 
(including both work outside the home and housework)? 
Not at all A little bit Moderately Quite a bit Extremely 
    
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9. These questions are about how you feel and how things have been with you 
during the past week.  For each question, please give the one answer that 
comes closest to the way you have been feeling.  How much of the time 
during the past week… 
 
 
10. During the past week, how much of the time has your physical health or 
emotional problems interfered with your social activities (like visiting 











    
   1    2    3    4    5 
 
 










     
 a Have you felt full of life? .................  1 ..............  2 ..............  3 ..............  4 ..............  5 
 b Have you been very nervous? ..........  1 ..............  2 ..............  3 ..............  4 ..............  5 
 c Have you felt so down in the  
dumps that nothing could  
cheer you up? ...................................  1 ..............  2 ..............  3 ..............  4 ..............  5 
 d Have you felt calm and   
peaceful? ..........................................  1 ..............  2 ..............  3 ..............  4 ..............  5 
 e Have you had a lot of energy? .........  1 ..............  2 ..............  3 ..............  4 ..............  5 
 f Have you felt downhearted   
and depressed? .................................  1 ..............  2 ..............  3 ..............  4 ..............  5 
 g Have you felt worn out? ...................  1 ..............  2 ..............  3 ..............  4 ..............  5 
 h Have you been happy? .....................  1 ..............  2 ..............  3 ..............  4 ..............  5 
 i Have you felt tired tired? .................  1 ..............  2 ..............  3 ..............  4 ..............  5 
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     
 a I seem to get sick a little 
easier than other people ...................  1 ..............  2 ..............  3 ..............  4 ..............  5 
 b I am as healthy as  
anybody I know ................................  1 ..............  2 ..............  3 ..............  4 ..............  5 
 c I expect my health to  
get worse ..........................................  1 ..............  2 ..............  3 ..............  4 ..............  5 








Thank you for completing these questions! 
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Appendix F – Diabetes -39 (D-39) Questionnaire 
Diabetes-39 
Quality of Life Survey 
A person’s quality of life is affected by many things. These things might include health, the 
opportunity for recreation and vacations, friends and family, and a job. This questionnaire is 
designed to help us learn about what affects the quality of life of people with diabetes. 
Below are questions about your quality of life. For each factor listed, we ask you to place an “X” on 
the line to show whether that factor affects your quality of life “extremely”. “not at all”, or some 
place in the middle. An example is shown in the box below. For example, if you thought “having an 
automobile” affected your quality of life to some extent, but not extremely, you might mark the line 
as shown. 
DURING THE PAST MONTH, HOW MUCH WAS THE QUALITY OF YOUR LIFE 
AFFECTED BY: 
  Having an automobile 
  1 2 3 4 5 6 7 
 
 
DURING THE PAST MONTH, HOW MUCH WAS THE QUALITY OF YOUR LIFE 
AFFECTED BY: 
 
1. Your diabetes medication schedule 
  1 2 3 4 5 6 7 
 
 
2. Worries about money matters 
  1 2 3 4 5 6 7 
 
 
3. Limited energy levels 
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4. Following your doctor’s prescribed treatment plan for diabetes 
  1 2 3 4 5 6 7 
 
5. Food restrictions required to control your diabetes 
  1 2 3 4 5 6 7 
 
 
6. Concerns about your future 
  1 2 3 4 5 6 7 
 
 
7. Other health problems besides diabetes 
  1 2 3 4 5 6 7 
 
 
8. Stress or pressure in your life 
  1 2 3 4 5 6 7 
 
 
9. Feelings of weakness 
  1 2 3 4 5 6 7 
 
 
10. Restrictions on how far you can walk 
  1 2 3 4 5 6 7 
 
 
11. Exercise requirements 
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12. Loss or blurring of your vision 




13. Not being able to do what you want 
  1 2 3 4 5 6 7 
 
 
14. Having diabetes 
  1 2 3 4 5 6 7 
 
 
15. Losing control of your sugar levels 
  1 2 3 4 5 6 7 
 
 
16. Other illnesses besides diabetes 
  1 2 3 4 5 6 7 
 
 
17. Testing your sugar (glucose) levels 
  1 2 3 4 5 6 7 
 
 
18. The time required to control your diabetes 
  1 2 3 4 5 6 7 
 
 
19. The restrictions your diabetes places of your family and friends 
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20. Being embarrassed because you have diabetes 




21. Diabetes interfering with your sex  life 
  1 2 3 4 5 6 7 
 
 
22. Feeling blue or depressed 
  1 2 3 4 5 6 7 
 
 
23. Problems with sexual functioning 
  1 2 3 4 5 6 7 
 
 
24. Getting your diabetes well controlled 
  1 2 3 4 5 6 7 
 
 
25. Complications from your diabetes 
  1 2 3 4 5 6 7 
 
 
26. Doing things that your family or friends don’t do 
  1 2 3 4 5 6 7 
 
 
27. Keeping a record of your sugar levels 
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28. The need to eat at regular intervals 




29. Not being able to do housework or other jobs around the house 
  1 2 3 4 5 6 7 
 
 
30. A decreased interest in sex 
  1 2 3 4 5 6 7 
 
 
31. Having your schedule centre around diabetes 
  1 2 3 4 5 6 7 
 
 
32. Needing to rest often 
  1 2 3 4 5 6 7 
 
 
33. Problems climbing steps 
  1 2 3 4 5 6 7 
 
 
34. Having trouble caring for yourself (dressing, bathing, or using the toilet) 
  1 2 3 4 5 6 7 
 
 
35. Restless sleep 
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36. Walking more slowly than others 




37. Being labelled a diabetic 
  1 2 3 4 5 6 7 
 
 
38. Having diabetes interfere with your family life 
  1 2 3 4 5 6 7 
 
 
39. Diabetes in general 




1. Please place an “X” on the line below that indicates your rating of your overall quality of life. 
  1 2 3 4 5 6 7 
 
 
2. Please place an “X” on the line below to show how severe you think your diabetes is. 
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EATING HABITS QUESTIONNAIRE 
 
Subject Name & Surname:           
Subject Code:       Group:      




1. What time of the day do you eat (mark all that are applicable): 
Breakfast  Lunch   Supper    Snacks 
 
For the following questions, please be as specific as possible including the type of bread that you 
consume (if applicable), the type of fruit, salad or vegetables that you eat and the frequency at 
which you eat them. Also, if you add sugar or sweeteners to any meals please indicate where 
applicable, and if you eat more than one carbohydrate (e.g. rice, potato, pasta, etc.) in one mealtime 
specify where applicable. 
 
2. What is your usual breakfast (if applicable): 
              
              
              
 
3. What is your usual lunch (if applicable): 
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4. What is your usual supper (if applicable): 
              
              
              
 
5. What is your usual snack(s) (if applicable): 
              
              
              
 
6. Do you eat at least three meals a day? 
Yes   No 
 
7. Do you take any vitamin/herbal supplements and/or meal replacements? 
Yes   No 
 
8. What do you spend on average per month on food? 
R      
 
9. Do you drink alcohol? 
Yes   No 
 
10. Do you smoke, and if yes, how many cigarettes a day? 
Yes   No  Number:  
 
11. If yes, what type of alcohol do you consume? 
Beer/Cider  Wine    Spirits   Shooters 
 
12. What quantity and how many times per week do you consume alcohol? 
Quantity (in units assuming that 250 ml = 1 unit):       
Frequency (per week):           
 
13. What do you spend on average per month on alcohol/cigarettes? 
R     
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14. Have you ever had dietary counselling or advice from a dietician before? 
Yes   No 
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HEALTH PROFESSIONAL USE QUESTIONNAIRE 
 
Subject Name & Surname:           
Subject Code:       Group:      
Date of Testing:      Time of Testing:    
 
 
1. Have you ever been to a doctor (general practitioner, specialist, etc.): 
Yes   No 
 
2. Where do you go to normally see a doctor? 
Hospital  Clinic   Private Practice   
 
3. How far do you have to travel to get to your doctor? 
< 5 km   6 – 10 km  11 – 20 km   > 20 km 
 
4. What is your mode of transportation? 
Walk   Bike   Train    Vehicle 
 
5. How often do you see your doctor per year (number of visits)? 
≤ 1 per year  2 – 5   6 - 11    ≥ 12 
 
6. What do you normally see your doctor for? 
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7. What other health professionals do you make use of? 
Nurse   Physio    OT   Other 
Other:        
 
8. Do you take regular medication? 
Yes   No 
 
9. What do you spend on medication per month? 
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Answer Legend: 1 = All the time ; 2 = Most of the time ; 3 = Sometimes ; 4 = Hardly ever ; 5 = Never 







ADAPTED DIABETES FAMILY BEHAVIOUR SCALE 
 
Subject Name & Surname:           
Subject Code:       Group:      
Date of Testing:      Time of Testing:    
 
Circle the answer that best tells how often these things happen or don’t happen in your family. There are no 




1. My family watches when I test for sugar .   1 2 3 4 5 
2. When there is a problem with my Diabetes we call the doctor.  1 2 3 4 5 
3. We know when there are problems with my Diabetes.   1 2 3 4 5 
4. My family does thing for me that I could do myself in taking  1 2 3 4 5 
    care of my Diabetes. 
5. My family reads books about Diabetes.    1 2 3 4 5 
6. My family reminds me to test my sugar.    1 2 3 4 5 
7. My family encourages me to get some exercise every day.  1 2 3 4 5 
8. My family buys sweets for everyone.     1 2 3 4 5 
9. At home, my family eats food that is NOT on my Diabetic diet. 1 2 3 4 5 
10. My Diabetes makes my family nervous.    1 2 3 4 5 
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11. We wait to call the doctor until I’m very sick because of my  1 2 3 4 5 
       Diabetes. 
12. I take care of my Diabetes myself.     1 2 3 4 5 
13. My family listens to my ideas about taking care of my Diabetes. 1 2 3 4 5 
14. If we’re not sure what to do we call for help.    1 2 3 4 5 
15. My family and I argue about whether I’m sticking to my  1 2 3 4 5 
       Diabetes diet. 
16. My family has regular meal times.     1 2 3 4 5 
17. My family seems embarrassed that I have Diabetes.   1 2 3 4 5 
18. My family listens to my problems about having Diabetes.  1 2 3 4 5 
19. My family member(s) makes my snacks.    1 2 3 4 5 
20. My family makes me feel good about taking care of my Diabetes. 1 2 3 4 5 
21. My family embarrasses me by talking about Diabetes with other 1 2 3 4 5 
       people. 
22. When we go out to eat, I choose things from the menu that are 1 2 3 4 5 
       in line with my Diabetic diet. 
23. Other family members eat sweets in front of me.   1 2 3 4 5 
24. I feel alone with my Diabetes.     1 2 3 4 5 
25. My family is always ready to help with my Diabetes when I  1 2 3 4 5 
       need it. 
26. My family tells me to stop acting as if I am sick.   1 2 3 4 5 
27. I don’t worry about what my sugar test results unless I start  1 2 3 4 5 
       feeling bad. 
28. My family knows how well I am taking care of my Diabetes.  1 2 3 4 5 
29. I have someone in my family to talk about Diabetes.   1 2 3 4 5 
30. My family gets angry with me when I make a slip in taking  1 2 3 4 5 
       care of my Diabetes. 
31. My family talks about Diabetes.     1 2 3 4 5 
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Appendix J – Exercise Programs (Week 1 to Week 10) 
Week 1: 
Exercise Sets Reps Notes 
On the spot marching 
1 20s each Warm-Up 
Step-touch (both ways) 
Step and Slide (both ways) 
Arm Lifts (forward, side) 
Arm lifts and clap (front and back) 
Arm circles – small to big 
On the spot marching 
Step-touch (both ways) 
Step and Slide (both ways) 
REST 2 minutes 
SEATED EXERCISES 
Knee Extension with diagonal heel touch 
(alternating unilateral) 
2 20 
Alternate legs during 
the set 
Hip Flexion (alternating unilateral) 2 20 
Alternate legs during 
the set 
Knee Extension with abduction (alternating 
unilateral) 
2 14 
Alternate legs during 
the set 
Resisted clams (seated with band) 2 20 
Use red bands around 
knees 
Discuss shoulder press (unilateral) Each side 2 10 
Complete one arm 
before moving to the 
next 
Sit-to-stand with handball raise 2 15 
Handball must be 
held away from body 
with arms straight 
REST 2 minutes 
Fast feet over rope (fwd, sdw, fwd) Each 30s 
Complete the three in 
succession 
Half Seated Holds (Hold for 10s) 2 8 
Start from standing 
position 
Sit-to-stand with isometric abduction (with 
band) 
2 12 
Use red bands around 
knees 
Calf Raises 2 12 Bilateral 
REST 2 minutes 
Fast feet over rope (fwd, sdw, fwd) Each 30s Complete the three in 
Stellenbosch University  https://scholar.sun.ac.za
 200 | P a g e  
 
succession 
Stork Stand/Single Leg Balance (eyes open) Each 30s 
Can be assisted or 
not 
Stork Stand/Single Leg Balance (eyes open) Each 30s 
Make sure to hold 
onto chair 
Stretch - Hamstrings 2 x 20s each leg 
GET RPE SCORES FROM EACH PERSON 
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Week 2: 
Exercise Sets Reps Notes 
On the spot marching 
1 30s each Warm-Up 
Step-touch (both ways) 
Step and Slide (both ways) 
Arm Lifts (forward, side) 
Arm lifts and clap (front and back) 
Arm circles – small to big 
On the spot marching 
Step-touch (both ways) 
Step and Slide (both ways) 
REST 1 minute 
SEATED EXERCISES 
Knee Extension with abduction (alternating 
unilateral) 
2 20 
Alternate legs during 
the set (10 each side) 
Tri-Directional Torso Rotation with Discus 2 20 
Make sure they sit up 
straight 
Sit-to-stand with isometric abduction (with 
band) 
2 12 
Use red bands around 
knees 
Wall Push Up with Twist 2 14 
Make sure their 
backs remain straight 
Fast feet over rope (fwd, sdw, fwd) Each 35s 
Complete the three in 
succession 
REST 2 minutes 
Fast feet over rope (fwd, sdw, fwd) Each 35s 
Complete the three in 
succession 
Half Seated Holds (Hold for 15s) 2 6 
Start from standing 
position 
Sumo Squats with Soccer Ball Extension 2 10 
Hold soccer ball in 
front, wide stance 
Calf Raises and Calf Raise Holds with 
Bounces 
2 12 Bilateral 
REST 1 minute 
Fast feet over rope (fwd, sdw, fwd, sdw, 
fwd) 
Each 30s 
Complete the five in 
succession 
Stork Stand/Single Leg Balance (eyes open) Each 30s 
Can be assisted or 
not 
Stork Stand/Single Leg Balance (eyes open) Each 30s 
Make sure to hold 
onto chair 
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Fast feet over rope (fwd, sdw, fwd, sdw, 
fwd) 
Each 30s 
Complete the five in 
succession 
Stretch - Hamstrings 2 x 20s each leg 
GET RPE SCORES FROM EACH PERSON 
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Week 3: 
Exercise Sets Reps Notes 
On the spot marching 
1 30s each Warm-Up 
Step-touch (both ways) 
Step and Slide (both ways) 
Arm Lifts (forward, side) 
Arm lifts and clap (front and back) 
Arm circles – small to big 
On the spot marching 
Step-touch (both ways) 
Step and Slide (both ways) 
REST 1 minute 
SEATED EXERCISES 
Knee Extension with abduction (alternating 
unilateral) 
2 20 
Alternate legs during 
the set (10 each side) 
Tri-Directional Torso Rotation with Discus 2 20 
Make sure they sit up 
straight 
Sit-to-stand with isometric abduction (with 
band) 
2 12 
Use red bands around 
knees 
Wall Push Up with Twist 2 14 
Make sure their 
backs remain straight 
Fast feet over rope (fwd, sdw, fwd) Each 35s 
Complete the three in 
succession 
REST 2 minutes 
Fast feet over rope (fwd, sdw, fwd) Each 35s 
Complete the three in 
succession 
Half Seated Holds (Hold for 15s) 2 6 
Start from standing 
position 
Sumo Squats with Soccer Ball Extension 2 10 
Hold soccer ball in 
front, wide stance 
Calf Raises and Calf Raise Holds with 
Bounces 
2 12 Bilateral 
REST 1 minute 
Fast feet over rope (fwd, sdw, fwd, sdw, 
fwd) 
Each 30s 
Complete the five in 
succession 
Stork Stand/Single Leg Balance (eyes open) Each 30s 
Can be assisted or 
not 
Stork Stand/Single Leg Balance (eyes open) Each 30s 
Make sure to hold 
onto chair 
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Fast feet over rope (fwd, sdw, fwd, sdw, 
fwd) 
Each 30s 
Complete the five in 
succession 
Stretch - Hamstrings 2 x 20s each leg 
GET RPE SCORES FROM EACH PERSON 
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Week 4: 
Exercise Sets Reps Notes 
On the spot marching 
1 30s each Warm-Up 
Step-touch (both ways) 
Step and Slide (both ways) 
Arm Lifts (forward, side) 
Arm lifts and clap (front and back) 
Arm circles – small to big 
On the spot marching 
Step-touch (both ways) 
Step and Slide (both ways) 
REST 1 minute 
SEATED EXERCISES 
Fast feet over rope (fwd, sdw, fwd) Each 35s 
Complete the three in 
succession 
Tri-Directional Torso Rotation with Discus 2 20 
Make sure they sit up 
straight 
Sit-to-stand with isometric abduction (with 
band) 
2 15 
Use red bands around 
knees 
Sumo Squats with Soccer Ball Extension 2 15 
Hold soccer ball in 
front, wide stance 
Fast feet over rope (fwd, sdw, fwd) Each 35s 
Complete the three in 
succession 
REST 1 minute 
Fast feet over rope (fwd, sdw, fwd) Each 35s 
Complete the three in 
succession 
Half Seated Holds (Hold for 15s) 2 6 
Start from standing 
position 
Fast feet over rope (fwd, sdw, fwd) Each 35s 
Complete the three in 
succession 
Calf Raises and Calf Raise Holds with 
Bounces 
2 15 Bilateral 
REST 1 minute 
Fast feet over rope (fwd, sdw, fwd, sdw, 
fwd) 
Each 30s 
Complete the five in 
succession 
Stork Stand/Single Leg Balance (eyes open) Each 30s 
Can be assisted or 
not 
Stork Stand/Single Leg Balance (eyes open) Each 30s 
Make sure to hold 
onto chair 
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Fast feet over rope (fwd, sdw, fwd, sdw, 
fwd) 
Each 30s 
Complete the five in 
succession 
Stretch – Hamstrings and Gluts 2 x 20s each leg 
GET RPE SCORES FROM EACH PERSON 
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Week 5: 
Exercise Sets Reps Notes 
On the spot marching 
1 30s each Warm-Up 
Step-touch (both ways) 
Step and Slide (both ways) 
Arm Lifts (forward, side) 
Arm lifts and clap (front and back) 
Air Squat with Alternating Bum Kick 
On the spot marching 
Step-touch (both ways) 
Step and Slide (both ways) 
REST 1 minute 
SEATED EXERCISES 
Fast feet over rope (fwd, sdw, fwd, sdw, 
fwd) 
Each 35s 
Complete the five in 
succession 
Shoulder Press into Forward Punch with 
Discus 
2 10 
Make sure they sit up 
straight 
Sit-to-stand with isometric abduction (with 
band) 
2 20 
Use red bands around 
knees 
Fast feet over rope (fwd, sdw, fwd, sdw, 
fwd) 
Each 35s 
Complete the five in 
succession 
REST 1 minute 
Stair Climbing (forward) 30s per leading foot 
As quickly as 
possible 
Stair Climbing (sideways) 30s per leading foot 
As quickly as 
possible 
Calf Raises and Calf Raise Holds with 
Bounces 
2 15 Bilateral at Stairs 
Half Seated Holds (Hold for 15s) 2 8 
Start from standing 
position 
Fast feet over rope (fwd, sdw, fwd, sdw, 
fwd) 
Each 35s 
Complete the five in 
succession 
Pelvic Tilt and Lift 2 15 
Make sure they 
activate their core 
Table Top 2 8 
Make sure they 
activate their core 
Cook Hip Lift 2 6 
Make sure hips are 
stable 
REST 1 minute 
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Fast feet over rope (fwd, sdw, fwd, sdw, 
fwd) 
Each 30s 
Complete the five in 
succession 
Step-touch (both ways) 2 x 30s 
Complete as a 
superset 
Step and Slide (both ways) 2 x 30s 
Complete as a 
superset 
Stretch – Hamstrings and Gluts 2 x 20s each leg 
GET RPE SCORES FROM EACH PERSON 
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Week 6: 
Exercise Sets Reps Notes 
On the spot marching 
1 30s each Warm-Up 
Step-touch (both ways) 
Step and Slide (both ways) 
Arm Lifts (forward, side) 
Arm lifts and clap (front and back) 
Air Squat with Alternating Bum Kick 
On the spot marching 
Step-touch (both ways) 
Step and Slide (both ways) 
REST 1 minute 
SEATED EXERCISES 
Fast feet over rope (fwd, sdw, fwd, sdw, 
fwd) 
Each 45s 
Complete the five in 
succession 
Diagonal Sholuder Abduction with Discus 2 10 
Make sure they sit up 
straight 
Sit-to-stand with isometric abduction (with 
band) with holds (last 5 reps hold for 10sec)  
2 20 
Use red bands around 
knees 
Fast feet over rope (fwd, sdw, fwd, sdw, 
fwd) 
Each 45s 
Complete the five in 
succession 
REST 1 minute 
Stair Climbing (forward) 2 x 45s per leading foot 
As quickly as 
possible 
Stair Climbing (sideways) 1 x 45s per leading foot 
As quickly as 
possible 
Calf Raises and Calf Raise Holds with 
Bounces 
2 15 Bilateral at Stairs 
Half Seated Holds (Hold for 15s) 2 10 
Start from standing 
position 
Fast feet over rope (fwd, sdw, fwd, sdw, 
fwd) 
Each 45s 
Complete the five in 
succession 
Pelvic Tilt and Lift 2 15 
Make sure they 
activate their core 
Table Top 2 10 
Make sure they 
activate their core 
Cook Hip Lift 2 8 
Make sure hips are 
stable 
Side-Lying Abduction 2 8 Make sure hips are 
Stellenbosch University  https://scholar.sun.ac.za
 210 | P a g e  
 
stacked on top of 
each other 
REST 1 minute 
Fast feet over rope (fwd, sdw, fwd, sdw, 
fwd) 
Each 45s 
Complete the five in 
succession 
Step-touch (both ways) 2 x 30s 
Complete as a 
superset 
Step and Slide (both ways) 2 x 30s 
Complete as a 
superset 
Stretch – Hamstrings and Gluts 2 x 20s each leg 
GET RPE SCORES FROM EACH PERSON 
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Week 7: 
Exercise Sets Reps Notes 
On the spot marching 
2 30s each Warm-Up 
Step-touch (both ways) 
Step and Slide (both ways) 
Arm lifts and clap (front and back) 
Air Squat with Alternating Bum Kick 
¼ Lunge (big step) 
REST 1 minute 
Fast feet over rope (Fwd/Sdw Pyramid) 
Start at 60s and work down 
by 10 sec until 20 sec per 
movement 
Complete the whole 
pyramid without a 
break 
Sit-to-stand with Discuss Press 2 12 
Make sure they sit up 
straight 
Standing Hip Abduction and Hip Extension 2 10 
From Hip Abd 
directly into Hip Ext 
¼ Lunge (Big Step) 2 8 
Complete 8 on each 
side 
Fast feet over rope (Fwd/Sdw Pyramid) 
Start at 60s and work down 
by 10 sec until 20 sec per 
movement 
Complete the whole 
pyramid without a 
break 
Half Seated Holds (Hold for 15s) 2 10 
Start from standing 
position 
Stair Climbing (forward) 
Pyramid Starting from 45 
seconds, 10 seconds off 
until 25 seconds per foot 
As quickly as 
possible 
Stair Climbing (sideways) 
Pyramid Starting from 45 
seconds, 10 seconds off 
until 25 seconds per foot 
As quickly as 
possible 
Pelvic Tilt and Lift 2 15 
Make sure they 
activate their core 
Table Top 2 12 
Make sure they 
activate their core 
Cook Hip Lift 2 10 
Make sure hips are 
stable 
Small Crunches (slide hands on upper legs) 2 10 
Make sure they don’t 
pull on their neck 
Side-Lying Abduction 2 10 
Make sure hips are 
stacked on top of 
each other 
REST 1 minute 
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Fast feet over rope (Fwd/Sdw Pyramid) 
Start at 60s and work down 
by 10 sec until 20 sec per 
movement 
Complete the whole 
pyramid without a 
break 
Step-touch (both ways) 2 x 30s 
Complete as a 
superset 
Step and Slide (both ways) 2 x 30s 
Complete as a 
superset 
Stretch – Hamstrings and Gluts 2 x 20s each leg 
GET RPE SCORES FROM EACH PERSON 
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Week 8: 
Exercise Sets Reps Notes 
On the spot marching 
3 30s each 
Warm-Up (No rest 
between sets) 
Step-touch (both ways) 
Step and Slide (both ways) 
Air Squat with Alternating Bum Kick 
½ Lunge (big step) 
REST 1 minute 
Fast feet over rope (Fwd/Sdw Pyramid) 
Start at 60s and work down 
by 10 sec until 20 sec per 
movement 
Complete the whole 
pyramid without a 
break 
Standing Hip Abduction and Hip Extension 2 12 
From Hip Abd 
directly into Hip Ext 
½ Lunge (Big Step) 2 10 
Complete 8 on each 
side 
Fast feet over rope (Fwd/Sdw Pyramid) 
Start at 60s and work down 
by 10 sec until 30 sec per 
movement 
Complete the whole 
pyramid without a 
break 
Sit-to-stands with abduction – into half 
seated holds at end of 15 repetitions 
2 20 
With red band 
around knees. 15 sit-
to-stands, 5 half 
seated holds of 20s at 
end 
Stair Climbing (forward) 
Pyramid Starting from 45 
seconds, 15 seconds off 
until 15 seconds per foot 
As quickly as 
possible 
Stair Climbing (sideways) 
Pyramid Starting from 45 
seconds, 15 seconds off 
until 15 seconds per foot 
As quickly as 
possible 
Stair Climbing (forward) 
Pyramid Starting from 30 
seconds, 5 seconds off until 
15 seconds per foot 
As quickly as 
possible 
Standing Lateral Bend with Discus 2 20 
20 each side, ensure 
back stays straight 
REST 1 minute 
Fast feet over rope (Fwd/Sdw Pyramid) 
Start at 60s and work down 
by 10 sec until 20 sec per 
movement 
Complete the whole 
pyramid without a 
break 
Step-touch (both ways) 2 x 30s 
Complete as a 
superset 
Step and Slide (both ways) 2 x 30s 
Complete as a 
superset 
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Stretch – Hamstrings and Gluts 2 x 20s each leg 
GET RPE SCORES FROM EACH PERSON 
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Week 9: 
Exercise Sets Reps Notes 
On the spot marching 
3 30s each 
Warm-Up (No rest 
between sets) 
Step-touch (both ways) 
Step and Slide (both ways) 
Air Squat with Alternating Bum Kick 
½ Lunge (big step) 
REST 1 minute 
Fast feet over rope (Fwd/Sdw Pyramid) 
Start at 60s and work down 
by 10 sec until 20 sec per 
movement 
Complete the whole 
pyramid without a 
break 
Standing Hip Abduction and Hip Extension 2 15 
From Hip Abd 
directly into Hip Ext 
Lunge (Big Step) 2 8 
Complete 8 on each 
side 
Fast feet over rope (Fwd/Sdw Pyramid) 
Start at 60s and work down 
by 10 sec until 30 sec per 
movement 
Complete the whole 
pyramid without a 
break 
Sit-to-stands with abduction – into half 
seated holds at end of 15 repetitions 
2 20 
With red band 
around knees. 15 sit-
to-stands, 5 half 
seated holds of 20s at 
end 
Stair Climbing (forward) 
Pyramid Starting from 45 
seconds, 15 seconds off 
until 15 seconds per foot 
As quickly as 
possible 
Stair Climbing (sideways) 
Pyramid Starting from 45 
seconds, 15 seconds off 
until 15 seconds per foot 
As quickly as 
possible 
Stair Climbing (forward) 
Pyramid Starting from 30 
seconds, 5 seconds off until 
15 seconds per foot 
As quickly as 
possible 
Seated Discus Torso Rotation with Press 2 20 
20 each side, ensure 
back stays straight 
REST 1 minute 
Fast feet over rope (Fwd/Sdw Pyramid) 
Start at 60s and work down 
by 10 sec until 20 sec per 
movement 
Complete the whole 
pyramid without a 
break 
Step-touch (both ways) 1 x 30s 
Complete as a 
superset 
Step and Slide (both ways) 1 x 30s 
Complete as a 
superset 
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Air Squat with Alternating Bum Kick 1 x 30s 
Complete as a 
superset 
Lunge (Big Step) 1 x 30s 
Complete as a 
superset 
Stretch – Hamstrings and Gluts 2 x 20s each leg 
GET RPE SCORES FROM EACH PERSON 
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Week 10: 
Exercise Sets Reps Notes 
On the spot marching 
3 30s each 
Warm-Up (No rest 
between sets) 
Step-touch (both ways) 
Step and Slide (both ways) 
Air Squat with Alternating Bum Kick 
½ Lunge (big step) 
REST 1 minute 
Fast feet over rope (Fwd/Sdw Pyramid) 
Start at 60s and work down 
by 10 sec until 20 sec per 
movement 
Complete the whole 
pyramid without a 
break 
Standing Hip Abduction and Hip Extension 2 15 
From Hip Abd 
directly into Hip Ext 
Lunge (Big Step) 2 10 
Complete 10 on each 
side 
Fast feet over rope (Fwd/Sdw Pyramid) 
Start at 60s and work down 
by 10 sec until 30 sec per 
movement 
Complete the whole 
pyramid without a 
break 
Sit-to-stands with abduction – into half 
seated holds at end of 15 repetitions 
2 20 
With red band 
around knees. 15 sit-
to-stands, 5 half 
seated holds of 20s at 
end 
Stair Climbing (forward) 
Pyramid Starting from 45 
seconds, 15 seconds off 
until 15 seconds per foot 
As quickly as 
possible 
Stair Climbing (sideways) 
Pyramid Starting from 45 
seconds, 15 seconds off 
until 15 seconds per foot 
As quickly as 
possible 
Stair Climbing (forward) 
Pyramid Starting from 30 
seconds, 5 seconds off until 
15 seconds per foot 
As quickly as 
possible 
Stair Climbing (sideways) 
Pyramid Starting from 45 
seconds, 15 seconds off 
until 15 seconds per foot 
As quickly as 
possible 
Seated Discus Torso Rotation with Press 2 20 
20 each side, ensure 
back stays straight 
REST 1 minute 
Fast feet over rope (Fwd/Sdw Pyramid) 
Start at 60s and work down 
by 10 sec until 20 sec per 
movement 
Complete the whole 
pyramid without a 
break 
Step-touch (both ways) 1 x 45s Complete as a 
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superset 
Step and Slide (both ways) 1 x 45s 
Complete as a 
superset 
Air Squat with Alternating Bum Kick 1 x 45s 
Complete as a 
superset 
Lunge (Big Step) 1 x 45s 
Complete as a 
superset 
Stretch – Hamstrings and Gluts 2 x 20s each leg 
GET RPE SCORES FROM EACH PERSON 
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Subject Name & Surname:           
Subject Code:       Group:      
Date of Testing:      Time of Testing:    
 
 
1. What did you enjoy most about the program? 
              
              
              
              
              
 
2. What were some of the barriers to participating in the program or improvements you could 
suggest? 
              
              
              
              
              
 
3. Would you recommend the program to friends and/or family that have Type 2 Diabetes? 
 
Yes   No 
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4. Your comments/thoughts on the exercise sessions? 
              
              
              
              
              
              
 
5. Your comments/thoughts on the dietician sessions? 
              
              
              
              
              
             
 
6. Your comments/thoughts on the psychology sessions? 
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Appendix L – Participant Post-Intervention Guide 
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Perform any of the three programs below at least 3 times per week, either individually or in a group. The 
first block in the programs gives the name of the exercise, as well as a picture showing how the exercise is 
performed. The second block gives an indication of the number of sets (E.g. 2 or 3), and repetitions (E.g. 
10 or 15) that need to be performed for the specific exercise. The third block gives a short description of 
the most important aspects of the specific exercise. 
 
 
Easy Exercise Program 
Warm Up Do a brisk walk around the block for approximately 10 minutes. 









 Sit upright on the 
edge of a chair. 
 Straighten your one 
leg diagonally 
outward, touching the 
floor with your heel. 
 Return to the start and 
repeat on the opposite 
leg. 








 Sit upright on the edge of 
a chair. 
 Lift your one leg off the 
ground, keeping your 
knee bent. 
 Return to the start and 
repeat on the opposite leg. 








 Sit upright on the 
edge of a chair. 
 Straighten one leg, 
and then swing it out 
to the side while 
keeping it straight. 
 Return to the start and 
repeat on the opposite 
leg. 
 








 Sit upright on the edge of 
a chair and place a 
band/rope around your 
knees. 
 Open your knees to 
tighten the band/rope and 
hold this position for 5 
seconds. 
e) Weighted Shoulder Press 









 Sit upright on the 
edge of a chair with a 
weight in one hand. 
 Push the weight 
directly up above your 
head. 
 Complete the 
repetitions on the one 
arm before changing. 
 


















 Place a rope on the floor 
in front of you. 
 Perform fast-feet jumps 
forward, sideways and 
forwards again for the 
required time. 








 From a standing 
position, sit half-way 
towards a chair. 
 Hold this position for 
10 seconds, ensuring 
that your back 
remains straight. 













 Stand on one leg, either 
with or without assistance 
for the required time 
period. 
 Perform the exercise on 
each leg, with both eyes 
open and closed. 
PART A – EXERCISE PROGRAMS 
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Moderate Exercise Program 
Warm Up Do a brisk walk around the block for approximately 15 minutes, incorporating some easy hills. 


















 Place a rope on the 
floor in front of you. 




forwards again for the 
required time. 









 Place a band or rope 
around your knees while 
seated and ensure that it 
remains taught throughout 
the exercise. 
 Perform standard sit-to-
stands, while ensuring the 
band remains taught and 
does not fall down. 


















 Place a rope on the 
floor in front of you. 




forwards again for the 
required time. 













 Perform a step up/stair 
climbing on one step, 
both forward and 
sideways for the required 
time period. 
 Change the leading foot 
every 25 seconds. 








 Perform 10 standard 
calf raises. 
 Hold the last 5 
repetitions for 10 
seconds each. 
 


















 Place a rope on the floor 
in front of you. 
 Perform fast-feet jumps 
forward, sideways, 
forwards, sideways and 
forwards again for the 
required time. 









 Lie on your back with 
your knees bent and 
feet flat on the floor. 
 Slowly lift your hips 
towards the ceiling, 
and return to the 
ground. 







 Lie on your back with your 
knees bent and feet flat on 
the floor. 
 Lift one leg, then the other 
in the air so that if forms a 
“table top” with your 
lower leg. 








 Lie on your back with 
your knees bent and 
feet flat on the floor. 
 Lift one leg to the 
table top position. 
 Push your hips up 
towards the ceiling 
using the foot that is 
on the ground. 













 Sit upright on the edge of a 
chair. 
 Straighten your one leg 
and try and touch your 
toes. 
 Hold this position for 20 
seconds before 
performing the stretch on 
the opposite leg. 
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Difficult Exercise Program 
Warm Up 
Do a brisk walk around the block for approximately 15 minutes, incorporating a combination of easy 
and difficult hills. 


















 Place a rope on the 
floor in front of you. 




forwards again for the 
required time. 
b) Standing Hip 









 Stand upright while 
supporting yourself on a 
chair. 
 While keeping your back 
straight, take the one leg 
out to the side, and then 
straight behind you. 
 Complete the 15 
repetitions before 









 Make sure that you 
take a big enough step 
that the knee doesn’t 
pass over your toes. 
 Alternate between 
legs during this 
exercise. 













 Perform a step up/stair 
climbing on one step, 
both forward and 
sideways for the required 
time period. 
 Change the leading foot 
every 45 seconds. 


















 Place a rope on the 
floor in front of you. 




forwards again for the 
required time. 










 Sit upright on the edge of 
a chair. 
 While holding a weight, 
rotate your upper body to 
the one side, followed by 
and upward press, then 
rotation to the other side. 



















 Place a rope on the 
floor in front of you. 




forwards again for the 
required time. 









 Lie on your back with your 
knees bent and feet flat on 
the floor. 
 Lift one leg, then the other 
in the air so that if forms a 
“table top” with your 
lower leg. 


















 Place a rope on the 
floor in front of you. 




forwards again for the 
required time. 














 Sit upright on the edge of a 
chair. 
 Straighten your one leg 
and try and touch your 
toes. 
 Hold this position for 20 
seconds before 
performing the stretch on 
the opposite leg. 
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Food Group Examples Role in the Body Portion Size 
Carbohydrate 
Rice, potato, bread, 
pasta, porridge, etc. 
Provides energy for the 
body. 
Size of a closed fist. 
Protein 
Beef, cheese, chicken, 
eggs, milk, etc. 
Helps with building cells 
in the body. 
Size of your palm. 
Fat 
Avocado, nuts, butter, 
etc. 
Helps with 
thermoregulation and the 
transport of minerals and 
vitamins. 
Size of your thumb. 
Fruits 
Apple, orange, pear, 
banana, kiwi, etc. 
Provides us with 
vitamins and minerals to 
keep us healthy. 
Size of a closed fist. 
Vegetables 
Carrots, broccoli, 
pumpkin, cabbage, etc. 
Provides us with 
vitamins and minerals to 
keep us healthy. 
Size of two palms. 
 











PART B – DIETARY GUIDELINES 
Low: 
< 4.0 mmol/L 
Good: 
4.0 – 7.0 mmol/L 
Bad: 
> 7.0 mmol/L 
1 x Fruit 
1 x Cup Oats 
1 x Cup Low Fat 
Milk 
1 x Palm Size Piece 
of Meat 
1 x Slice Low GI 
Bread 
1 x Cup Veg/Salad 
1 x Palm Size Piece 
of Meat 
½ Cup Rice 
½ Cup Veg/Salad 
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Our motivation to eat well and exercise regularly is linked to the way we think, our emotions, our stressors, 
and the support we get from those around us. Changing life-long habits of eating and exercising is a tough 
job! Congratulations for taking the first step by participating in the Type II Diabetes program. Here are some 
tips to help you when the going gets tough and you need some inspiration to carry on: 
 Remember that social and emotional support is crucial!  
 Educate your family and friends about your Diabetes and ask them to help you stay on track.  
 Set up a regular meeting with others who have the same struggles as you, so that you can celebrate 
your achievements together, and laugh or cry about your struggles without judgement.  We are social 
creatures – don’t try to do it alone!  
 Stress contributes to illness and eats away at our motivation! Talking about our stresses and anxieties 
makes them easier to deal with.   
 Set up a regular schedule for exercise and ask others to exercise with you. Support each other by 
insisting that you all come to exercise sessions. You are more likely to do the exercise this way, and 
more likely to enjoy it! 
 Start up an informal gathering of people from the program. Meet for tea once a week or twice a 
month to support each other. Invite others who struggle with Diabetes to join you and inspire them to 
diet and exercise too. 
 Remind yourself why you have taken the challenge to become healthier. Is it to live longer for your 
grandchildren, to keep your body as a temple, or to feel more comfortable? Use your answer to keep 
yourself motivated! 
 Ask yourself, what is it that makes it difficult to control my sugar levels? How can I try to overcome 
this? What works for others may not work for you – you need to find your own unique plan. 
 When you struggle to feel motivated to exercise, imagine how you know you will feel afterwards! 
 Be kind to yourself. If you get off track with diet or exercise, don’t be too hard on yourself. No one is 
perfect. Pat yourself on the shoulder for trying, and remember that change doesn’t happen overnight. The 
fact that you are actively attempting to maintain healthy behaviors is a step in the right direction. It’s 
okay to admit that it’s hard - because it is. Carrying on in spite of the many difficulties you face it is 
what counts.  
 Take a moment to ponder the following thoughts: Think about how hard it felt when you started 
the exercise routine. Think about how good it felt when you actually 'survived' it. Think about how, 
surprisingly, you felt positive change effects in your body as a result of your training. Moral of the story: 
it’s not easy - but it’s worth it. 
PART C – LIFESTYLE TIPS 
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